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Summary
This work concerns the identification of the information controlling the 
accumulation of the influenza virus nucleoprotein (NP) in the nuclei of 
Xenopus oocytes.
The NP accumulates in the nuclei of Xenopus oocytes whether introduced 
into the oocytes as the protein itself or encoded in RNA or DNA. Since 
no other influenza virus components are present in the oocytes injected 
with DNA, this accumulation appears to be a property of the NP itself.
In vitro mutagenesis of the cloned NP cDNA has then been used to 
identify which regions of the protein are important in its nuclear 
accumulation. Mutant proteins lacking amino acids 327-345 of wild-type 
NP enter the nucleus but do not accumulate there to the same extent as 
the wild-type protein, suggesting that this region has a role in nuclear 
accumulation. This proposed location is strengthened by studies 
involving the production of fusion proteins in which various amino- 
terminal sequences of the NP gene are fused to the complete chimpanzee 
<*-j-globin sequence: when globin cDNA is injected into and expressed in 
oocytes the protein remains in the cytosol, however when the globin cDNA 
is fused to a portion of NP cDNA which includes the region encoding 
amino acids 327-345 the resulting fusion protein enters and accumulates 
in the nucleus. Fusion proteins lacking this region of the NP enter but 
do not accumulate in the nucleus.
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31. Preamble
The eukaryotic cell can be envisaged as a collection of membrane- 
delimited compartments surrounded by a plasma membrane. These 
compartments include the endoplasmic reticulum (ER), Golgi apparatus, 
mitochondria, nucleus and a variety of other organelles whose presence 
depends on the cell type. Each compartment contains a characteristic 
complement of proteins which, apart from the few that are synthesised in 
the mitochondria, the chloroplasts and (controversially) nuclei, all 
begin being synthesised in the cytosol. It is therefore necessary for 
these proteins to be transported from the cytosol to their final 
destination and this transport necessitates the crossing of at least one 
cellular membrane. In the last 15 years a great deal of work has led to 
many insights into the mechanisms of these transmembrane movements and 
such studies represent one of the few research areas where scientists 
using prokaryotic and eukaryotic systems co-operate, eukaryotic studies 
leading the way in biochemistry and prokaryotic studies leading the way 
in genetics. I would like to begin by discussing the translocation 
mechanisms in eukaryotic cells and for recent reviews of these processes 
see Davis and Tai (1980); Kreil (1981); Lodish et al_. (1981); Meyer 
(1982 ); Sabatini e_t al^ . (1982 ); Strauss and Boime (1982); De Robertis 
(1983) and Silhavy et al. (1983).
42. The Endoplasmic Reticulum
The secretory pathway was outlined in a series of experiments by Palade 
and co-workers (see Palade, 1975). Secretory proteins are synthesised 
in association with the rough endoplasmic reticulum (RER) (Siekevitz and 
Palade, 1960) before being immediately segregated into the lumen of this 
organelle (Redman e£ a_l., 1966) and subsequently transported out of the 
cell via the Golgi apparatus and secretory vesicles/granules (Jamieson 
and Palade, 1967a, 1967b). After the elucidation of this pathway 
studies of the transport at the molecular level were initiated and led 
to the formulation of the signal hypothesis (Blobel and Sabatini, 1971). 
In the ensuing years this hypothesis has been extended and modified to 
encompass subsequent findings (see Figures 1, 2 and 3). Present beliefs 
are as follows:
1. Like all proteins synthesised in the cytosol the translation of 
secretory proteins is initiated on free ribosomes.
2. Translation proceeds until 10 to 40 amino acids of the nascent chain 
have emerged from the ribosome. At this point the translation of 
secretory and non-secretory proteins differ (Figure la).
3. In secretory proteins there is a specialised amino-terminal signal 
sequence which directs the binding of a 250,000 dalton RNA/protein 
complex called signal recognition particle (SRP) (Walter and Blobel,
1981). This complex is cytoplasmic in location and may already be 
attached to ribosomes (Meyer et a[., 1982a). The binding of this 
complex stops the translation of the secretory mRNA.
5Figure 1 A model of the role of a transient amino-terminal signal 
sequence in the biosynthesis of secretory proteins and 
certain integral membrane proteins
The amino-terminal signal sequence emerges from the ribosome (a) and 
interacts with the ER membrane leading to ribosome attachment and 
passage of the nascent chain through the membrane (b). The signal 
sequence is removed by a membrane-associated signal peptidase (c) which 
leads to the complete translocation of secretory proteins into the ER 
lumen (d). In transmembrane proteins such as the G protein of vesicular 
stomatitis virus translocation is stopped by the presence of a stop 
transfer sequence (e).
I
4. The translation block persists until the ribosome-SRP-nascent chain 
complex contacts the RER and binds to an ER specific membrane 
protein called the docking protein (Meyer and Dobberstein, 1980a, 
1980b; Meyer e£ al^ ., 1982b). This protein releases the block 
(Meyer e_t al^ ., 1982a), translation resumes and translocation begins 
(Figure lb). The SRP and docking protein dissociate from the 
translational complex almost immediately.
5. During translocatin, or soon afterwards, the signal sequence is 
removed by a specific protease called signal peptidase (Figures lc 
and Id).
There are still many questions that remain unanswered concerning some of 
the details in this process, the main area of debate being the actual 
movement of the protein through the membrane. The original signal 
hypothesis predicted the involvement of membrane proteins in the 
formation of a pore (Blobel and Dobberstein, 1975a, 1975b). Possible 
candidates for these proteins are two glycoproteins (65,000 and 63,000 
daltons) which are prsent in the RER but are apparently absent in smooth 
membranes (Kreibich e£ a^. , 1978a). Since these proteins, termed 
ribophorins, can be cross-linked to ribosomes (Kreibich et al., 1978b) 
it has been suggested that they play a role in the binding of the 
ribosome to the RER. However, smooth ER and RER are equivalent with 
respect to their _in vitro binding of polysomes bearing nascent chains 
(Bielinska e£^  a_l., 1979) and these workers also showed that the isolated 
smooth ER is capable of efficiently translocating and processing 
secretory polypeptides.
7Alternative models, which do not involve membrane proteins mediating the 
transport of the growing chain, include the 'helical hairpin hypothesis' 
(Engelman and Steitz, 1981) and the 'direct transfer hypothesis' (von 
Heijne and Blomberg, 1979; von Heijne, 1980).
a
As often happens, even with^good hypothesis, there are exceptions and at 
least one secretory protein, ovalbumin, does not contain a cleavable 
signal sequence (Palmiter ££ £l., 1978; Chambón et al., 1979). It is 
hypothesised that there is an uncleaved signal sequence but there is 
conflicting evidence regarding its position, claims being made for both 
a central (Lingappa eit a_l^. , 1978, 1979) and an ami no-terminal location 
(Braell and Lodish, 1982a, 1982b; Meek £t^  al., 1982; Tabe et al.,
1984), although not extending to the extreme amino terminus. An 
uncleaved signal sequence is also found with neuraminidase, a 
transmembrane protein (Davis et al., 1983; Markoff e£ al., 1984), and 
translocation without cleavage has been reported in an in vitro system 
using the ER of isolated rat pituitaries and preprolactin containing the 
threonine analogue /3-hydroxy-norvaline (Hortin and Boime, 1981).
The ovalbumin data illustrates a further modification of the original 
signal hypothesis and this involves the transport of the nascent chain 
through the membrane. The original hypothesis envisaged that transport 
occurred in a threadlike manner but the ovalbumin results suggest that 
insertion must occur via a looped formation. These results, and 
observations on the final disposition of various transmembrane proteins, 
have also prompted the formulation of alternative models to accomodate 
the insertion of looped polypeptides into and through the ER membrane 
(von Heijne and Blomberg, 1979; Wickner, 1980; Engelman and Steitz,
wmmmmmammm
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1981 ). In these models a looped method of insertion has been evoked on 
the basis of a postulated interaction between the amino-terminal amino 
acids of the proteins to be transported and the cytoplasmic side of the 
ER membrane (von Heijne and Blomberg, 1979), or as a means of generating 
favourable free energies for transfer (Engelman and Steitz, 1981).
Although originally proposed for the translocation of secretory proteins 
several lines of evidence indicate that the signal hypothesis and 
associated pathway is also relevant to the transport of most integral 
membrane proteins of the ER and the plasma membrane. For example, yeast 
mutants defective in protein secretion are also defective in the 
incorporation of certain proteins into the cytoplasmic membrane (Novick 
and Schekman, 1979). During the synthesis of most membrane proteins, 
for example the glycoprotein (G) of vesicular stomatitis virus (for 
review see Lodish and Rothman, 1979), the co-translational translocation 
through the ER membrane is incomplete and the protein remains anchored 
in the membrane by a short sequence of 20 to 25 hydrophobic amino acids 
(see Figure 1). This stretch of hydrophobic residues is termed the stop 
transfer sequence (Blobel, 1980).
As with secretory proteins (e.g. ovalbumin) some integral membrane 
proteins are synthesised without cleavable signal peptides but are 
translocated into the ER membrane co-translationally (Figure 2c). These 
include the ER integral membrane proteins cytochrome P450 (Haugen e_t 
al., 1977; Bar-Nun et^  al^ . , 1980; Kumar and Pamanaban, 1980) and 
epoxide hydratase (Gonzalez and Kasper, 1980).
Each of the transmerabrane proteins described above are simlar in that
f  '
m
Figure 2 A model of the role of internal permanent signal sequences
in the biosynthesis of secretory proteins and certain 
integral membrane proteins
The affinity of the signal sequence (|) for the membrane (a and b) may 
be overcome by interaction with another portion of the polypeptide ($) 
(d) which facilitates passage of the entire molecule through the 
membrane (f) unless translocation is interrupted by a stop transfer 
sequence (e). The protein may remain embedded in the membrane by the 
signal sequence (c) in which case the topology is the same as that in 
Figure 3c except that a larger portion of the amino terminus is located 
on the cytosolic side of the membrane.
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they span the membrane once with their carboxyl terminus in the cytosol. 
Some proteins, for example the influenza virus neuraminidase (Blok et 
> 1982) and the intestinal brush border aminopeptidase (Maroux and 
Louvrd, 1976 ) and isomaltase (Brunner et al., 1979), are orientated with 
their amino termini in the cytosol. These proteins are inserted into 
the membrane co— translationa1ly, but have signal sequences which are not 
cleaved and are not situated at the extreme amino terminus (Figures 2c 
and 3). They are therefore similar to ovalbumin except that 
translocation is incomplete and they are retained in the membrane, 
usually by the signal sequence. Such sequences have been termed 
"extended signal sequences" (Frank e£ a_l., 1978; Blobel, 1980).
The erythrocyte anion transport protein (Band III) is co-translationally 
inserted into membranes (Braell and Lodish, 1981, 1982a, 1982b) and 
spans the membrane at least twice (Steck e_t a K , 1976; Drickamer, 1977; 
Rao and Reithmeier, 1979; Williams e£ a K , 1979). Such a topology can 
be explained by proposing multiple signal sequences and stop transfer 
sequences within a single polypeptide (Figure 3).
All of the integral membrane proteins discussed so far are co- 
translationally inserted into the ER membrane, although some are 
synthesised without a cleavable signal sequence. In contrast, 
cytochrome b5 (Krieter and Shires, 1980; Rachubinski e£ al^ ., 1980) and 
NADH-cytochrome b5 reductase (Borghese and Gaetani, 1980) are 
synthesised on free polyribosomes and inserted into the membrane post- 
translationally. Both proteins are anchored by a hydrophobic portion at 
the carboxyl termini with the remainder of the protein in the cytosol.
The fact that these proteins become inserted into a variety of cellular
11
Figure 3 A model of the roles of permanent sequences in the
biosythesis of a variety of incegral membrane proteins
The amino-terminal signal sequence emerges from the ribosome (a), 
interacts with the ER membrane and directs the initiation of 
translocation (b). In the absence of cleavage of the signal sequence 
the protein remains in the membrane with most of the protein on the 
luminal side of the membrane (c), e.g. neuraminidase. If the protein 
contains a stop transfer sequence then it will span the membrane twice 
with both termini on the cytosolic side of the membrane (d). A third 
crossing of the membrane may occur if the stop transfer sequence is 
followed by an interior signal sequence Ce-h). Multiple crossings may 
be generated by alternating interior signal sequences and stop transfer 
sequences, and the location of the carboxyl terminus depends on whether 
the last transmembrane signal was a signal sequence or a stop transfer
sequence.
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membranes and bind Co natural and synthetic membranes j^ n vitro suggests 
their insertion is not wholly specific. Such post-translational 
insertion has led to the formulation of the 'membrane triggering 
hypothesis' (Wickner, 1979, 1980). Here it is envisaged that the fully 
folded protein is conformational ly changed by association with the 
correct cellular membrane so that it can cross or become inserted into 
the membrane. In those proteins containing cleavable signal sequences 
it is thought that the sequence is important in the correct folding of 
the protein and its removal is seen as making the membrane interaction 
irreversible.
From the above 
occur via many 
same location, 
transport into
discussion it is obvious that compartmentalisation can 
different pathways, even for proteins destined for the 
Similar conclusions resulted from the study of protein 
cellular organelles.
3. Mitochondria
Mitochondria possess four compartments, the matrix, the inner membrane, 
the intermembrane space and the outer membrane. The transport of 
proteins into these various compartments has recently been reviewed 
(Neupert and Schatz, 1981; Schatz and Butow, 1983) and the major 
findings are outlined below.
Most of the proteins synthesised in the cytosol and destined for the 
matrix and the inner membrane of the mitochondrion share common 
biosynthetic pathways. Following their complete synthesis on free 
polyribosomes the proteins exist in the cytosol as precursors with 
amino-terraina1 extensions (see, for example Neupert and Schatz, 1981). 
The size of the extension varies considerably among different precursors 
and is usually much longer than the corresponding prepeptide of 
secretory proteins. For example, the extension of the ATPase 
proteolipid subunit of Neurospora crassa has 66 amino acids (Viebrock et 
al., 1982). The precursors appear to bind to receptors on the 
cytoplasmic face of mitochondria (Henning and Neupert, 1981; Zimmerman 
et al., 1981) and are transported to their intra-mitochondrial location. 
Little is known about the transport mechanism but it requires an 
electrochemical potential across the mitochondrial inner membrane 
(Gasser ^t aj^., 1982; Schleyer et^  al_. , 1982), and this could labilise 
the lipid bilayer (Komor et al., 1979) and facilitate transport via the 
formation of inverted lipid micelles (Cullis and De Kruijff, 1979).
Once at their destination the precursors are converted to their mature 
forms by a protease located in the matrix (Bohni ££ a^. , 1980; Mori et_ 
al., 1980; McAda and Douglas, 1982). Some proteins, for example the
*adenine nucleotide translocator of the inner membrane (Zimmerman and 
Neupert, 1980), are synthesised without a cleavable amino-terminal 
extension but the precursors appear to be conformationally different to 
the mature proteins.
Transport to the intermembrane space is more complicated than import 
into the matrix-inner membrane compartment and several mechanisms exist. 
Cytochrome b2 for example, is synthesised as a 68,000 dalton precursor 
which is transported across both mitochondrial membranes before being 
cleaved to an intermediate form (MW = 65,000) by the matrix protease.
This intermediate, which probably spans the inner membrane with its bulk 
in the intermembrane space, is then further cleaved by a second protease 
to release the mature protein (MW = 58,000) into the soluble 
intermembrane space ( Daum e_t a^., 1982; Gasser ^t a_l., 1982). Not all
intermembrane space proteins are transported by a two-step pathway 
however and both adenylate kinase (Watanabe and Kuba, 1982) and the 
heme-free apoprotein of cytochrome C (Zitoraer and Hall, 1976; Zimmerman 
et al., 1979) are imported without proteolytic cleavage.
Proteins to be imported into the mitochondrial outer membrane are not 
synthesised as precursors and their transport does not require an 
energised inner membrane (Freitag e^ al^ . , 1982).
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4. Chloroplasts
It appears that all cytoplasmica1ly synthesised chloroplast proteins 
share the same biosynthetic pathway regardless of their final
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destination (for a review of the structure of chloroplasts see Chua and 
Schmidt, 1979). All of the proteins studied to date are synthesised 
with amino-terminal extensions ("transit peptides") which are removed 
during or soon after their post-translational import into the 
chloroplast. These include the small subunit of ribulose 1,5— 
bisphosphate carboxylase (Roy e£ a_l., 1976; Dobberstein ^t a^., 1977; 
Highfield and Ellis, 1978), the 5 subunit of the proton translocating 
ATPase complex (Nelson et al^ . , 1980) and two apoproteins of the pea 
light harvesting chlorophyll a/b protein complex (Cashmore e^ a K , 1978; 
Schmidt e£ a_l., 1979a, 1979b; Grossman £t_ al^ . , 1980). The transit 
peptide is different from the signal sequence of secretory and integral 
membrane proteins as it is generally longer, more hydrophilic and has no 
long clusters of hydrophobic residues (Palmiter, 1977; Schmidt ££ al. , 
1979b). As in some mitochondrial proteins the transit peptide may be 
cleaved in two stages (C. Robinson and R. J. Ellis, submitted for 
publication).
Although the above sections imply that protein transport into 
mitochondria and chloroplasts is post-translational, the demonstration 
of cytoplasmic ribosomes on the outer membrane of yeast mitochondria 
(Kellems et a_l., 1974, 1975) led to suggestions that co-translational 
transport may also take place. Indeed if the rate of protein synthesis 
in yeast spheroplasts is reduced by the addition of cycloheximide these 
mitochondria associated ribosomes are enriched in mRNA encoding for 
some, but not all, mitochondrial proteins (Kellems e£ a_l., 1974, 1975; 
Ades and Butow, 1980; Suissa and Schatz, 1982). No ribosomes have yet 
been demonstrated on the outer membrane of chloroplasts (Gunning and 
Steer, 1975).
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5. Lysosomes
Lysosomal enzymes follow similar biosynthetic routes to the majority of 
secretory and membrane proteins (for review see Hasilik, 1980 and 
Neufeld and Ashwell, 1980). The pathways seem to diverge at the Golgi
/
apparatus where the majority of lysosomal enzymes are routed to the 
lysosomes. However, some enzymes are directed to the lysosomes after 
being secreted and endocytosed. The signals involved in directing 
lysosomal enzymes to lysosomes are discussed in a later section of the 
introduction.
6. Peroxisomes
Although these membrane enclosed organelles seem to form by budding of 
the ER at least two of the enzymes, catalase and uricase, are 
synthesised on free ribosomes and therefore seem to be, but have not yet 
been shown to be, incorporated post-translationally (Goldman and Blobel, 
1978; Robbi and Lazarow, 1978). It is not known if these proteins are 
synthesised as larger precursors. The situation is therefore somewhat 
similar to plant glyoxysomes where malate dehydrogenase is incorporaed 
post-translationally after being synthesised as a larger precursor 
(Kawajiri et al., 1972).
17. Nuclei
The majority (possibly all) of nuclear proteins are synthesised in the 
cytoplasm and are transported into the nucleus post-translationally with 
no detectable modification of the protein (Gurdon, 1970; Bonner, 1975a, 
1975b; De Robertis e_t al^ ., 1978; Dabauvalle and Franke, 1982;
Dingwall et_ a^., 1982 ). The nucleus is different to the organelles 
discussed above since it is possible that the proteins do not cross 
membranes as such but pass through holes ('nuclear pores') in the 
nuclear envelope.

The above section has gone some way to describing the mechanisms by 
which proteins are transported into or across cellular membranes. This 
section deals with how these proteins are targeted towards the membranes 
prior to the initial interaction and also how, where relevant, post- 
translocational transport is controlled. The collective term 
'topogenesis' was introduced to describe these targeting procedures 
(Blobel, 1980). Blobel proposed that the information for intracellular 
topogenesis resides in discrete topogenic sequences that constitute a 
permanent or transient part of the polypeptide chain. The number of 
distinct topogenic sequences has been predicted to be relatively small 
since many different proteins would be targeted to the same 
intracellular location (i.e. topologically equivalent). Four types of 
topogenic sequence have been postulated (Blobel, 1980):
1 . Signal sequences
A signal sequence is classically defined as a short stretch (""15-30) of 
hydrophobic amino acids which are transiently located at the amino 
terminus of secretory or integral membrane proteins, and direct the 
vectorial transfer of the polypeptide into or across membranes. For a 
recent compilation of published signal sequences see Watson (1984). The 
structure, function and processing of these signals have also been 
reviewed (Wickner, 1980; Kreil, 1981; Michaelis and Beckwith, 1982). 
Although the majority of signal sequences conform to this description, 
in several cases they are neither cleavable (Bos e^ al^ . , 1984; Julius 
et al., 1984) nor located at the extreme amino terminus (e.g. ovalbumin
1
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and neuraminidase see earlier).
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Proteins which are transported across two membrane bilayers into 
mitochondria and chloroplasts have also been found to have transient 
amino-terminal regions (Blobel, 1980; Neupert and Schatz, 1981; Schatz 
and Butow, 1983). Although these can be considered as signal sequences 
they are different to those involved in translocation into and across 
the ER membrane being generally longer and more hydrophilic. These 
differences are not surprising since they must be clearly distinguished 
from the 'export' signal sequences and because their transport is 
initiated only after translation is complete. It is not possible to 
describe a general structure for the signal sequences of mitochondrial 
and chloroplast proteins since only a small sample is available and 
different sequences may be responsible for the targeting of the proteins 
to the different intra-organellar compartments.
The transport of proteins into nuclei can also be considered to be 
controlled by a signal sequence (De Robertis e£ £l^ . , 1978; De Robertis, 
1983) but, as discussed in more detail elsewhere in the thesis, these 
sequences are permanent, not necessarily amino-terminal and function 
pos t-translat iona1ly.
2. Stop transfer sequences
These hydrophobic sequences interrupt the translocation process that was 
previously initiated by a signal sequence and result in the asymmetric 
integration of proteins into membranes (Lingappa et a 1. , 1978).
3. Insertion sequences
These sequences interact directly with the lipid bilayer and result in 
the anchoring of the protein in the membrane.
4. Sorting sequences
These sequences act as determinants for the post-translational movement 
of proteins from their original site of membrane translocation to their 
final destination. Proteins with an identical destination may share the 
same sorting sequences. The most significant site of origin of proteins 
for post-translocational transport is the ER, which probably supplies 
proteins to essentially all of the intracellular organelles derived from 
the ER and also to the plasma membrane (Palade, 1975). Of the four 
topogenic sequences this is the one for which there is least data and 
most speculation.
Some sorting sequences are mediated via oligosaccharide side chains.
All of the proteins which are inserted through the ER membrane have one 
or more oligosaccharide side chains added and there are specific 
instances where the carbohydrate moiety plays an important role in the 
targeting of proteins to specific destinations. The best example is the 
phosphomannose recognition system of lysosomal enzymes (for review see 
Neufeld and Ashwell, 1980).
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During their transport through the Golgi apparatus lysosomal enzymes 
acquire mannose-6-phosphate residues by a two-step reaction (Waheed et 
al. , 1981b; Pohlman et: , 1982; Goldberg and Kornfeld, 1983 ). The
first step is the addition of N-acetylglucosamine-l-phosphate to the C6 
hydroxyl position of one or two mannose residues (Varki and Kornfeld, 
1980b; Hasilik et^  a_l., 1981; Reitman and Kornfeld, 1981). The enzyme 
responsible for this reaction appears to recognise both the carbohydrate 
and protein moieties (Waheed e£ a_l., 1982), suggesting that there may be 
a common protein sorting sequence in lysosomal enzymes (Fischer et al^ . , 
1980; Waheed £t a_l. , 1982). In the second step the mannose-6-phosphate 
residues are exposed (Varki and Kornfeld, 1980a, 1981; Waheed ££ al., 
1981a). This results in a specific interaction with a mannose—6— 
phosphate receptor in the Golgi apparatus which leads to sequestration 
of the lysosomal enzymes and ultimately their transport to lysosomes 
(Fischer ££ al_., 1980; Varki and Kornfeld, 1981). Failure to add the 
recognition marker to lysosomal enzymes, as in I-cell disease (Hasilik 
and Neufeld, 1980; Hasilik ££ a^., 1981; Reitman et al^ ., 1981), leads 
to the secretion of recognition defective enzymes (Hickman e£ al.,
1974). Thus although localisation is mediated via mannose-6-phosphate 
residues the information appears to ultimately reside in a sorting 
sequence within the enzyme. This sequence has not been identified.
The biosynthetic pathways of lysosomal enzymes and 'export' proteins 
diverge at the Golgi apparatus and it has been suggested that this 
organelle, at which all glycoproteins seem to spend some time, plays an 
important role in directing many proteins to their final destinations 
(Palade, 1975; Tartakoff, 1980; Farquhar and Palade, 1981; Rothman e_t 
al., 1981). Indeed, in the case of secretory proteins, there is now
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direct evidence for two distinct pathways which probably diverge at the 
Golgi apparatus and are presumably controlled by sorting sequences 
(Gumbiner and Kelly, 1982). The first pathway, which occurs in most, if 
not all, cell types, mediates an apparently continuous and non- 
concentrative exocytosis of secretory proteins while in the second 
pathway newly synthesised glycoproteins are concentrated and stored in 
intracellular granules. These granules can be induced to fuse with the 
plasma membrane by specific secretagogue stimuli. The information 
controlling these pathways is currently being investigated by Kelly and 
co-workers.
The transport of lysosomal enzymes from the Golgi apparatus to lysosomes 
appears to occur via clathrin-coated vesicles (Friend and Farquhar,
1967; Nichols e£ al^ ., 1971; Campbell and Rome, 1983; Campbell ££ al. , 
1983). These vesicles also appear involved in the intracellular 
transport of proteins from the RER to the Golgi body (Palade and 
Fletcher, 1977), through the Golgi apparatus (Palade, 1975; Rothman and 
Fine, 1980; Rothman e£ a_l., 1980; Farquhar, 1981; Rothman, 1981), and 
from the Golgi body to the plasma membrane (see Brown et al., 1983).
They are also involved in protein transport in the opposite direction, 
i.e. the uptake of proteins from the extracellular medium (receptor 
mediated endocytosis) (for reviews see Goldstein et a_l., 1979; Pastan 
and Willingham, 1981). It seems therefore that coated vesicles play a 
central role in the transport of glycoproteins through the cytoplasm and 
in order for them to perform this role effectively they must also play a 
part in directing proteins to specific organelles. In view of this, it 
has been suggested that coated vesicles may be involved in sorting 
(Pearse and Bretscher, 1981; Rothman e£ a_l., 1981). Proteins with the
2correct sorting sequence would presumably be recognised by a specific 
receptor protein, either in the lumen of the RER or the Golgi apparatus 
or at the plasma membrane, and taken up into a coated vesicle. After 
uncoating, the vesicle is directed to a specific organelle by means of a 
second signal on its cytoplasmic surface. This targeting may be 
mediated through random interactions between the vesicles and target 
organelles (Rothman e£ a_l., 1981), which would require a 'docking' 
protein in the membrane of the target organelle, or it may be achieved 
by the vesicles being directly targeted to specific organelles by some 
sort of 'tram-line' system (Jamieson, 1981; Pastan and Willingham,
1983; Wehland and Willingham, 1983). Although this targeting is 
presumably controlled by sorting signals within the proteins they remain
unidentified.
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If topogenic sequences are defined stretches of amino acids within a 
polypeptide chain then mutation of this region should alter the fate of 
the protein. Most of the experiments of this type have been performed 
using bacteria and so before describing these experiments I will briefly 
describe the protein localisation mechanisms in bacteria. For reviews 
of bacterial transport and its manipulation see Emr et al. (1980a, 
1980b), Kreil (1981), Michaelis and Beckwith (1982) and Silhavy e£ al. 
(1983 ).
1. Protein transport in bacteria
The cytosol of Escherichia co1i is bounded by two membranes which define 
three extra-cytoplasmic compartments; the inner membrane, the outer 
membrane and the intermembrane or periplasmic space. Most proteins 
destined for these compartments are synthesised on membrane-bound 
ribosomes as precursors with amino-terminal extensions which are removed 
during or soon after their co-translation translocation (Canceeda and 
Schlessinger, 1974; Randall and Hardy, 1977; Smith e_t a_l. , 1977, 1979, 
1980). This similarity with the eukaryotic signal hypothesis extends 
even to allowing interchangeability between the systems, eukaryotic 
proteins being processed and exported from prokaryotic cells (Fraser and 
Bruce, 1978; Talmadge e_t al^ ., 1980 ) and prokaryotic proteins being 
processed by eukaryotic membranes ijrt vitro (Roggenkamp et al., 1981; 
Muller ££ a_l. , 1982 ). Evidence regarding pos t-trans la t iona 1 transport 
in prokaryotes is contradictory. For example, although the /9-lactamase 
precursor can be found in the cytosol (Koshland and Botstein, 1980) the
proposed post-translational transport to the periplasmic space is 
difficult to reconcile with results obtained from in vitro systems 
derived from eukaryotes (Muller et^  a^., 1982) and also with results 
obtained using fusion proteins (Talmadge et al^., 1980) and mutation 
analysis (Koshland and Botstein, 1980; Koshland et a^. , 1982). Even in 
in vitro systems derived from prokaryotes, membrane vesicles must be 
added very early to observe any transport (Goodman et a_K , 1981 ; Watts 
et al., 1981). A possible explanation is provided by the recent work of 
Randall (1983) who showed that, although transport proteins are 
synthesised in association with membranes, the time at which they are 
transported is variable. Some proteins are transported in a co- 
translational manner analogous to the eukaryotic situation while others 
are only transported when all or nearly all of the protein has been 
produced.
Although all of the characterised periplasmic and outer membrane 
proteins and most of the inner membrane proteins contain an amino- 
terminal signal sequence that is removed during the export process, 
several inner membrane proteins are not made in precursor form. These 
include the lactose permease (Ehring e^ al^ . , 1980), the histidine 
permease (Higgins e_t a K  , 1982) and two subunits of the Fo complex of 
ATPase (Nielsen et^  a^. , 1981). Although these proteins may contain a 
non-cleavable signal sequence they are highly hydrophobic and may simply 
partition into the membrane after synthesis, i.e. they may contain 
sequences that are functionally equivalent to insertion sequences in the 
signal hypothesis.
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22. Signal sequences
The importance of the signal sequence in initiating the co-translational 
interaction between proteins and membranes has been demonstrated by both 
mutating (see Silhavy e_t a^., 1983) and removing (Gething and Sambrook,
1982) this region in a variety of proteins. The mutagenesis of 
prokaryotic signal sequences has allowed the further identification of 
those features of the signal such as the positions of hydrophobic and 
hydrophilic residues which are necessary for this mediation (for review 
see Silhavy et al., 1983). In the majority of cases the signal sequence 
is apparently also sufficient for this interaction between proteins and 
membranes. This has been shown in both prokaryotes (Bremer e_t al.,
1980, 1982; Ito and Beckwith, 1981; Boeke and Model, 1982; Koshland 
et al., 1982) and eukaryotes (Sveda and Lai, 1981; Gething and 
Sambrook, 1982; Rose and Bergman, 1982; Sveda e£ a_l., 1982). In some 
situations however a signal sequence is not sufficient for the export of 
a protein from the cytoplasm (Moreno e_t a_l. , 1980) and other sequences 
within the protein are involved.
The mutation of signal sequences responsible for transport into 
mitochondria and chloroplasts has yet to be reported, while the mutation 
of signals involved in the accumulation of proteins in nuclei is 
described elsewhere in the thesis.
3. Stop transfer sequences
Removal of the hydrophobic stop transfer sequence from both prokaryotic 
(Boeke and Model, 1982) and eukaryotic (Sveda and Lai, 1981; Gething 
and Sambrook, 1982; Rose and Bergman, 1982; Sveda e^ al^ ., 1982) 
transmembrane proteins results in their complete translocation across 
the relevant membrane. For bacterial inner membrane proteins this 
causes export to the periplasm while for the eukaryotic proteins it 
leads to their secretion.
A similar situation exists naturally in eukaryotic cells where, as a 
result of different RNA splicing events, the gene encoding the p-chain 
of immunoglobulin M (IgM) can direct the synthesis of both a secreted 
and membrane-bound form of the protein (Alt et_ al_. , 1980; Early et al., 
1980; Kehry et^  a_l., 1980; Rogers et^  ajK , 1980). The only difference 
between the two forms is at the carboxyl terminus where the secreted 
form has a hydrophilic sequence while the membrane-bound form has a 
hydrophobic sequence which is believed to retain the protein in the 
membrane. The stop transfer capability of this hydrophobic sequence was 
demonstrated by the construction of a series of plasmids encoding 
transmembrane proteins from plasmids which previously encoded secreted 
proteins (Yost e^ al_., 1983 ). The sequence for the transmembrane 
portion of the IgM heavy chain was inserted between the coding regions 
for /3-lactamase and globin in a fusion protein. Whereas the protein had 
previously been translocated across microsomal membranes in a cell-free 
transcription-linked translation system it was now retained in the 
membrane (Yost et al., 1983).
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4. Sorting sequences
As mentioned earlier there is little information available regarding the
identification of sorting sequences. There are a number of examples
however where an alteration in the sequence of a protein leads to a
change in its transport pathway. In eukaryotic cells the majority of
these examples involve proteins that are synthesised at the ER.
Mutation of the cytoplasmic tail region of the G protein of vesicular
ostomatitis virus, for example, leads to the accumulatj[n of the protein
in the ER membrane (Rose and Bergman, 1983). This is not a general
aphenomenon however since mutation of the cytoplasmic tail of the E2 
protein of Semliki Forest virus (Garoff e£ al^ ., 1983) and mouse Class I 
antigens (Zuniga et al., 1983) has no effect on either the surface 
expression or the function of these proteins.
As is always possible in such analysis the mutation of a protein may 
change its conformation and thereby influence the results. For example, 
a conformational change arising from a single amino acid change is 
invoked to explain a variant MOPC 315 immunoglobulin light chain which 
is capable of entering the ER lumen but fails to be secreted from both 
myeloma cells (Mosmann e^ al^ . , 1979) and Xenopus oocytes (Valle e^ al. , 
1983 ).
It appears that in the case of imported mitochondrial proteins, 
different proteins may use different polypeptide regions for targeting. 
It has been reported that the carboxyl-terminal region of a yeast 
mitochondrial outer membrane protein is not necessary for its
localisation (Reizraan al., 1983), however, it is necessary for 
correct localisation of apocytochrome C to the intermembrane space 
(Matsuura et al., 1981).
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The above sections reveal that although a great deal is known about the 
mechanisms of intracellular protein transport there are many gaps in our 
knowledge. Until recently one of these largest gaps was how proteins 
were transported into and accumulated in cell nuclei, and it is this 
area which this thesis is concerned with. Based on the distribution of 
a protein with respect to the cytoplasm and the nucleus it is possible 
to distinguish three classes of endogenous proteins in Xenopus oocytes 
(Gurdon, 1970; Bonner, 1975a, 1975b; De Robertis et a^. , 1978) and, 
presumably, other eukaryotic cells. There are those proteins which are 
found in both the cytoplasm and the nucleus and there are those which 
are either predominantly cytoplasmic or nuclear in location. The 
following is a more detailed discussion of each of these classes.
1 . Proteins found in both the cytoplasm and the nucleus
These include some abundant soluble proteins such as the soluble forms 
of actin (Clark and Merriam, 1977; De Robertis al^ ., 1978) and 
certain chromatin constituents such as protein HMG-1 (Rechsteiner and 
Kuehl, 1979; Kleinschmidt e£ al^ . , 1983 ). The equal distribution of 
soluble actin has been shown by the fractionation of radioactively 
labelled Xenopus oocytes (De Robertis et a_l., 1978) and by studies of 
the movement of iodinated actin injected into these cells (De Robertis 
et a 1., 1983 ). Similar results with Amoeba proteus has been interpreted 
as suggesting that the equal distribution of actin was due to the free 
movement of the protein across the nuclear envelope (Goldstein ej: a 1■,
1977). It should be noted that not all of the actin in a cell is
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diffusible and in Xenopus oocytes about 25% of the nuclear actin is 
stably associated with an insoluble nuclear gel (Clark and Merriam, 
1977).
2. Proteins found predominantly in the cytoplasm
This class describes those proteins which, after synthesis, remain in 
the cytoplasm and are excluded from the nucleus, or at least are 
maintained at a much higher concentration in the cytoplasm. This is a 
controversial class of proteins since the exclusive localisation of 
certain proteins to the cytoplasm either after the fractionation of 
radioactively labelled Xenopus oocytes (De Robertis ££ al^ . , 1978) or 
following the micro-injection of radioactively labelled proteins into 
these cells (Bonner, 1975b; De Robertis et_ al^ . , 1983 ) might be 
explained by their assembly into, or association with, large particles 
(see Goldstein and Ko, 1981). For example, the cytoplasmic localisation 
of tubulin (De Robertis e_t^ a_l. , 1978, 1983 ) could be explained by its 
inclusion into microtubules.
Better examples of this class of proteins have recently been described 
(De Robertis e£ , 1983; Dabauvalle and Franke, 1984). The first is 
a group of five proteins which bind to U-Sn RNAs (cited in De Robertis 
et al., 1983). In the absence of U-Sn RNA the proteins are stockpiled 
in the cytoplasm and are excluded from the nucleus. When U—Sn RNA 
becomes available, for instance by the injection of the purified RNA, 
the proteins bind to the RNA and are transported into the nucleus
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(Zeller e_t a_l., 1983 ). Dabauvalle and Franke (1984) have recently 
identified several soluble proteins which apparently remain enriched in 
the cytoplasm or both Xenopus oocytes and HeLa cells. These include 
some of the most abundant soluble proteins in these cells and many are 
of a size that is estimated to be able to pass freely through the 
nuclear pores (see Section V).
3. Proteins found predominantly in the nucleus
These are proteins which, soon after their synthesis in the cytoplasm, 
rapidly migrate into and accumulate in the nucleus. Such proteins are 
called karyophilic proteins and they are often found to be more than 
100-fold more concentrated in the nucleus than in the cytoplasm (Krohne 
and Franke, 1980b; Mills e]t al^ . , 1980; Feldherr e^ al^ . , 1983 ). The 
ability of these proteins to accumulate in nuclei has been demonstrated 
by their injection into the cytoplasm of Xenopus oocytes (Gurdon, 1970; 
Bonner, 1975a, 1975b; De Robertis et al^ . , 1978; Mills ££ al^ . , 1980;
Dabauvalle and Franke, 1982; Dingwall e_t a^. , 1982).
SECTION V
TRANSPORT OF PROTEINS ACROSS THE
NUCLEAR ENVELOPE
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1. Structure of the nuclear envelope
Most, if not all, proteins which accumulate in the nucleus appear to 
cross the nuclear envelope and so this section describes the basic 
structure of this barrier. Since the amount of information regarding 
the structure of the nuclear envelope is so great only the major 
findings are described here and for a more extensive treatment of the 
subject the reader is referred to the reviews of Franke (1974a), Franke 
and Scheer (1974), Kasper (1974) and Fry (1976, 1977).
The existence of a membranous boundary between the nucleus and the 
cytoplasm had been postulated for a long time before being confirmed by 
the use of light and interference microscopy (Baud, 1948). The boundary 
does not constitute a membrane as such, and so is more correctly 
referred to as the nuclear envelope (Anderson, 1953). It consists of 
two roughly parallel lipid bilayers, one of which is in contact with the 
nucleoplasm (inner membrane) while the other is in contact with the 
cytoplasm (outer membrane). The two membranes are separated by a gap of
Oabout 150—300 A called the perinuclear space (Policard and Bessis,
1956). This contains neither cytoplasm nor nucleoplasm and is 
presumably filled with a fluid similar to that contained in the 
cisternae of the endoplasmic reticulum (see below). It has very little 
distinctive structure although there have been reports of fibers 
crossing the space and connecting the two membranes (see, for example, 
Franke et al., 1973). These fibers may be involved in protecting the 
nuclear envelope during osmotic shock.
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The early view of the nuclear envelope as being a distinct membranous 
boundary has now been replaced with one of it being a specialised 
interface interacting with both the cytoplasm and the nucleoplasm. Many 
cytoskeletal elements run parallel to, and often bind to, the outer 
membrane and these are believed to be involved in determining the shape 
of the nucleus and also in anchoring the nucleus within the cell (Franke 
and Scheer, 1974; Osborn and Weber, 1977; Lehto et a_l., 1978). The 
outer membrane has ribosomes studded along much of its cytoplasmic face 
and at several points it is continuous with the endoplasmic reticulum 
(Palade, 1955; Watson, 1955). Lining the inner aspect of the envelope 
is an electron-dense layer that has been alternatively referred to as 
the fibrous lamina (Fawcett, 1966), the zonula nucleura limitans (Patrizi 
and Poger, 1967) and the internal dense lamella (Stevens and André, 
1969), although the preferred term nowadays is the nuclear lamina 
(Kaufmann et al., 1981). It appears to be composed of homogeneous, 
finely granular material which is predominantly proteinaceous in content
(Bronens and Kasper, 1973; Jackson, 1976; Shaper £t a_l. , 1979). The
© . . .thickness of the lamina is usually 150-200 A although it is species, 
tissue and cell cycle dependent (Fawcett, 1966; Oryschak e^ al., 1974).
oIn some cell types no lamina is visible by electron microsoc^jy, but the 
ability to isolate corresponding structures from these cells (see, for 
example, Aaronson and Blobel, 1975) suggests that the lamina is a 
ubiquitous feature of nuclei.
At irregular intervals the outer and inner membranes fuse to leave small
gaps in the envelope where there is no membranous element between the
nucleoplasm and the cytoplasm. Structural and dynamic studies indicate
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Figure 4 Basic features of the nuclear envelope
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that these gaps are not holes as such but are filled with electron
opaque material called annular material and have subsequently been
termed nuclear pores. The pores are circular or octagonal in appearance
and are extensively connected to the nuclear lamina (Aaronson and
Blobel, 1975; Berezney and Coffey, 1976). The number of pores per unit
area of nuclear envelope is variable and depends on the type of cell
being studied, its metabolic state and also its stage of division
(Franke and Scheer, 1974; Wunderlich et^  al^ ., 1974; Zerban and Werz ,
1975; Schel et al., 1978). In electron micrographs the pore complex,
i.e. the pore and its associated material, appears as a hollow cylinder
©extending through the envelope and to a distance of about 200 A on
Oeither side. The central channel is about 150-200 A in diameter and 
often contains a central granule. The staining properties of this 
granule (Abelson and Smith, 1970) and its sensitivity to RNase treatment 
(Mentred, 1969) suggest it may contain ribonucleoprotein but it is 
unclear whether this represents a particle in transit or is a genuine 
structural element of the pore complex. This point is discussed in more 
detail elsewhere in the introduction (see page 48). As yet no enzymic 
activity has been conclusively ascribed to the pore complex and although 
an ATPase activity has been tentatively located there (Yasazumi and 
Tsubo, 1966; Yasazumi et^ a_l., 1967 ) the situation is unclear (Vorbrodt , 
1974; Clawson and Shuckler, 1979). For a more exhaustive review of 
nuclear pores see Maul (1977). Figure 4 illustrates the basic features 
of the nuclear envelope.
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2. Transport of non-nuclear proteins across the nuclear envelope
In the last 20 years there have been many studies on the permeability of 
the nuclear envelope. The technique employed in the majority of these 
studies involves the micro-injection of substances with known properties 
into the cytoplasm of a cell and then monitoring their entry into the 
nucleus. Such studies led to the conclusion that the principle factor 
governing the nuclear entry of a substance that is not naturally found 
in nuclei is its size. This is probably best illustrated by the work of 
Paine and co-workers who used cryofixation and autoradiography to 
monitor the nuclear entry of tritiated dextrans following their 
injection into the cytoplasm of Rana pipiens oocytes (Paine e^ a_l. , 
1975). In an aqueous environment the dextrans behave as spheres 
(Grotte, 1956) and by using dextrans of different lengths it is possible 
to generate a series of molecules which differ only in their size. From 
the rates with which the different dextrans entered the oocyte nucleus 
it was possible to calculate that the nuclear pores have a permeant
Oradius of about 45 A (Paine e£ a_l., 1975 ). Such a value not only 
substantiates the earlier semi-quantitative studies using similar 
tracers (Paine and Feldherr, 1972; Horowitz ££ al_. , 1973; Feldherr, 
1974), but also agrees with results obtained following the injection of 
non-nuclear proteins into the cytoplasm of these cells. (The term non­
nuclear is used to describe proteins which do not accumulate in nuclei). 
The use of proteins in these studies is complicated by the fact that the 
majority are aspherical and some, for example 7-globulin, are polymeric 
and can complicate interpretation by dissociating within the cytoplasm 
(for example see Bonner, 1975a). It is possible, however, to use the 45 
A pore model to distinguish three classes of non-nuclear proteins.
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a ) Proteins where the longest molecular dimension is less than 90 A 
When these proteins are injected into the cytoplasm of amphibian oocytes 
they rapidly enter the nucleus and become evenly distributed between 
this compartment and the cytoplasm within 24 h. Within this class the 
rate with which a protein enters the nucleus is inversely proportional 
to its size (Paine and Feldherr, 1972; Bonner, 1975a).
b ) Proteins with one molecular dimension less than 90 A 
These proteins exhibit a slow but definite entry into the nucleus 
following their injection into the cytoplasm (Gurdon, 1970; Bonner, 
1975a). The most conspicuous example of this group is bovine serum 
albumin (BSA) which has a molecular weight of 67,000 and molecular 
dimensions of 150 x 38 A (Young, 1963). After injection into the 
cytoplasm of Xenopus oocytes BSA enters the nucleus but is still not 
evenly distributed between the nucleus and the cytoplasm after 72 h. A 
possible explanation for the slow rate of nuclear entry of these 
proteins is that they can only pass through the nuclear pores in an 
'end-on' configuration.
c ) Proteins where the shortest molecular dimension is more than 90 A
Proteins of this size, for example ferritin which has a molecular
Odiameter of 95 A, do not enter the nucleus following injection into the 
cytoplasm (Gurdon, 1970; Paine and Feldherr, 1972; Bonner, 1975a).
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Initially, for technical reasons, such direct demonstrations were 
limited to amphibian oocytes and other large cells such as cockroach 
oocytes (Paine and Feldherr, 1972) and the salivary gland cells of 
Chironomus thummi (Paine, 1975). However, because of the extraordinary 
conservation of the structure of the nuclear envelope between 
phylogenetically distant species (Franke, 1970; Feldherr, 1972; Harris 
et al., 1974), it was assumed that these results would be typical of 
most cells. This assumption was proved correct following the 
development of a method for the micro-injection into HeLa cells (Stacey 
and Allfrey, 1976). Although the time scale for transport to the 
nucleus was much shorter than in the large cells, probably as a 
consequence of the shorter path-length from the site of injection to the 
nucleus, the HeLa nuclei were found to exclude proteins on a similar 
basis.
Recently the technique of fluorescence microphotolysis has been used to 
estimate the permeant radii of nuclear pores in rat liver nuclei 
(Peters, 1983). These pores were found to have a permeant radius of 
about 56 A, and the small difference between this and the estimate from 
amphibian oocytes may reflect slight species dependent variations which 
are also observed by electron microscopy (Fry, 1977).
Although the above experiments primarily monitor movement from the 
cytoplasm to the nucleus, the fact that many injected particles rapidly 
equilibrate between the two phases suggests that their exit from the 
nucleus follows the same mechanism as their entry. The ability of a 
variety of proteins to equilibrate between the cytoplasm and the nucleus
at the same rate regardless of their injection site, shows this 
suggestion to be correct (Paine, 1975; Stacey and Allfrey, 1976).
Whereas the size of a protein greatly influences its rate of transport 
across the nuclear envelope, its charge has little or no effect. 
Acidic, neutral and basic proteins have all been shown to enter nuclei 
at rates predicted solely on their molecular dimensions (Paine and 
Feldherr, 1972; Bonner, 1975a; De Robertis al_., 1978).
3. Transport of nuclear proteins into nuclei
As discussed above the most important feature of non-nuclear proteins 
with regard to their ability to cross the nuclear envelope is their 
size. This observation, however, does not apply to proteins normally 
found in nuclei.
On the basis of the above work proteins larger than ovalbumin (44,000 
daltons ) should enter nuclei very slowly while proteins larger than BSA 
(67,000 daltons) should not enter nuclei at all. One might therefore 
predict that there should be a maximum size limit on nuclear proteins of 
about 60-70,000 daltons. Many nuclear proteins, however, are 
considerably larger than this. Xenopus oocyte nuclei, for example, 
contain a number of proteins in excess of 110,000 daltons (Feldherr, 
1975; De Robertis et a_l. , 1978; Mills et al., 1980), while one of the 
major nuclear proteins of Rana oocytes has a molecular weight of 148,000
daltons (Feldherr et al., 1983). The following sections discuss a
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number of ways in which such large proteins may find themselves in 
nuclei.
a ) Influence of molecular shape
One insight as to how large proteins may pass through nuclear pores 
comes from electron micrographs apparently showing ribonucleoproteins in 
transit from the nucleus to the cytoplasm (Takamoto, 1966; Monneron and 
Bernhard, 1969; Franke and Scheer, 1970b). These particles seem to 
pass through the nuclear pore by unfolding and constricting to a radius
o •of about 50 A even though they may be up to 1000 A across on either side 
of the pore. By analogy to this a large nuclear protein may pass 
through pores by constricting itself or by already being rod shaped. A 
good example of this is myosin which consists of two subunits of 234,000 
daltons and yet enters HeLa cell nuclei at the same rate as ovalbumin 
which has a molecular weight of 44,000 daltons (Stacey and Allfrey, 
1976). The important consideration here appears to be the rod-like
. . . . Oconfiguration of myosin with its molecular dimensions of 435 x 29 A.
Further evidence for proteins entering nuclei in an end-on configuration 
is provided by certain steroid receptors. When steroid hormones such as 
progesterone enter cells they bind to a receptor protein in the 
cytoplasm to form a protein-steroid complex. This complex becomes 
activated by the binding of a third protein termed protein X, and enters 
the cell nucleus by an apparently passive diffusion process (Shyamala 
and Gorski, 1969; Gorski and Raker, 1973). The majority of such 
activated complexes are larger than would be expected to enter nuclei
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under the considerations described earlier, but most have high axial 
ratios. The activated progesterone receptor, for example, has a 
molecular weight of 90,000 daltons but an axial ratio of 18:1 (Sherman 
et al., 1970).
It therefore seems conceivable that at least some large nuclear proteins 
could gain entry through nuclear pores by having a rod-like 
configuration. The transport of these proteins would be greatly 
facilitated if there was some form of interaction between the protein 
and the pore complex which resulted in the protein being presented to 
the pore in an "end-on" manner. A similar interaction between the 
protein and the nuclear pore complex forms the basis of the second 
proposed means of entry.
b ) Change in the permeant radius of the nuclear pore
Since the molecular weight of a spherical protein increases as a 
function of the cube of its radius, a large increase in molecular weight 
is accompanied by a relatively small increase in molecular size. 
Similarly a small increase in the permeant radius of the nuclear pore 
would have a profound effect on its ability to allow the passage of 
large proteins. For an in depth discussion of this point see Paine et 
a U  (1975).
It is possible therefore that proteins which are too large to pass
e
through a nuclear pore having a permeant radius of 45 A enter the
nucleus by Interacting with the pore complex in such a way as to 
increase the permeant radius. Although there is no direct evidence to 
support this model the pore complex does seem to have the potential to 
accomodate such an increase since the permeant radius of 45 A is
oremarkably small compared to the inner pore radius of about 350 A (Gall, 
1967; Franke and Scheer, 1970b).
The above mechanisms both assume that the passage of proteins across the 
nuclear envelope occurs via the nuclear pores. I think it is therefore 
appropriate at this point to briefly review the evidence suggesting that 
the nuclear pores constitute a route across the nuclear envelope. There 
are principally three lines of evidence implicating pores in transport 
across the nuclear envelope.
The first of these has been discussed in detail elsewhere and concerns 
the fact that following their injection into the cytoplasmic regions of 
cells, the observed nuclear transport of a variety of substances was 
correlated with their ability to pass through holes with a radius of 
45 A (Paine ££ a K  , 1975 ).
Further evidence comes from electron microscopy showing material 
apparently in transit across the nuclear envelope. Gold particles 
injected into amoebae, for example, are often seen in nuclear pores 
(Feldherr, 1962a, 1965), while studies of virus-infected cells suggest 
that certain viruses use the pore as an entry route for their nucleic 
acid (Morgan e£ a_l., 1969; Summers, 1969, 1971; Chardonnet and Dales, 
1970), and as an exit route for structures produced during infection
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(Bates ££ a_l., 1974). Although these results may be due to the 
perturbation of the cell several studies of non-manipulated cells also 
show structures apparently in transit through pores (Tokamoto, 1966; 
Monneron and Bernhard, 1969; Franke and Scheer, 1970b). These 
structures contain ribonucleoprotein and the results have led to 
suggestions that the central granule observed in some pores is not a 
component of the pore complex but represents these particles in transit. 
Indeed, the staining properties (Abelson and Smith, 1970) and RNase 
sensitivity (Mentrg, 1969) of the granules indicate a ribonucleoprotein 
containing structure. The fact that the percentage of pores containing 
granules increases with an increased synthetic activity of the nucleus 
(Merriam, 1962; Comes and Franke, 1970; Franke and Scheer, 1970b; 
Wunderlich and Speth, 1972), also indicates a transitory structure 
although it is possible that a low activity means that the granules are 
more readily lost during isolation or are more difficult to see due to a 
change in their structure (Wunderlich, 1969; Scheer, 1970).
Indirect evidence for the involvement of pores in nuclear transport 
comes from the general correlation between the frequency of occurrence 
of the pores and the need for the exchange of macromolecules across the 
nuclear envelope. In developing oocytes, for example, where there is a 
high rate of protein synthesis which presumably requires a steady flow 
of materials across the nuclear envelope, there is a high pore frequency 
(Krauskopf, 1968; Szollosi e£ a_l. , 1972 ). As the oocytes mature the 
level of synthetic acitivity decreases and so does the pore frequency 
(Szollosi et al., 1972). Similar correlations are also seen during the 
development of the mammalian erythroid series (Grasso e£ al^ . , 1962), and
during the phytohaemagglutinin stimulation of lymphocytes (Maul et al., 
1972).
Although it seems that the pores represent the most likely route across 
the nuclear envelope a number of other routes can be imagined.
c ) Transport via vesicles
Under certain conditions, usually during periods of high nuclear 
activity, some cells exhibit vésiculation of one or both of the nuclear 
membranes (Frasca e£ a_l., 1965; Darlington and Moss, 1968, 1969; 
Krauskopf, 1968; Nii e_t al^ ., 1968; Adams and Hertig, 1969; Killarski 
and Jasinski, 1970; Sylvester and Richardson, 1970; Gulyas, 1971; 
Franke and Scheer, 1974). Most of the vesicles that are formed are 
found on the cytoplasmic side of the nuclear envelope suggesting that if 
it is a method of transport it is more likely to be a route of nuclear 
exit rather than nuclear entry.
d ) Transport during mitosis
During mitosis the nuclear envelope fragments and there is a generalised 
mixing of the cytoplasmic and nucleoplasmic components. This mixing has 
been demonstrated using both autoradiographic (Prescott and Goldstein, 
1968) and immunofluorescent techniques (Beck, 1962; Gilden et al.,
1965). Towards the end of mitosis the nuclear envelope begins to
reassemble and it is therefore conceivable that proteins too large to 
pass through nuclear pores could enter nuclei by becoming entrapped 
within the reforming nucleus. Such a route of nuclear entry has been 
demonstrated in the amoeba Chaos chaos (Feldherr, 1966), and these 
workers also found that immediately after mitosis the nuclei allowed the 
entry of particles which were too large to enter the nuclei during 
interphase. Whether these large particles entered the post-mitotic 
nuclei via gaps in the reforming nuclear envelope or whether their entry 
was due to differences in the nuclear pore structure between the post­
mitotic and the interphase nuclei is not known. However, the fact that 
proteins larger than 70,000 daltons can enter interphase nuclei (Bonner, 
1975a; De Robertis ^t a_l., 1978; Dingwall £t £l. , 1982) suggests that, 
at best, specific entry at mitosis is a relatively minor route, although 
it could be important with regard to cell differentiation in those cases 
where differentiation is preceeded by cell division (see Dienstman and 
Holtzer, 1975).
e ) Nucleus-associated synthesis of proteins
It is possible that some nuclear proteins are synthesised in association 
with the nucleus and this association could mean that they do not cross 
the nuclear envelope as such. One can suggest three ways in which this 
could happen. The first of these is the case where the proteins may be 
synthesised by the ribosomes found on the outer nuclear membrane and 
cross the envelope co-translationa1ly in a nascent or unfolded state. 
Alternatively the proteins could be synthesised by the ribosomes on the
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endoplasmic reticulum and be transported to the perinuclear space via 
the connecting pathways that exist between the ER and the nuclear 
envelope. Obviously these proteins would still need to cross the inner 
nuclear membrane, but one could suggest that they exist in the 
perinuclear space in an immature form that is capable of passing through 
the membrane. Both these possibilities arise from electron microscopy 
observations (Gorovsky, 1969; Kuehl and Sumsion, 1971), and there is, 
as yet, no direct evidence for them acting as pathways of nuclear entry.
Since translationa 1 ly active polysomes have been prepared from a variety 
of cell nuclei (Goidl e£ al_. , 1975; Chatterjee ej^  a_l., 1977; Gozes £t^  
al., 1977 ), it is possible that some proteins could be synthesised 
within the nucleoplasm. From studies on these nuclear polysomes, 
however, it has been estimated that the translational activity of the 
nucleus represents less than 1% of the total cell activity (Allen,
1978), and it is therefore unlikely to represent a major source of 
nuclear proteins. A possible role for this nuclear synthesis is 
suggested by the fact that some of the proteins synthesised by nuclear 
polysomes are apparently not produced by cytoplasmic polysomes (Gozes et 
al., 1977), and although these proteins have not been identified they 
could be regulators of nuclear activity.
As suggested above the nucleus-associated synthesis of proteins is 
unlikely to represent major routes of entry into the nucleus and this 
belief is reinforced by the ability of mature nuclear proteins to cross 
the nuclear envelope (see, for example, Bonner, 1975a; De Robertis e£ 
al. 1978; Dabauvalle and Franke, 1982) and the fact that most nuclear 
proteins are synthesised in the cytoplasm.

Whereas the previous 
the nuclear envelope 
accumulation of some
section dealt with the passage of proteins across 
this section is concerned with the selective 
of these proteins in the nucleus.
Almost any substance that can pass easily across the nuclear envelope 
will accumulate to some extent in the nucleus in vivo (for examples see 
Bonner, 1978). Whilst the phenomenon of cytoplasmic exclusion can 
explain low level accumulation (see 'Methods A'), many proteins have 
been found to accumulate to very high levels in the nuclei of a variety 
of cells including Xenopus oocytes (Gurdon, 1970; Bonner, 1975a, 1975b; 
De Robertis ej^  a_l. , 1978; Mills e£ a_l., 1980; Dabauvalle and Franke, 
1982; Dingwall ej: a^. , 1982), amoebae (Legnarae and Goldstein, 1972; 
Jelinek and Goldstein, 1973), rat uterine cells (Stumpf, 1968) and giant 
salivary gland cells (Kroeger ££ a_l. , 1963 ). Two alternative models are 
commonly considered to explain the nuclear accumulation of these 
proteins (Dingwall e£ al_. , 1982; De Robertis, 1983; Hall e_t al.,
1984). The first suggests that the accumulation of nuclear proteins is 
due to their selective transport across the nuclear envelope while the 
second envisages the free diffusion of all proteins into the nucleus 
with the subsequent retention of nuclear proteins by their binding to 
non-diffusible nuclear elements. The relative merits of these models 
are discussed below.
f
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1• Selective transport across the nuclear envelope
This section does not refer to the mediated transport of large nuclear 
proteins since although specific import mechanisms have been inferred 
for such proteins (see, for example, Feldherr et al., 1983 ) there is no 
evidence that these are the cause of nuclear accumulation.
The classical way to test the function of a particular component in a 
system is to perturb or remove that component and then assess the effect 
of such a manoeuvre on the system. Both types of experiment have been 
performed on the nuclear envelope. It is possible to damage the nuclear 
envelope in Xenopus oocytes by repeatedly puncturing it with a glass 
needle (Feldherr and Pomerantz, 1978; Feldherr and Ogburn, 1980). Such 
action dramatically increases the rate at which large non-nuclear 
proteins are transported into the nucleus but has no effect on the 
nuclear uptake of nuclear proteins. Secondly, De Robertis and co­
workers have succeeded in removing the nuclear envelope from isolated 
Xenopus oocyte nuclei and injecting the resulting nuclear gel into the 
cytoplasmic region of fresh oocytes. The re-introduced "nuclei" were 
still capable of accumulating nuclear proteins (cited in De Robertis,
1983). Although these results suggest that the nuclear envelope plays 
little or no role in the accumulation of most proteins in the nucleus, 
it is important in the nuclear accumulation of nucleoplasmin (Dingwall 
et al., 1982). Nucleoplasmin is the most abundant protein in oocyte 
nuclei (Krohne and Franke, 1980a; Mills et a K , 1980) and accumulates
in the nucleus following injection into the cytoplasm (Mills £ £  a l .,
1980). In oocytes the nucleoplasmin exists as a pentamer of 168,000
daltons and proCease digestion reveals the presence of two structural 
domains: a protease resistant core and five sensitive tail regions
(Dingwall e£ al^ . , 1982). By sequential removal of the tails it has been
shown that the rate of nuclear accumulation, but not the final extent of 
accumulation, depends on the number of tails remaining. The complete 
removal of the tails leaves a core particle which remains in whichever 
cellular compartment it was micro-injected into, while the tails 
themselves accumulate in the nucleus (Dingwall e_t a K  , 1982). These 
results suggest that the nuclear accumulation of nucleoplasmin is due to 
selective transport across the nuclear envelope rather than selective 
retention within the nucleus and that the information for this 
accumulation resides in the protease sensitive tail region of the 
protein.
2. Selective binding within the nucleus
Any system involving the binding of one component to another will 
exhibit specificity, saturation and competition. All three of these 
properties are exhibited by the accumulation of histones in the nuclei 
of Xenopus oocytes (Gurdon, 1970; Bonner, 1975a). The specificity of 
the accumulation is obvious since histones injected into the cytoplasm 
of oocytes become more than 100-fold more concentrated in the nucleus 
than in the cytoplasm within 20 h (Gurdon, 1970). The saturation and 
competition aspects were demonstrated in a similar study using purified 
histone fractions (Bonner, 1975a). These properties are also evident in 
the nuclear accumulation of other nuclear proteins in Xenopus oocytes
Ul
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(Bonner, 1975b), hormone receptors (Stumpf, 1968; Williams and Gorski, 
1972), and the shuttling proteins in amoebae (Goldstein and Ko, 1974). 
Another characteristic of the nuclear accumulation of a variety of 
proteins is that their binding within the nucleus is weak. Binding 
constants calculated for histones and hormone receptors, for example, 
are about 10-^ to 10”  ^M (Williams and Gorski, 1972; Bonner, 1978). It 
therefore seems that the nuclear accumulation of many proteins may be 
explained by their passive transport into the nucleus and their 
subsequent binding to non-diffusible intranuclear structures. If this 
is so it poses the problem of identifying these intra-nuclear 
structures .
Although hormone receptors appear to bind to DNA in the nucleus 
(Yamamoto and Alberts, 1976; Bonner, 1978) the situation with other 
nuclear proteins is less clear. On purely logical grounds it is 
unlikely that histones are accumulated by a similar binding to DNA.
Under normal conditions Xenopus oocytes contain about 50 pg of DNA with 
one of each histone molecule bound every 25 base pairs, but following 
the injection of saturating amounts of purified H2B there is the 
equivalent of 32 H2B molecules per base pair of DNA (Bonner, 1975a).
The fact that the different histone fractions accumulate to different 
extents is also suggestive that they are not accumulating as 
nucleohistone (Bonner, 1975a). A possible insight into this 
accumulation of histone is the finding that, in oocyte nuclei, histones 
H3 and H4 are bound to two related acidic nuclear-migrating proteins 
called N1 and N2 (Kleinschmidt and Franke, 1982).
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These findings have led to the proposal that the nuclear binding sites 
are quasi-functional, that is they do not represent the sites at which 
the proteins ultimately function (see Bonner, 1978). This is almost 
certainly true for hormone receptors and histones, but it is not 
possible to comment on the majority of nuclear proteins since their 
functions remain unknown. A possible candidate for a quasi-functional 
binding component, at least in Xenopus oocytes, is nucleoplasmin. As 
mentioned previously, nucleoplasmin is the most abundant protein in the 
oocyte nucleus and such a role would not only explain its vast abundance 
but could also be a reason for the relatively unusual uptake mechanism 
thought to be employed by this protein (Dingwall et^ al^ . , 1982). It 
could be, however, that there is no binding component as such but that 
nuclear accumulation is the result of complex interactions between 
several molecules which are either the same or different. It is known, 
for example, that the protein concentration within cells is very high 
and under these conditions protein-protein interactions can become much 
more important than in dilute aqueous solutions (for discussion see 
Fulton, 1982).
This second model proposes that all proteins enter nuclei by passive 
diffusion through nuclear pores. In Xenopus oocyte nuclei these pores
Ohave a permeant radius of 45 A (Paine e_t aL. , 1975 ), and if transport 
through the pore was by passive diffusion then one could predict both 
the rate at which small proteins would enter these nuclei and also the 
maximum size of protein that should enter the nuclei. As discussed 
earlier, whereas non-nuclear proteins obey these rules after injection 
into Xenopus oocytes, nuclear proteins do not.
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3. Karyophilic signals
Since nuclear accumulation is selective and occurs post-translationally 
with no apparent modification of the proteins (Gurdon, 1970; Bonner, 
1975a, 1975b; De Robertis e_t a_l., 1978; De Robertis and Black, 1981; 
Dabauvalle and Franke, 1982; Dingwall et_ a_l. , 1982), it has been 
proposed that nuclear proteins contain within their mature molecular 
structure a signal sequence which controls their accumulation in nuclei 
(De Robertis e£ a_l., 1982).
In recent years, two types of approach have been used to identify and 
localise such karyophilic signals in a variety of nuclear proteins. The 
first is exemplified by the work of Dingwall ^t a K  (1982) who used 
partial proteolysis of nucleoplasmin to produce two fragments, only one 
of which retained the ability to migrate into and accumulate in the 
oocyte nucleus. This approach has also been used to locate the 
karyophilic signal of Xenopus histone HI to the carboxyl-terminal domain 
of this protein (Dingwall and Allan, 1984). The second approach 
involves the use of recombinant DNA technology to construct genes in 
which various regions have been deleted or altered. In this way 
Kalderon et a_l. (1984) have identified a region of the SV40 large-T 
antigen necessary for its accumulation in the nuclei of transformed 
Rat-1 cells. A further modification of this approach involves the 
construction and expression of chimeric genes containing various regions 
of a nuclear protein fused to a cytosolic protein. In this way Hall e£ 
al. (1984) have identified an amino-terminal region of the yeast protein 
a2 which can cause the accumulation of bacterial /3-galactosidase in the
nuclei of yeast cells
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The work described in this thesis attempts to identify the karyophilic 
signal sequence in the nucleoprotein of influenza virus. As a host 
system we have used Xenopus laevis oocytes.
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1. Morphology and polypeptides
There are three sub-types of influenza viruses, A, B and C, 
distinguished by the serological relatedness of their internal 
nucleoprotein antigen. They all have similar morphologies (Flewett and 
Apostolov, 1967), and can be either filamentous or spherical. Both 
forms have diameters of 80 to 120 nra and the filamentous forms are at 
least 4 pm in length. The percentage of a sample exibiting spherical 
morphology increases with the number of passages in culture (Choppin 
al., 1960). Since only sub-type A viruses are used in the work 
described in this thesis the following discussion is limited to this 
type.
The virion has a lipid envelope that is derived from the host cell 
(Kates et^  a K , 1961; Klenk and Choppin, 1969, 1970), and bears 
transmembrane surface protein projections or spikes. On the average 
spherical virion there are about 700-900 spikes packed in a honeycomb 
arrangement (Wrigley, 1979). These spikes are of two types; rod-shaped 
spikes of haemmaglutinin (HA) and, in much lesser abundance, mushroom­
shaped spikes of neuraminidase (NA) (Laver and Valentine, 1969). On the 
inner surface of the lipid bilayer is an electron-dense layer composed 
of the viral membrane or matrix protein (M). This is believed to 
stabilise the structure of the particle, and may also act as an 
organiser for viral assembly at the plasma membrane. Internal to this 
layer are the ribonucleoprotein (RNP ) structures which consist of four 
protein components and eight different segments of single stranded RNA. 
The predominant protein component is the nucleoprotein (NP) and the
three other proteins, PBl, PB2 and PA, are found in much smaller 
quantities. The RNA segments, which are of the opposite polarity to 
messenger RNA and therefore, by convention, termed negative sense 
(Baltimore, 1971), constitute the viral genome. Characterisation of the 
segmented genome and the assignment of specific segments to virus 
polypeptides is reviewed in Lamb (1983). The RNA segments are numbered 
according to their order of migration on glyoxal gels (Desselberger and 
Palese, 1978), and the sections below describe the polypeptide(s ) 
encoded by each segment.
a ) RNA segments 1-3 : The P proteins
The three largest RNA segments direct the synthesis of single protein 
products with molecular weights ranging from 82,000 to 95,000. These 
proteins, designated PBl, PB2 and PA (Horisberger, 1980), are components 
of the transcriptase complex found in both virus particles (Bishop et 
al., 1972 ) and infected cells (Caliguiri and Compans, 1974). Although 
all three are believed to be involved in RNA synthesis their individual 
roles remain unclear. From the use of temperature sensitive mutants PBl 
and PB2 appear to be involved in mRNA synthesis while PA appears to play 
a role in the production of new viral genomes (Krug et al., 1975; 
Scholtissek and Bowles, 1975; Palese e£ a_l. , 1977). Ijn vitro 
transcription studies indicate that PB2 is responsible for binding the 
cap-structure of the host-cell primer mRNA (Ulmanen ejt a_l. , 1981, 1983; 
Blaas et^  al^ . , 1982; Penn e_t a_l., 1982) while PBl is involved in
initiating transcription (Ulmanen e£ a_l., 1983).
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b ) RNA segment 4 : The haemagglutinin
The haemagglutinin (HA) is an integral membrane protein with a molecular 
weight of 77,000. It is the major surface antigen of the virus and is 
the antigen against which neutralising antibodies are directed (Laver 
and Kilbourne, 1966). Changes in the antigenic structure of this 
molecule are associated with the recurrent epidemics observed with 
influenza. As well as its role in mediating the attachment of the virus 
to the plasma membrane of the susceptible host cell, it is also 
responsible for the entry of the virus into the cell (Klenk et al.,
1975; Lazarowitz and Choppin, 1975).
The HA is synthesised as a single polypeptide chain and its biosynthetic 
route follows that taken by many cellular integral membrane proteins. 
This route is described in more detail elsewhere in the thesis and is 
therefore only briefly outlined here. At some time during its co- 
translational insertion into the endoplasmic reticulum the amino­
terminal signal peptide is removed (Air, 1979; McCauley et a K , 1979), 
and the nascent polypeptide undergoes core glycosylation (Compans,
1973a; Hay, 1974; Klenk et^  a_l. , 1974; Elder et a_l. , 1979; McCauley 
et al. , 1980). Further glycosylation modifications occur during 
transport from the ER to the plasma membrane (Compans, 1973b; Rott and 
Klenk, 1977 ). In the majority of cases the HA is proteolytica 1ly 
cleaved into a heavy amino-terminal (HAl , MW~50,000) and a light 
carboxyl-terminal (HA2, MW~27,000) chain. This cleavage depends upon 
the virus strain, the host cell type and the growth conditions being 
studied (Lazarowitz e_t a_l., 1971 , 1973a, b; Klenk e£ a_l., 1972;
Skehel, 1972). It does not affect the antigenic or receptor binding 
properties of the HA (Lazarowitz £t a U , 1971, 1973a, b; Lohmeyer and 
Klenk, 1979; McCauley et a_l., 1980) but does increase the infectivity 
of the virus (Klenk et^  a_l., 1975; Lazarowitz and Choppin, 1975) and 
hence is important for pathogenicity (Bosch et a K , 1970; Rott, 1979) 
and the spread of infection in the organism (Rott £t a_l. , 1980). The 
two chains are not separate entities but remain bound by disulphide 
bridges as a single subunit (Laver, 1971). In the final virus particle 
three such subunits are non-covalently associated to form a single HA 
spike (Wiley e^ a_l., 1977).
c ) RNA segment 5 : The nucleoprotein
The nucleoprotein (NP) is the type specific antigen of the influenza 
viruses although NPs from the same influenza type do show minor 
antigenic differences (Schild e£ a U , 1979). It is the major protein 
that interacts with virus specific RNA segments of both polarities 
(Pons, 1971, 1975) to produce the viral ribonucleoproteins (RNPs) (Pons 
et al., 1969; Krug, 1971; Compans e£ a K , 1972). The fact that the NP 
is a component of the transcriptase complex could indicate that, like 
the P proteins discussed above, it has an enzymic role in transcription. 
Indeed the addition of NP specific monoclonal antibodies to the 
transcriptase complex inhibits its activity i^n vitro (van Wyke e_t al., 
1980), but whether this inhibition is due to steric hinderance or 
interference with a non-structural activity of NP is unclear. When 
temperature sensitive mutants with lesions in the NP gene are grown at
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the non-permissive temperature they synthesize normal yields of virion 
RNA and other components but no infectious progeny are produced 
(Scholtissek and Bowles, 1975). This may be due to an inability of the 
RNPs to be packaged into progeny. It has been proposed that packaging 
involves an interaction of the RNPs with the matrix protein at the 
plasma membrane (Choppin e_t a_l., 1972; Compans and Choppin, 1975), as 
has been suggested for Sendai virus (Shimizu and Ishida, 1975). This 
idea is supported by biochemical evidence showing a specific association 
of matrix protein with RNPs (Rees and Dimmock, 1981a).
During infection a proportion of the NP molecules become phosphorylated
(Privalskya and Penhoet, 1977, 1978). This phosphorylation occurs
within ten minutes of the synthesis of the NP and as the infection
progresses increasing amounts of the newly-synthesised molecules become
phosphorylated (Almond and Felsenreich, 1982). In vitro results
indicate that phosphorylation stimulates the activity of the
transcriptase complex (Kamata and Watanabe, 1977) while iji vivo work
suggests that it is associated with the migration of the NP into the
nucleus (Almond and Felsenreich, 1982). This lajter point is disputed by 
einsults obtained in our laboratory (Petri and Dimmock, 1981). Another 
possibility (for which there is no evidence) is that the phosphorylation 
alters the specificity of the transcriptase complex to accomodate the 
synthesis of template, messenger and virion RNA.
r
d ) RNA segment 6 : The neuraminidase
Like the HA the neuraminidase (NA) is an integral membrane glycoprotein
and it is therefore not surprising that they share many common
o
biosynthetic steps. The NA is co-translat^/nally inserted into the 
membrane of the ER where it is core glycosylated. Further glycosylation 
occurs during its transport to the plasma membrane (Compans, 1973a, b; 
Stanley e£ aJU , 1973; Hay, 1974; Rlenk e£ a K , 1974). Unlike the HA 
however, the signal sequence is not removed and is responsible for 
retaining the protein in the membrane (Fields et al., 1981; Blok et 
al., 1982). This means that the NA is orientated with its amino- 
terminus inserted into the viral membrane. Differences are also 
observed in the make up of the final viral spike which in the case of NA 
contains four uncleaved molecules of about 56,000 daltons bound by 
disulphide bounds (Lazdins et al., 1972).
The role(s) of the NA is not fully understood but all of its proposed 
functions employ its ability to remove terminal n-acetylneuraminic acid 
(sialic acid) residues from carbohydrate chains in glycoproteins 
(Gottschalk, 1957). The earliest proposal was that the NA mediates the 
release of the progeny virus from the host cell surface (Gottschalk, 
1965; Seto and Rott, 1966; Webster and Laver, 1967; Compans et al., 
1969). More recent work using fragments of monoclonal antibodies 
suggests that this is not correct (Becht e_t a_l., 1971). These fragments 
inhibit the enzymic acitivity of the NA but do not prevent the release 
of progeny virus.
Since influenza virions do not normally contain sialic acid residues, it 
has been suggested that the NA is responsible for removing these 
residues from the region of the plasma membrane where viral maturation 
is occurring (Klenk e£ al., 1970). Support for this suggestion comes 
from the use of a temperature sensitive mutant defective in NA activity 
(Palese et^  al^ ., 1974). The progeny virions produced at the 
non—permissive temperatures were clumped into large aggregates since 
they contained sialic acid residues which served as receptors for the 
viral HA. This removal of the sialic acid residues is also thought to 
be necessary for the cleavage of the HA (Schulman and Palese, 1977), but 
there is contradictory evidence (Bosch et al., 1979).
Evidence for an involvement of the NA in the uptake of the influenza 
virus is similarly contradictory. The use of antibodies suggest that 
the NA is not involved in uptake (Seto and Rott, 1966; Webster and 
Laver, 1967; Kilbourne e£ a_l. , 1968; Compans et^  al_., 1969), whereas 
studies on the fusion of cell membranes with lipe^osomes containing 
influenza glycoproteins reveal an absolute requirement of the NA for 
membrane fusion (Huang £t a_l^. , 1980b). Both approaches are open to 
criti/cisms, for example, the antibodies may not completely inhibit NA 
activity while membrane fusion between the host cell and the influenza 
virus has not been demonstrated in vivo. An absolute requirement for 
the NA in membrane fusion is also difficult to reconcile with the fusion 
of CV-1 cells expressing a cloned HA gene (White e_t a_l. , 1982).
In many animals influenza is an infection of the respiratory tract. The
tract is lined with sialomucoproteins which seem to bind the viral HA
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and thereby reduce infectivity (Shen and Ginsberg, 1968). The NA may 
free the virus from these proteins and therefore help the virus to reach 
its target cells.
e ) RNA segment 7 : The matrix protein (M) and the non-structural 
protein M2
Three major mRNA species are transcribed from RNA segment 7 (see Lamb 
and Lai, 1981; Lamb et al^, 1981). The most abundant is a colinear 
transcript which encodes the matrix protein (M). The other mRNAs are 
produced as a result of splicing of this transcript.
M has a molecular weight of about 25,000 and is the most abundant 
polypeptide in the virus particle (Skehel and Schild, 1971). It seems 
to form a protein shell beneath the virion envelope (Apostolov and 
Flewett, 1969; Compans and Dimmock, 1969) which may give structural 
support to the virion (Laver, 1973; Schulze, 1973). The fact that 
virions produced at 39°C have half the normal M content and decreased 
stability (Kendal e_t a_l., 1977a) supports this idea of a structural 
role. The ability of M to interact with both lipid (Bucher et al.,
1980; Gregoriades, 1980; Gregoriades and Frangione, 1981) and viral 
RNPs (Reginster and Nermut, 1976; Rees and Dimmock, 1981a) could 
indicate a role for M in viral assembly (see Choppin ££ a K , 1972 and 
Compans and Choppin, 1975). Such a role for the corresponding M protein 
has been suggested in the assembly of Sendai virus particles (Shimizu 
and Ishida, 1975).
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The major spliced transcript of segment 7 encodes the non-struetural 
protein M2. M and M2 share the same nine amino acids at their amino 
termini but the splicing process means that the remainder of the M2 mRNA 
is translated in the +1 reading frame (Lamb ejt a^., 1981). From its 
nucleotide sequence M2 has a molecular weight of about 11,000 
(Lamb et al., 1981), but it migrates anomalously on polyacrylamide gels 
with a molecular weight of about 15,000 (Lamb and Choppin, 1981). It is 
only found in infected cells (Lai £t^  al., 1980; Lamb and Choppin, 1981) 
and no information is yet available regarding its function. A second 
interrupted mRNA is also transcribed from RNA segment 7 (Inglis and 
Brown, 1981; Lamb e£ a K , 1981). This mRNA, called M3 mRNA, has the 
coding potential for a peptide of nine amino acids which would be the 
same as the last nine amino acids of M, but there is no evidence for the 
existence of such a peptide in either infected cells or virus particles.
RNA segment 7 has been implicated in the differential susceptibility of 
influenza virus strains to the antiviral drug amantidine (Lubeck ejt al., 
1978; Hay e£ al^ ., 1979). It has not been possible however to determine 
either the mechanism of inhibition or the mechanism of resistance.
f) RNA segment 8 : The non-structural proteins NSI and NS2
As with RNA segment 7, segment 8 directs the 
transcript. The larger, colinear transcript 
give NS1 but is also spliced to give the NS2 
Lamb, 1983). NS1 and NS2 share the same ten
synthesis of more than one 
is not only translated to 
mRNA (for discussion see 
amino acids at their amino
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termini but the splicing process means that the remainder of the NS2 
mRNA is translated in the +1 reading frame (Lamb and Lai, 1980). 
Neither NS1 nor NS2 are found in virus particles.
NS1 has a predicted molecular weight of about 26,000 but runs on gels 
with an apparent molecular weight of only 23,000. It is synthesised in 
large amounts early in infection (Lazarowitz e£ al_., 1971; Skehel,
1972; Meier—Ewert and Compans, 1974) and has been found associated with 
polysomes and nucleoli (Lazarowitz £t a_l. , 1971; Pons, 1972; Compans, 
1973a; Krug and Etkind, 1973; Krug and Soiero, 1975). It has been 
implicated in the synthesis of viral RNA (Almond £t a K , 1977; Maeno e£ 
a 1., 1979; Wolstenholme e_t al - , 1980) and the inhibition of host 
protein production (Stephenson and Dimmock, 1974; Krug and Soiero, 
1975). Late in infection it is often involved in the formation of 
cytoplasmic paracrystalline inclusions (Morrongiello and Dales, 1977; 
Shaw and Compans, 1978) and the purification of these inclusions show 
them to be composed of NS1 in association with RNA that is primarily 
cellular in origin (Yoshida et al., 1981). Although these inclusions 
may have a functional significance it is more likely that they arise as 
a consequency of the great abundance of NS1 in the dying cell and 
because its basic nature attracts RNA.
From its nucleotide sequence NS2 has a predicted molecular weight of 
14,000 but runs on gels with an apparent molecular weight of 11,000. It 
is synthesised late in infection and is predominantly cytoplasmic 
(Skehel, 1972; Follett £t a_l. , 1974; Minor and Dimmock, 1975; Lamb 
and Choppin, 1978, 1979; Lamb ££ a_l., 1978). No function has yet been 
assigned to this protein.
2. The association of influenza virus proteins with the nuclei
of infected cells
The replication of influenza virus has an absolute requirement for an 
active host cell nucleus (Follett e£ a K , 1974; Kelly et^ al^ ., 1974).
The principal nuclear function that is required is the synthesis of host 
cell mRNA which serves as a primer for the transcription of virus- 
specific mRNA (for discussion see Krug et al^ ., 1981). It has also been 
suggested that the synthesis of viral RNA (vRNA ) (Avery, 1974; Barrett 
et al. , 1979; Barry and Mahy, 1979; Mark et a_l., 1979; Krug et_ al., 
1981; Jackson e£ al^ ., 1982) and the initial association of this RNA 
with virus proteins prior to their incorporation into progeny virions 
(Flawith, 1979) takes place in the nucleus. Not surprisingly therefore, 
the majority of the influenza proteins can be found in the nucleus at 
some stage during the replication cycle.
a) The P proteins
Studies on the localisation of the P proteins is difficult since they 
are synthesised in low amounts throughout infection. Early work was 
inconclusive since although the P proteins could be detected in the 
nuclei of infected cells the gel systems used in these studies were 
unable to resolve Che three P proteins (Krug and Etkind, 1973; Hay and 
Skehel, 1975), and it was therefore possible that the proteins behaved 
differently to each other. Indeed more recent studies, using improved 
gel systems, have shown that early in infection PB1 and PB2 accumulate
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in the nucleus to a greater extent than PA, but by 6 h p.i. all three 
proteins are accumulated in the nucleus to the same extent (Cook £t al., 
1979b; Briedis e£ al_. , 1981). The preferential accumulation of PB1 and 
PB2 in the nucleus early in infection is in agreement with their 
proposed roles in mRNA synthesis and the belief that mRNA synthesis 
occurs in the nucleus. Similarly the increased nuclear migration of PA 
later in infection agrees with its proposed involvement in vRNA 
synthesis and with the suggestion that this synthesis also occurs in the 
nucleus.
b ) The nucleoprotein
NP was first detected in the nuclei of infected cells by specific 
immunofluorescence staining (Watson and Coons, 1954; Liu, 1955; 
Breitenfeld and Schafer, 1957 ), and the analysis of radio labe 1 led 
proteins following the fractionation of infected cells revealed that 
after its synthesis in the cytoplasm the majority of the NP rapidly 
migrates to the nucleus and associates with the nucleoplasm (Dimmock, 
1969; Joss e£ al_. , 1969; Taylor £t a_l. , 1969, 1970; Lazarowitz ££ 
al., 1971; Krug and Etkind, 1973; Hay and Skehel, 1975; Briedis ejt 
al., 1981). This nuclear accumulation and the fact that most of the NP 
in the nucleoplasm is in the form of ribonucleoprotein complexes (Krug, 
1972; Krug and Etkind, 1973) is consistent with its predicted role as a 
component of the viral transcriptase. The observation of a 45 min lag 
between the synthesis of NP and its incorporation into progeny virions 
(Hay and Skehel, 1975) could also mean that the NP must enter the
nucleus prior to this incorporation. Studies employing both 
immunofluorescence staining (Breitenfeld and Schafer, 1957;
Fraser, 1967; Maeno and Kilbourne, 1970) and radioactive pulse­
labelling (Flawith and Dimmock, 1979), do indeed suggest that the NP 
migrates back out of the nucleus and the time of peak virion release 
fits chronologically with the notion that nuclear NP becomes virion NP 
(Flawith and Dimmock, 1979). These last results should be viewed with 
caution since it is not possible to distinguish between those protein 
molecules which have remained in the cytoplasm and those which have 
migrated into the nucleus and then been transported out again.
c ) The matrix protein and M2
Within a few minutes of its synthesis the matrix protein is found 
associated with all of the cellular membranes (Klenk ejt al^ . , 1974; 
Meier-Ewert and Compans, 1974; Hay and Skehel, 1975), but its migration 
to the nucleus remains debatable. Some investigators claim that M 
becomes accumulated in the nucleus (Gregoriades, 1973, 1977; Hay and 
Skehel, 1975; Flawith and Dimmock, 1979), while others claim it is 
entirely cytoplasmic (Lazarowitz e^ a_l. , 1971; Krug and Etkind, 1973;
Mahy e£ a_l. , 1980; Briedis e^ al^ ., 1981). The likely explanation is 
that the nuclear accumulation of M depends upon the virus strain and/or 
the host cell type being studied. No information is yet available on
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the cellular location of M2.
Following its synthesis in the cytoplasm a proportion of the NS1 
migrates to the nucleus (Taylor et al., 1969, 1970; Lazarowitz et al. , 
1971; Hay and Skehel, 1975) and accumulates in the nucleoli (Dimmock, 
1969; Krug and Etkind, 1973; Krug and Soiero, 1975). Its association 
with nucleoli could be a result of its ability to bind RNA or may be 
connected with its proposed inhibition of host protein synthesis. NS2 
appears to remain predominantly in the cytoplasm (Briedis et al., 1981) 
and an earlier report claiming a nuclear location (Krug and Etkind, 
1973) may have been confused by the presence of fragments of NS1 (Lamb 
et aj... 1978).
e ) The viral glycoproteins
The two viral glycoproteins, the haemagglutinin and the neuraminidase, 
do not enter the nucleus during infection (Breitenfeld and Schafer, 
1957; Dimmock, 1969; Maeno and Kilbourne, 1970; Oxford and Schild, 
1975). This is not surprising since following their synthesis on the 
rough endoplasmic reticulum they are transported to the plasma membrane 
via smooth internal membranes (Compans, 1973a; Stanley e£ al., 1973; 
Hay, 1974; Klenk et al., 1974).
SECTION VIII
XENOPUS LAEVIS OOCYTES
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Fully grown Xenopus laevis oocytes have a diameter in excess of 1 nnn and 
contain a reserve of various macromolecules and organelles which are 
used during early embryonic development (Woodland, 1982). These 
features have made oocytes attractive hosts for the introduction of a 
variety of macromolecules such as proteins, RNA and DNA (see below) and 
organelles (Richter and Smith, 1981). The principal advantage over the 
simpler and usually more economical cell-free systems is the ability of 
the oocyte to carry out the modification, processing and segregation of 
many foreign proteins. In the last few years numerous exhaustive 
reviews extolling these properties have been published (Asselbergs,
1979; Gurdon and Melton, 1981; Wickens and Laskey, 1981; Lane, 1983;
Colman et al_., 1984; Soreq, 1984) and rather than repeat the findings 
at length I will summarise the properties which make the oocyte well 
suited for use as a surrogate host in many situations. References are 
only included where specific examples are quoted and the reader is 
referred to the above reviews for further references.
1. Cleavage of polypeptides
As discussed elsewhere, the majority of secretory and integral membrane 
proteins are synthesised with an amino-terminal signal sequence which
I
specifies their association with cellular membranes and is removed 
during, or soon after, translocation. The first indication that oocytes 
could correctly process such proteins came from studies involving the 
injection of mRNAs for secretory and non-secretory proteins. Secretory 
proteins were incorporated into membrane vesicles (Zehavi-Wi1lner and
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Lane, 1977) and subsequently exported (Colman and Morser, 1979), while 
non-secretory proteins remained in the cytosol. In several cases the 
mobility of the vesicular form was greater than the in vitro product 
(see Colman et al^ ., 1984) suggesting the correct removal of the signal 
peptide although a direct demonstration, using amino-terminal amino acid 
sequencing, has only been made in one case (Lane et al., 1981a).
Many proteins exist in the lumen of the endoplasmic reticulum as a 
propeptide with a further amino-terminal peptide which is usually 
removed intracellularly during maturation. Oocytes are unable to 
perform this second cleavage with promellitin (Lane ££ al^., 1981a) and 
carp pro-insulin (Rapoport, 1981) suggesting that the cleavage enzymes 
are probably tissue specific. Frog vitellogenin, on the other hand, is 
cleaved to phosvitin and lipovitellin in yolk platelets following its 
secretion from, and endocytosis by, oocytes which have been previously 
injected with mRNA (Lane e_t a K , 1983). The correct cleavage of a 
number of viral proteins has also been observed in oocytes (for 
references see Lane, 1983).
2. Glycosylation
Most, if not all, secretory and membrane proteins are glycosylated. The 
initial step is usually the en bloc addition of oligosaccharide chains 
to selected asparagine residues in the nascent peptide (core 
glycosylation). These side chains are subsequently modified during the 
transport of the protein through the cell (peripheral glycosylation)
(for review, see Hubbard and Ivatt, 1981). Oocytes add oligosaccharide 
chains to only those proteins which, in their "native" state, are 
N-giycosylated (Jilka e_t a K , 1979). Since the composition of these 
"core" chains is tissue specific it is probable, but not yet proven, 
that the chain added by the oocyte will differ from the chains in the 
"native" proteins. It is known however that, in some cases at least, 
the subsequent modifications in oocytes are different from those in the 
"native" cell (Mous et^ aj^ ., 1980, 1982).
3. Phosphorylation
Oocytes are able to phosphorylate the translation products of several 
injected mRNAs encoding phosphoproteins. These include trout testis 
protamine (Gedame e£ al^ ., 1978) and frog vitellogenin (Berridge and 
Lane, 1976) which is phosphorylated prior to cleavage. Synthetic 
peptides injected into oocytes are also phosphorylated (Mailer et al., 
1978). Guinea-pig caseins produced in oocytes however, are not 
phosphoryiated (Lane, 1983) suggesting that at least some 
phosphorylation events are tissue specific.
4. Post-translationa1 modification of amino acid residues
The p o s t-tr a n s l a t i o n a 1 modification of many amino acid residues occurs
correctly in oocytes. These modifications include the acetylation of
a m i n o - termina 1 methionines in calf lens A 2 - c rysta 11 in (Berns et al.,
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1972), the amino acetylation of sea urchin histones (Woodland and Wilt, 
1980) and the hydroxylation of proline residues in mouse fibroblast 
collagen (Lane and Knowland, 1975). Certain types of modification such 
as the iodination of thyroglobulin (Vassart e_t al., 1977 ) and the 
synthesis of the C-terminal amide of promellitin (Kindas-Mugge et al., 
1974) do not occur in oocytes. These modifications are probably tissue 
specific.
5. Assembly of multi-subunit proteins
In many cases the injection of mRNA into oocytes results in the non- 
covalent assembly of the products into an active protein complex. 
Probably the best example of this is the injection of torpedo electric 
organ mRNA which results in the synthesis and assembly of all four 
subunits of the nicotinic acetylcholine receptor into a functional 
receptor in the plasma membrane (Sumikawa ££ al., 1981; Miledi et al., 
1982). Functional activity however should not be taken as evidence that 
the complex is identical to its "native" counterpart. Oocyte made mouse 
-glucuronidase , for example, is active but not "native" (Labarca and 
Paigen, 1977). Not all oligomeric complexes are assembled correctly in 
oocytes (for examples see Asselbergs e£ al., 1978).
Covalent assembly via disulphide bridges has also been observed with 
oocytes (for examples see Deacon and Erbinger, 1979; Valle et al.,
1981, 1982; Colman et al., 1982).
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6. Segregation of proteins
The ability of oocytes to secrete a variety of proteins has been 
mentioned above. The only documented exception is bee venom 
promellitin. Although the signal peptide is removed from this protein 
it is not secreted to any significant extent (Lane e_t a K  , 1981a). This 
may be due to the inability of the oocytes to correctly cleave the 
propeptide.
The transport of proteins into nuclei (Lane et_ a_l., 1981b), yolk 
platelets (Berridge and Lane, 1976; Lane et^  a_l., 1983), intracellular 
membranes (Ohlsson et. al^ ., 1981) and storage granules (Hurkman ££ al., 
1979, 1981; Larkins ££ a_l., 1980) have also been observed in mRNA- 
injected oocytes.
7. Conclusion
Nearly all of the examples cited above involve the injection of mRNA 
into oocytes. However, the oocyte can also be used as a coupled 
transcript ion-translation system as first demonstrated by De Robertis 
and Mertz (1977) and reviewed by Gurdon and Melton (1981), Wickens and 
Laskey (1981) and Lane (1983). The production of a functional 
eukaryotic mRNA normally involves the addition of a 5'-terminal "cap" 
and a 3'-terminal poly(A) tail and the removal of intervening sequences 
(for a review see Darnell, 1979). Although these processes can occur 
correctly in oocytes, as evidenced in the production of ovalbumin
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(Wickens et al^ , 1980) and certain viral proteins (De Robertis and 
Mertz, 1978; Laskey e£ a_K, 1978; Rungger and Turler, 178; Rungger e£ 
al., 1979; McKnight and Gavis, 1980; Cordingley and Preston, 1981; 
Preston and Cordingley, 1982) it is quite inefficient when heterologous 
genes are used. In addition many eukaryotic promotors are either not 
used or used very inefficiently in Xenopus oocytes. A better choice for 
injection is a full length cDNA coupled to a powerful promotor as 
exemplified by the work of Krieg e£ a_l. (1984) who studied the synthesis 
and segregation of a variety of secretory proteins using plasmids 
containing cDNAs under the transcriptional control of the herpes simplex 
virus thymidine kinase promotor. In this way, these workers were able 
to identify those features of ovalbumin which are important to its 
segregation in membranes (Tabe ££ . 1984). The potential use of
oocytes for a similar study of the transport of nuclear proteins is 
greater since the nucleus can be isolated manually and there is no 
suitable cell-free system for such studies.
even
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SPECIFIC AIM
The specific aim of this work was to identify the information 
controlling the accumulation of the influenza virus nucleoprotein 
nuclei of Xenopus oocytes.
in the
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1. Anaesthetics
Sodium Barbitone (Euthetal) was obtained from May and Baker Ltd., 
Dagenham, Essex. Ethyl m-amino-benzoate (MS222) was obtained from Sigma 
Chemical Co. Ltd., Poole, Dorset.
2. Antisera
FITC-conjugated goat-anti-rabbit immunoglobulin antiserum and rabbit 
anti-human globin antiserum were obtained from Miles Laboratories Ltd., 
Stoke Poges , Slough.
Mouse monoclonal antisera against the influenza virus NP were a kind 
gift from Dr. R. G. Webster (St. Jude Children's Research Hospital, 
Memphis, USA), (van Wyke £t^  a K , 1980).
Rabbit polyclonal antiserum against the influenza virus NP was a kind 
gift from Mr. A. S. Carver (University of Warwick), and was prepared by 
the subcutaneous injection of polyacrylamide gel-purified NP into half­
lop rabbits (Hylyne, Marston, Cheshire).
3. Bacterial culture media
Antibiotic medium 3 (Bacto-Penassay Broth), Bacto-Agar, Bacto-Tryptone 
and casamino acids were obtained from Difco Laboratories, East Molesey, 
Sussex. Oxoid yeast extract was obtained from Oxoid Ltd., Basingstoke, 
Hampshire. Ampicillin and chloroamphenicol were obtained from Sigma 
Chemical Co. Ltd., Poole, Dorset.
85
4. Chemicals
All Chemicals not listed were obtained as AnalaR grade from BDH 
Chemicals Ltd., Poole, Dorset. Dithiothreitol, ethidium bromide, HEPES, 
L-methionine, nucleotide triphosphates and Trizma were obtained from 
Sigma Chemical Co. Ltd., Poole, Dorset.
5. Electrophoresis components
Acrylamide and N-N1-methylene bisacrylamide (specially pure) were 
obtained from BDH Chemicals Ltd., Poole, Dorset. N,N,N',N'- 
tetramethylenediamine (TEMED) was obtained from BioRad Laboratories 
Ltd., Watford, Herts.
Agarose (Type II) was obtained from Sigma Chemical Co. Ltd., Poole, 
Dorset.
6. Enzymes
Calf intestinal phosphatase, Escherichia coli DNA polymerase (Klenow 
fragment) and T4 DNA ligase were obtained from Boehringer Corporation 
(London) Ltd., Lewes, Sussex. Nuclease Bal-31 and the restriction 
enzymes Aha II, Bgl I, Bgl II, Nae I, Nco I and Stu I were obtained from 
C.P. Laboratories, Herts. The restriction enzymes Acc I, Bam HI,
Cia I, Hae III, Hind III, Pvu II, Sal I and Sraa I were obtained from 
Bethesda Research Laboratories Ltd., Cambridge. Lysozyme and 
ribonucléase A were obtained from Sigma Chemical Co. Ltd., Poole,
Dorset
V
1
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7. Filter paper
Whatmann 3 MM filter paper was obtained from Whatman Sales Ltd.
Maidstone, Kent.
8. Photographic components
Fuji RX X-ray film was obtained from Fujimex Ltd., Swindon. X-Omat S 
X-ray film was obtained from Kodak (Photographic) Ltd., Hemel Hempstead 
Herts. DX 80 X-ray film developer and FX 40 X—ray film fixer were 
obtained from Kodak Chemicals Ltd., Kirkby, Liverpool. The Polaroid 
Land camera and Polaroid Land film type 665 were obtained from Polaroid 
(UK) Ltd., St. Albans, Herts.
9. Radiolabelled components
L-[^^S]-methionine, 1200-1400 Ci/mmol was obtained from Amersham
International pic, Amersham, Bucks.
10. Tissue culture media
All tissue culture media and newborn calf serum were obtained from Flow 
Laboratories Ltd., Irvine, Ayrshire. The antibiotics benzyl penicillin 
(sodium) BP and streptomycin sulphate were obtained from Vestric Ltd., 
Brierley Hill, Staffs.
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1. Cells
Primary chick embryo fibroblast (CEF) cells were prepared as described 
by Morser e£ a K  (1973) and seeded at concentrations of 9 x 10® cells/
3 ml in 5 cm plastic Petri dishes or 2 x 10® cells/200 ml in roller 
bottles. The monolayers were used when confluent.
Madin-Darby canine kidney (MDCK) cells (Flow Laboratories, Irvine, 
Ayrshire) were maintained as a continuous cell culture using Dulbecco's 
modified Eagle's medium containing 5% newborn calf serum.
Baby hamster kidney (BHK-21) cells (Flow Laboratories, Irvine, Ayrshire) 
were maintained as a continuous cell culture using Glasgow's modified 
Eagle's medium (GMEM) containing 52 newborn calf serum.
2. Viruses
The type A influenza viruses used in this study were the avian strain 
A/FPV/Rostock/34 (FP/R) (H7N1 ) and the human strain A/NT/60/68 (H3N2) (a 
kind gift from Dr. G. Both, CSIRO, Genetic Research Laboratory, New 
South Wales, Australia). Both were grown by inoculation of about 10^ 
pfu into the allantoic cavity of 11-day embryonated chicken's eggs.
Those infected with FP/R were incubated for 18 h at 37°C, and those 
infected with A/NT/60/68 for 48 h at 33°C. After chilling the eggs at 
4°C overnight the allantoic fluid was collected, clarified by low speed 
centrifugation and snap-frozen in dry ice/ethanol before storing in 1 ml
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aliquots at —70°C. This was used as inoculum.
The infectivity of FP/R was determined by plaque assay on monolayers of 
primary CEF cells as described by Dimmock and Watson (1969) and 
Meier-Ewert and Dimmock (1970).
The infectivity of A/NT/60/68 was determined by plaque assay on 
monolayers of MDCK cells under an agar/medium 199 overlay containing 
0.04% DEAE-dextran, 0.14% BSA and 2.5 pg/ml trypsin-TPCK which cleaves 
the viral HA and renders progeny virus infectious (Appleyard and Maber, 
1974; Klenk e_t al^ . , 1975; Lazarowitz and Choppin, 1975). Because 
human strains are inhibited by serum, the cells were washed thoroughly 
in PBS and incubated with serum-free medium for 1 h prior to infection. 
The overlay also contained no serum.
3. Measurement of influenza virus haemagglutinin
Haemagglutinin was measured by making doubling dilutions in PBS and 
adding chicken erythrocytes to 0.5% (Borland and Mahy, 1968). The titre 
was determined by estimating the 50% end-point between full 
agglutination and no agglutination after 30 min at room temperature.
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4. Radiolabelling and purification of FP/R virus
O C
[ S]-methionine-labelied FP/R for use as markers in polyacrylamide gel 
electrophoresis, was prepared in roller bottles containing monolayers of 
primary CEF cells. Cell monolayers were washed with prewarmed PBS and 
incubated in GMEM containing 1% newborn calf serum and l/10th the normal 
methionine concentration (that is, 1.5 mg/litre) for 24 h before 
infecting with virus at a multiplicity of infection of 1 pfu/cell.
After 1 h the inoculum was replaced with 50 ml of the above medium 
containing 1 mCi [35S]-methionine. Incubation was continued for 20 h. 
Radiolabe1led virus was purified essentially as described by Dimmock et 
al. (1977 ) except that no unlabelled carrier virus was added. Briefly, 
the tissue culture fluid was clarified by centrifugation at 1,000 g for 
10 min at 4°C and the virus was precipitated with 60% saturated ammonium 
sulphate on ice. After centrifugation at 20,000 g for 20 min the virus 
pellet was resuspended in 3 ml of PBS and loaded onto a 60 ml 15-45% 
(w/v) linear sucrose gradient. Following centrifugation at 90,000 g for 
90 min at 4°C the gradient was fractionated into 2 ml aliquots and 
assayed for haemagglutinin activity and radioactivity. Where these 
activities formed a coincident peak the fractions were pooled. The 
virus was pelleted by centrifugation at 75,000 g for 2 h at 4°C, 
resuspended in 10 mM Tris-HCl (pH 7.4) and stored in aliquots at -70°C.
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5. Preparation of radiolabelled cell lysate
FP/R in allantoic fluid was added to monolayers of primary CEF cells in 
5 cm Petri dishes to give a multiplicity of infection of 30 pfu/cell. 
After 1 h incubation at 37°C the inoculum was replaced with 2 ml of 
prewarmed GMEM containing l/10th of the normal methionine concentration 
(that is, 1.5 mg/litre). 10 min prior to radiolabelling the cells were 
washed with prewarmed buffered Earle's saline (BES) and incubated with 
2 ml of BES. The cell monolayers were now incubated in a metal tray 
floating on a water bath at 37°C. At the time of labelling (3.5 h after 
addition of virus) the medium was replaced with 0.2 ml of BES containing
O  C
50 pCi f-’-'S]-methionine, and after 10 min the cells were washed twice 
with ice cold resuspension buffer (RB) (8.8 mM NaCl, 1 mM HEPES, pH 7.6) 
and scraped into 0.1 ml of RB. The cells were disrupted with ultrasound 
at 1.5 A (Soniprobe, Dawe Instruments Ltd.), dialysed against RB, freeze 
dried and resuspended in distilled water to one-tenth original volume. 
Prior to injection into oocytes the lysate was centrifuged at 12,000 g 
for 3 min at 4°C to remove any particulate matter.
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6. Preparation of mRNA
The solutions used in the preparation of mRNA are described in Table 1.
FP/R in allantoic fluid was added to monolayers of primary CEF cells in 
roller bottles (approximately 2 x 108 cells/bottle) to give a 
multiplicity of infection of 30 pfu/cell. After 1 h incubation at 37°C 
the inoculum was replaced with prewarmed medium 199 and incubation 
continued for a further 2.5 h. The cells were washed twice with ice 
cold PBS and scraped into 10 ml of the same solution using a rubber 
policeman. The cells were collected by centrifugation at 2,000 g for 
5 min at 4°C and gently resuspended in 10 ml of ice cold homogenisation 
buffer (see Table 1). After homogenisation the nuclei were pelleted by 
centrifugation at 2,000 g for 5 min. The supernatant was collected, 
made to 1% SDS, 2 mM EDTA (using stock solutions) and left at room 
temperature for 15 min. After being extracted twice with 
phenol:chloroform (Table 3) and twice with chloroform, the RNA was 
precipitated with ethanol and dissolved in 4 ml of binding buffer 
(Table 1). The preparation was enriched for poly A+ RNA by binding to 
oligo(dT)-cellulose and eluting with the same buffer lacking the LiCl. 
The polyadenyla ted RNA was ethanol precipitated, resuspended in 
distilled water to a concentration of 1 mg/ml and stored in aliquots at 
-20°C.
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Table 1 Solutions for the preparation of mRNA 
Homogenisation Buffer
0.2 M Tris-acetate (pH 8.5)
0.35 M Sucrose (ribonucléase free )
50 mM KC1
10 mM Magnésium acetate
1.3% Triton X-100
Binding Buffer
10 mM Tris—HCl (pH 7.5)
1 mM EDTA
0.1% SDS
0.5 M LiCl
The solutions were prepared from autoclaved stock solutions. All 
glassware was heat-treated at 200°C for 6 h to inactivate ribonucleases.
7. DNA techniques
The Escherichia coli strain HB101 was used throughout the study. The 
bacteria were stored at -20°C in 15% glycerol.
All enzymes were used as recommended by their manufacturers and so, for 
convenience, the conditions are omitted. Additional information is 
outlined below.
a ) Partial digestion of DNA
In many cases it was necessary to digest DNA at some, but not all, of 
the sites available to a particular restriction enzyme. To obtain the 
desired extent of digestion a reaction mixture was set up which would 
attain complete digestion after 90 min incubation. At various times 
during the incubation, samples were removed from the reaction and made 
to 1% SDS, 15 mM EDTA to stop digestion. From analysis by agarose gel 
electrophoresis it was possible to determine the time at which the 
desired extent of digestion had been obtained. An identical reaction 
mixture was then set up and allowed to incubate for this length of time 
before being made to 1% SDS, 15 mM EDTA. The desired fragment(s) was 
then purified as described in Section 12 of 'Methods A'.
b ) Digestion of DNA with two restriction enzymes
When DNA was to be digested with two restriction enzymes employing the 
same buffer, the digestions were carried out simultaneously in a single 
reaction mixture. If, however, the enzymes used different buffers then 
the DNA was digested with the first enzyme, phenol:chloroform extracted
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and ethanol precipitated and then digested with the second enzyme, 
c ) Nuclease Bal-31 digestion of DNA
Nuclease Bal-31 has an exonuclease activity which simultaneously 
degrades both the 3' and 5' termini of duplex DNA. To determine the 
length of time required to remove the desired number of nucleotides from 
a DNA sample a reaction mixture was set up as described by the enzyme 
manufacturers. At appropriate times, samples were removed from the 
reaction and made to 20 mM EGTA to stop digestion. From analysis by 
agarose gel electrophoresis it was possible to determine the time at 
which the desired amount of digestion had been obtained. An identical 
reaction mixture was then set up and allowed to incubate for this length 
of time before being made to 20 mM EGTA. The desired fragment was then 
purified as described in Section 12 of 'Methods A 1.
8. Transformation of bacteria
50 ml of L-broth (see Table 2) in a 500 ml flask was inoculated with 
1 ml of a 10 ml overnight bacterial culture. The cells were incubated 
at 37°C with vigorous shaking until the culture had reached 0.35 OD600 
(typically 95 min). This was found to give approximately 107 viable 
cells/ml. After chilling the culture on ice for 40 min the cells were 
pelleted by centrifugation at 4,000 g for 5 min at 4°C, washed once in 
25 ml of ice cold 0.1 M MgCl2 and resuspended in 2.5 ml of ice cold 
0.1 M CaCl2 (freshly made). 0.2 ml aliquots were dispensed into pre­
chilled tubes and stored at 4°C for 6 h. Between 10 and 40 ng of
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Table 2 Preparation of bacterial media
L-Broth
Bacto-tryptone 10 g
Bacto-yeast extract 5 g
NaCl 10 g
Made to 600 ml with distilled water, titrated to pH 7.5 with 1 M NaOH 
and adjusted to 1 litre with distilled water before autoclaving.
For preparing plates Bacto-agar was added to a concentration of 1.5% 
(w/v) just prior to autoclaving.
When required, ampicillin was added to the cooled medium to a 
concentration of 100 pg/ml. When preparing plates containing ampicillin 
the autoclaved agar was allowed to cool to 45°C before addition of the 
ampici11 in and pouring of the plates. A 25 mg/ml stock solution of the 
sodium salt of ampicillin in water was filter sterilised and stored in 
aliquots at -20°C.
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ligated DNA in 0.1 M Tris—HC1 (pH 7.4) was added to each tube, inverted 
and left on ice for 30 min with periodic inversions. The cells were 
heat shocked at 42°C for 2 min in a preheated water bath and returned to 
the ice bath for a further 30 min. To allow the bacteria to become 
resistant to ampicillin, 0.5 ml of L-broth was added to each tube and 
incubated at 37°C for 40 min. Ampicillin—containing plates (see Table 
2) were spread with 0.2 ml aliquots of the transformation mixture and 
incubated inverted at 37°C for 16-20 h.
9. Preparation of plasmid DNAs
Plasmid DNA from both 1 ml and 200 ml bacterial cultures was prepared by 
the alkaline lysis method (Birnboim and Doly, 1979). The composition 
and preparation of all the solutions required for the preparation of 
plasmid DNAs is described in Table 3.
For screening of colonies, selected clones were grown in 2.5 ml of L- 
broth containing 100 pg/ml ampicillin in 6 ml vials. After an 18 h 
incubation at 37°C with vigorous shaking, 1 ml of the cultures was 
transferred to a 1.5 ml eppendorf tube for plasmid extraction and the 
remainder was stored at -20°C after the addition of glycerol to 15%. 
Bacteria were pelleted by centrifugation for 1 min and the supernatant 
removed using a fine-tip aspirator. The cell pellet was resuspended in 
40 pi of solution I (see Table 3). After 5 min on ice, 80 pi of 
solution II was added and the tube gently vortexed. After a further 
5 min on ice, 50 pi of solution III was added and the contents of the
93
Tabl-e 3 Composition and preparation of the solutions required for the 
preparation of plasmid DNAs
Solution I
50 mM Glucose
25 mM Tris-HCl (pH 8.0)
10 mM EDTA
2 mg/ml Lysozyme
Prepared when required using crystalline lysozyme and stock solutions of
the other components.
Solution II
0.2 M NaOH
1Z SDS
Prepared when required using stock solutions. To avoid precipitation 
the solutions were added separately to the appropriate volume of water.
Solution III
3 M Sodium Acetate (pH 4.6)
Prepared by dissolving 246 g of sodium acetate in the minimum volume of
water, titrating to pH 4.6 with glacial acetic acid and then adjusting 
the volume to 1 litre. 3 M sodium acetate (pH 7.0) was prepared in the
same way.
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Table 3 contd.
Solution IV
Ribonuclease A at 10 mg/ml
Prepared by gently dissolving 20 mg of crytalline ribonuclease A in 1 ml 
of distilled wter. After the addition of an equal volume of glycerol 
the mixture was heated for 10 min in a boiling water bath to destroy any 
deoxyribonuclease activity and stored in aliquots at -20°C.
The phenol:chloroform mixture was prepared by freshly mixing equal 
volumes of chloroform and phenol (redistilled phenol equilibrated with 
1 mM EDTA, 50 mM ^-mercaptoethanol, 0.2 M NaCl, 0.1 M Tris-HCl, pH 
8 . 0 ) .
tube gently mixed by inversion. The tube was incubated on ice for 10 
min and then centrifuged for 5 min. This pelleted most of the 
precipitated protein, high molecular weight RNA and chromosomal DNA and 
produced an almost clear supernatant containing the plasmid DNA. The 
supernatant was recovered and transferred to a second centrifuge tube 
containing 5 pi of solution IV and incubated with shaking at 37°C for 30 
min. During the transfer, small amounts of floating material were 
sometimes carried over, but these were removed at later stages. After 
two phenol:chloroform (see Table 3) extractions and two chloroform 
extractions, 500 pi of ethanol was added to the aqueous phase, mixed by 
vortexing and incubated at -20°C for 16 h to precipitate the plasmid 
DNA. The precipitate was collected by centrifugation, dissolved in 
200 pi of 0.2 M sodium acetate (pH 7) and reprecipitated with 2 volumes 
of cold ethanol for 8 h at -20°C. The precipitate was again collected 
by centrifugation and dissolved in 25 pi of distilled water. 5 pi was 
applied to an agarose gel for electrophoretic analysis and 5 pi aliquots 
used for restriction analysis.
For the large scale preparation of DNA 2 ml of a 10 ml overnight 
bacterial culture was used to inoculate 200 ml of L-broth containing 
ampicillin. This was incubated at 37°C with vigorous shaking untl the 
culture had reached between 1.0 and 1.5 OD^qq (typically 3-6 h). 
Chloroamphenicol was added to a final concentration of 170 pg/ml and 
incubation continued for a further 20 h. The bacteria were harvested by 
centrifugation for 15 min at 5,000 rpm in an MSE 6 x 250 ml rotor. The 
centrifuge pots were drained thoroughly and the bacteria resuspended in 
4 ml of solution I before being transferred to a 50 ml Oakridge tube.
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This was chilled on ice for 30 min before adding 8 ml of solution II. 
Mixing was achieved by gently stirring with a glass rod. After chilling 
on ice for 10 min, 5 ml of solution III was added and the contents of 
the tube gently mixed by inversion. The tube was incubated on ice for 
40 min and the precipitate removed by centrifugation for 15 min at 
15,000 rpm in an MSE 8 x 50 ml rotor. The supernatant was collected and 
transferred to an Oakridge tube containing 50 pi of solution IV and 
incubated with shaking at 37°C for 30 min. After 2 phenol:chloroform 
extractions and 2 chloroform extractions the plasmid DNA was ethanol 
precipitated twice and resuspended in distilled water to a concentration 
of 1 mg/ml.
All DNA solutions were stored in aliquots at -20°C.
10. Preparation of DNA for injection into oocytes and 
cultured cells
Since circular DNA is the best template for injection (Gurdon and 
Melton, 1981 ) a sucrose gradient was used to purify this form from the 
plasmid DNA prepared from 200 ml bacterial cultures. The gradient was 
made by layering 5.5 ml of 10% sucrose (w/v) (in 10 mM Tris-HCl, pH 7.6, 
1 mM EDTA) onto an equal volume of 40% sucrose in a 14 ml centrifuge 
tube. After sealing with 'Nescofilm' the tube was placed horizontally 
at 37°C for 90 min and then vertically at 4°C for 30 min prior to 
loading. Approximately 200 pg of DNA was loaded per gradient. The 
tubes were centrifuged at 34,000 rpm in an MSE 6 x 14 ml rotor for 16 h
The fractions were analysed by agarose gel electrophoresis and those 
containing the closed circular DNA pooled and diluted with an equal 
volume of distilled water. After ethanol precipitation the DNA was 
resuspended in distilled water to a concentration of 1 mg/ml and stored 
in aliquots at -70°C.
at 4°C and fractionated by dropwise collection into 0.5 ml aliquots.
11. Agarose gel electrophoresis of DNA
The solutions required for the agarose gel electrophoresis of DNA are 
described in Table 4.
Restricted and non-restricted DNA samples were analysed using a mini gel 
apparatus (Cambridge Biotechnology Laboratories, Cambridge) in the 
submarine mode. The gel was prepared by adding the required amount of 
agarose to 38 ml of distilled water in a narrow necked flask. This was 
weighed, boiled to dissolve the agarose, reweighed and adjusted to the 
starting weight with distilled water. When the solution had cooled to 
50°C 2 ml of 20 x TEA (Table 4) was added and the gel poured. The 
agarose was dissolved in this way to avoid overheating of the buffer.
The electrophoresis buffer was TEA and, prior to loading, the samples 
were mixed with one-fifth volume of sample buffer. Electrophoresis was 
at a constant current of 100 mA until the dye front had migrated the 
required distance. After electrophoresis the gels were stained with 
ethidium bromide for 30 min and viewed on an ultra-violet light box. 
Photographic records were made using a Polaroid light camera with
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Table 4 Solutions for the agarose gel electrophoresis of DNA
TEA
20x concentrated stock
Working solut ion solution (per litre)
Tris 40 mM 96.9 g
Sodium acetate 20 mM 32.8 g
EDTA (disodium salt) 2 mM 14.9 g
A 20x concentrated stock solution was prepared by dissolving the shown 
amounts of each reagent in the minimum volume of distilled water, 
titrating to pH 8.3 with glacial acetic acid and adjusting to 1 litre 
with distilled water.
Sample Buffer
25% sucrose, 0.05% Bromophenol Blue in TEA
Ethidium Bromide 
A stock solution at 
room temperature in
a concentration of 10 mg/ml in water 
a dark bottle and diluted to 5 Mg/ml
was stored at 
in TEA when
required.
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Polaroid type 665 land film.
12. Gel purification of DNA fragments
The gel purification of DNA fragments was done by the method of Girvitz 
et al. (1980). After electrophoresis, a slit was made in the gel 
directly in front of the leading edge of the band to be purified. A 
piece of Whatman 3 MM paper backed with a piece of single dialysis 
tubing was placed into this slit with the 3 MM paper nearest the DNA 
band. Electrophoresis was then continued, using the non-submarine mode 
of operation, until the DNA band had migrated into the paper. The paper 
and dialysis membrane were removed and placed in a 400 pi microfuge tube 
which had had a hole made in the bottom using a 26 gauge needle. This 
tube was placed inside a 1.5 ml tube and centrifuged for 30 sec. The 
eluate was recovered from the 1.5 ml tube and the paper and dialysis 
membrane washed several times with TEA. The pooled eluates were 
extracted twice with phenol:chloroform and twice with chloroform and the 
DNA was recovered by ethanol precipitation.
13. Preparing oocytes for microinjection
Adult, female Xenopus laevis were obtained from the South African Snake
Farm, Windhoek, Cape Province, South Africa and maintained in tanks at1 9 _ 2 l ° c .  The frogs w e r e  fed and cleaned by Mrs. C. Kwasnik.
When a large number of oocytes were required a mature female was killed 
by the injection of Euthetal (0.3 ml per 100 g of body weight). The 
complete ovary was then removed via a small incision in the ventral 
surface of the animal.
When only a few oocytes were required the female was anaesthetised by 
immersion for about 25 min in a 0.1% solution of MS222, and a small 
incision was made in the ventral surface of the animal. The required 
number of ovary lobes were teased out through this hole, ligatured and 
excised from the animal. The incisions in the skin and body wall were 
sutured separately and the frog was left to recover partially immersed 
in 0.5% NaCl for 24 h . This method of obtaining oocytes without killing 
the frog is not only economical, but has the advantage of allowing the 
same frog to be used again at a later date, an important consideration 
since the level of translational product resulting from injected DNA 
varies between oocytes obtained from different frogs (Asselbergs et al., 
1983; Colman, 1984a).
After removal, the ovarian lobes were washed in modified Barths' saline 
(MBS) (see Table 5) and manually dissected into individual oocytes.
These were incubated in modified Barths' saline at 21°C. Only stage V 
and VI oocytes (Dupont, 1972) were used for injection.
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Table 5 Composition and preparation of modified Barths' saline (MBS)
Composi t ion
88.0 mM NaCl
1.0 mM KC1
2.4 mM NaHC03
15.0 mM HEPES-NaOH CpH 7.6)
0.30 mM CaN03 . 4 H20
0.41 mM CaC 12 . 6 H20
0.82 mM MgS04 . 7 H20
10 pg/ml Sodium penicillin
10 pg/ml Streptomycin sulphate
Preparation 
To prepare MBS,
Solution A
the solutions were mixed in the following order:
919 ml of sterile distilled water
40 ml of high salt stock solution A
40 ml of divalent cation stock solution B
1 ml of antibiotic stock solution C
ligh Salt Stock
NaCl 128 g
KC1 2 g
NaHCOj 5 g
HEPES 89 g
Table 5 contd.
These reagents were dissolved in distilled water, titrated to pH 7.6 
with 1 M NaOH and adjusted to 1 litre. After autoclaving the solution 
was stored in 40 ml aliquots at -20°C.
Solution B Divalent Cation Stock
CaN03 . 4 H20 1.90 g
CaCl2 • 6 H20 2.25 g
MgS04 . 7 H20 5.00 g
These reagents were dissolved in 1 litre of distilled water, autoclaved 
and stored in 40 ml aliquots at -20°C.
Solution C Antibiotic Stock
A solution of sodium penicillin and streptomycin sulphate, each at 10 
mg/ml was prepared just prior to use.
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14. The microinjection and subsequent culturing of oocytes
The equipment and basic manipulations necessary for the micro injection 
of oocytes is described in Colman (1984b).
a ) Injection of radiolabelled cell lysate into oocytes
After centrifugation of the radiolabelled cell lysate to remove any 
particulate matter, approximately 40 nl of sample was injected into the 
cytoplasmic region of each oocyte. To minimise the possibility of 
injecting the sample into the nucleus, and to try to keep the site of 
injection constant relative to the position of the nucleus, the oocytes 
were injected as shown in Figure 5. Injected oocytes were incubated in 
MBS for various times before being enucleated (see below).
b ) Injection of mRNA into oocytes
Prior to injection the mRNA was centrifuged at 12,000 g for 2 min at 4°C 
to remove any particulate matter. Approximately 40 nl of sample was 
injected into the cytoplasmic region of each oocyte and the injected 
oocytes were incubated in MBS for 24 h to allow the mRNA to assemble 
into polysomes. Unhealthy oocytes were discarded and the remainder 
radiolabelled for 24 h in MBS containing 1 mCi/ml [^ ^S]-methionine in 
microtitre wells (Flow Laboratories, Irvine, Ayrshire) with 30 pi 
medium/5 oocytes. The [^ S ]-methionine was dried under vacuum prior to 
the addition of the MBS since this was found to increase oocyte 
viability. After radiolabe11ing the oocytes were analysed as required.
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Prior to injection the DNA was centrifuged at 12,000 g for 2 rain at 4°C 
to remove any particulate matter. Of the two methods commonly used for 
injection into the nucleus (Colman, 1984a), the 'blind' injection method 
was preferred. This involves inserting the needle into the centre of 
the pigmented region of the oocyte to a depth where the nucleus is 
believed to be; the relative positions of the needle, the oocyte and 
the nucleus are shown in Figure 6. This method was preferred to the one 
which involves centrifugation to push the nucleus to the oocyte surface 
since it was more difficult to isolate intact nuclei from the 
centrifuged oocytes. We were also concerned that the change in both the 
shape of the nucleus and its position in the cell caused by the 
centrifugation might affect its ability to transport and accumulate 
proteins.
The success of the 'blind' injection method was estimated by the use of 
a solution of Trypan Blue in PBS (see Colman, 1984a), which showed that 
in regular practice sessions over 90% of the nuclei were being 
successfully injected.
The survival of the oocytes was increased when they were kept at 4°C for 
30 min both before and after injection. Injected oocytes were incubated 
in MBS for 24 h to allow the assembly of chromatin and the accumulation 
of mRNA before being radiolabe 1 led for 6 h in MBS containing [^ ■’s]- 
methionine at a concentration of 1 mCi/ml. After radiolabe11ing the 
oocytes were analysed as required.
c ) Injection of DNA into oocytes
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Figure 6 Relative positions of the needle, the oocyte and the
nucleus when injecting DNA by the 'blind' method
In some experiments it was necessary to perform an unlabelled chase on 
the radiolabe1led oocytes. This was achieved by thoroughly washing the 
oocytes in MBS containing 10 mM methionine and then incubating in the 
same medium for the desired length of time before analysis.
Each oocyte was injected with 25 nl of DNA at a concentration of
150 pg/ml since this was found to give the maximum expression of protein
(see 'Results', Section II).
d ) Preparation of radiolabelled cloned NP protein for 
injection into oocytes
Sixty oocytes injected with the plasmid pTKNP were radiolabelled and 
enucleated as described elsewhere in the methods. The enucleated 
oocytes were drained of excess medium, disrupted with a glass rod and 
centrifuged at 12,000 g for 3 min at 4°C. This gave a soluble 
cytoplasmic fraction containing radiolabelled cloned NP (cyt-NP). The 
nuclei were collected in the minimum volume of MBS and disrupted by 
passage through a 50 pi Hamilton syringe to produce a nuclear fraction 
containing radiolabelled cloned NP (nuc-NP). These samples were not 
frozen but kept on ice before being injected into freshly isolated 
oocytes (see below).
e ) Injection of radiolabelled cloned NP protein into oocytes 
Both the cyt-NP and nuc-NP samples were centrifuged at 12,000 g for 
2 min at 4°C prior to injection into oocytes. The samples were injected 
within 2 h of preparation. Injection into the cytoplasmic or nuclear 
regions of oocytes was as described above except that 25 nl of sample
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was used in each case. The injected oocytes were incubated in MBS for 
the required time and then analysed.
15. Enucleation of oocytes
Oocytes were enucleated in MBS at 4°C by holding the oocyte with a pair 
of watchmaker's forceps and making a slit in the apex of the pigmented 
animal half with the tip of a 26-gauge syringe needle. During this 
puncturing it was important that the needle did not penetrate into the 
cytoplasm since this would be likely to damage the nucleus. The oocyte 
was then gently squeezed around its middle to extrude the nucleus 
(Figure 7). Any cytoplasmic material adhering to the nucleus was 
removed by pipetting it up and down in a wide-mouthed plastic 
micropipettor tip. Isolated nuclei were collected in a minimum volume 
of saline and transferred to an eppendorf tube on ice. The enucleated 
oocytes were transferred using watchmakers forceps to a separate tube 
which was also kept on ice. Both samples were homogenised immediately 
after isolation.
From start to finish the enucleation procedure took about 20 sec and the 
loss of proteins during isolation was minimal as estimated from the 
analysis of the protein content of total oocytes and the combined 
cytoplasmic and nuclear fractions.
1A superficial slit was made in the apex of the pigmented half of the 
oocyte. By gently squeezing the oocyte around the equ/torial region the 
gradually extruded (A) and eventually became free.
Figure 7 Stages in the enucleation of an oocyte
nucleus was
Figure 7 Stages in the enucleation of an oocyte
A superficial slit was made in the apex of the pigmented half of the 
oocyte. By gently squeezing the oocyte around the equ/torial region the 
nucleus was gradually extruded (A) and eventually became free.
16. Homogenisation of oocytes and ooc y t e  fractions
Total oocytes and enucleated oocytes were homogenised at 4°C in 
homogenisation buffer (HB) (see Table 6) at 60 pi per fraction and 
clarified by centrifugation at 12,000 g for 1 min at 4°C. This gave 
three layers which, from the bottom, were a pellet of yolk platelets and 
pigment granules, a soluble fraction and a lipid pellicle. The middle 
soluble fraction was collected using a drawn out glass pipette and 
stored at -20°C.
Nuclei were disrupted with ultrasound from a probe at 1.5 A at 4°C in 
60 pi HB per nucleus. This was stored at -20°C and, when required, the 
thawed sample was resonicated prior to analysis.
17. Immunoprécipitation of oocyte fractions
440 pi of immunoprécipitation buffer A (Table 6) was added to 60 pi 
aliquots of oocyte sample. After addition of antibody the mixture was 
incubated at 26°C for 1 h. During this time a sample of the frozen 
j>. aureus (see Section 18 of 'Methods A') was thawed at 37°C, pelleted 
by centrifugation at 12,000 g for 30 sec and resuspended to 10% (v/v) in 
immunoprécipitation buffer B (Table 6). Resuspension was attained by 
repeatedly sucking up and down using an eppendorf micropipette. This 
suspension was left at room temperature for 15 min, repelleted and 
washed three more times in buffer B. The washed pellet was resuspended 
to 10% (v/v) in buffer B and 100 pi was added to the antibody/sample
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Tab l e  6 Composition and preparation of solutions for oocyte 
homogenisation, immunoprécipitation and polyacrylamide gel 
electrophoresis (PAGE)
Homogenisation buffer 
10 mM 
1 mM
1 %
Tris-HCl (pH 7.4) 
PMSF*
NP40
*PMSF stock solution: 0.1 M in ethanol. Stored at -20°C and dispensed 
just prior to use.
Cracking buffer
25% Glycerol
10% SDS
0.01% Bromphenol blue
3.5 M ,3-mercaptoethanol
Immunoprécipitation buffer A
0.1 M Tris-HCl (pH 8.2) 
0.1 M KC1
5 mM MgCl2
1% Triton X-100
1% Sodium deoxycholate
0.5% SDS
ImM PMSF
1 1 7
Table 6 c o n t d .
Immunoprécipitation buffer B
0.1 M Tris-HCl (pH 8.2)
0.1 M KC1
5mM MgCl2
1% Triton X-100
ImM PMSF
The immunoprécipitation buffers were prepared by mixing stock reagents 
in the following order:
Buffer A Buffer B
1 M Tris-HCl (pH 8.0) 10 ml 10 ml
1 M KC1 10 ml 10 ml
1 M MgCl2 0.5 ml 0.5 ml
10% Triton X-100 10 ml 10 ml
10% Sodium deoxycholate 10 ml -
10% SOS 5 ml -
0.1M PMSF 1 ml 1 ml
Each was adjusted to 100 ml with distilled water. The pH of each
solution was now 8.2
mixture. The mixture was incubated on a slowly rotating wheel at 4°C 
for 16 h and the bacteria were then pelleted and washed five times with 
fresh immunoprécipitation buffer A. The washed pellets were resuspended 
by vortexing in a mixture of 4 parts 10 mM Tris (pH 7.4) to 1 part 
cracking buffer. The sample was boiled for 2 min, vortexed, boiled for 
a further 2 min and centrifuged at 12,000 g for 2 min prior to analysis 
by SDS—PAGE.
Sufficient antibody was added to the immunoprecipitates to precipitate 
all of a protein in a particular sample.
18. Growth and treatment of Staphylococcus aureus for use in 
immunoprécipitation
This followed the method of Kessler (1975). A 10 ml overnight culture 
of Staphylococcus aureus Cowan 1 strain (kindly provided by H. Killen, 
University of Warwick) was used to inoculate 1 litre of growth medium 
(see Table 7) in a 4 litre standard Erlenmeyer flask. This was 
incubated with shaking at 37°C for 20 h. The bacteria were pelleted by 
centrifugation at 8,000 g for 10 min and washed twice in PBS containing 
0.05% (w/v) sodium azide. The washed pellet was resuspended to 10% 
(w/v) in PBS-azide containing 1.5% formalin and stirred for 90 min at 
23°C. The bacteria were pelleted, washed twice in PBS-azide and 
resuspended to 10% (w/v) in the same solution. They were then added to 
a large Erlenmeyer flask to a depth of less than 1.5 cm and killed by 
rapid swirling for 5 min in an 80°C water bath followed by rapid cooling
Table 7
Made Co
Composition and preparation of the growth medium for 
Staphylococcus aureus
Penassay - broth 17.5 g
Difco - yeast extract 2.5 g
Casamino acids 5.0 g
litre with distilled water and titrated to pH 7.2.
(The addition of^-glycerophosphate, niacin and thiamine-HCl (Kessl 
1975) did not increase the cell yield or their ability to bind 
antibodies and so were omitted from the growth medium).
in an iced water bath. After 2 more washes in PBS-azide the 
concentration was set at 10% (v/v) with the aid of a micrometer. The 
bacteria were stored in 1 ml aliquots at -70°C.
19. Analysis of unimmunoprecipitated oocyte fractions
One volume of cracking buffer (see Table 6) was added for every 4 
volumes of sample. The sample was vortexed, boiled for 3 min and 
analysed by SDS-PAGE (see below).
20. Polyacrylamide gel electrophoresis (PAGE) of proteins
In most cases electrophoresis used linear gradient polyacrylamide gels 
containing 0.1% sodium dodecyl sulphate (SDS) (Cook e£ al. , 1979a) and 
the buffer system of Laemmli (1970). The polyacrylamide gradient was 
from 10-30% (w/v) and was stabilized by 0 to 8% glycerol. The reagents, 
and their relevant amounts, used in the preparation of these gels are 
shown in Table 8. Gradients were prepared using a twin chambered 
gradient maker and poured under gravity. To obtain a level surface to 
the gel it was overlaid with water-saturated butan-l-ol during 
polymerisation. The ammonium persulphate concentrations were designed 
such that acrylamide polymerisation started at the lowest concentration 
of acrylamide (i.e. the top of the gel) and proceeded downwards. This 
was to minimise disturbance to the gradient through heating effects.
Once polymerised (typically 90 min at room temperature) the butan-l-ol
.,
■ i.
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was removed and Che top of the gel washed extensively with distilled 
water. The stacking gel (see Table 9) was added and allowed to 
polymerise for 20 min before use. Electrophoresis (see Table 9 for 
electrophoresis buffer) was at 14 mA for 16 h.
In some cases single concentration gels were used. The reagents, and 
their relevant amounts, used in the preparation of these gels are shown 
in Table 10. The electrophoresis buffer used for these gels was the 
same as described in Table 9. Electrophoresis was at 14 raA until the 
dye front had reached the bottom of the gel.
Gels with sufficient radioactivity were dried under suction onto filter 
paper and exposed to Fuji RX X-ray film. If increased sensitivity was 
required the gels were f1uorographed (Bonner and Laskey, 1974) and 
exposed to preflashed X-omat S film at -70°C.
21 . Determination of the amount of radioactivity in protein bands
After exposing for autoradiography, the gels were aligned with the 
developed film and the positions of the relevant bands marked. These 
were excised from the gel and placed into 3 ml of gel slice scintillant. 
This comprised, per litre: 92 ml of NCS tissue solubiliser, 42 ml of 
liquifier (4 g PPO and 50 mg POPOP in toluene), 856 ml of toluene and 
10 ml of water. Slices were incubated for 48 h at 37°C and 6 h at 4°C 
before measuring the radioactivity.
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Table 9 Solutions used in gradient polyacrylamide gel electrophoresis
Stacking gel
Reagent Volume (ml) Molar or 
% concentration
30% Acrylamide plus 0.8% Bis-acrylamide 1.50 4.5% Acrylamide
0.12% Bis-acrylamide
1 M Tris-HCl (pH 6.8) 1.25 0.125M
Water 7.09
10% SDS 0.10 0.1%
10% Ammonium persulphate 0.03 0.03%
TEMED 0.03
Electrophoresis Buffer
Reagent Molar or % concentration
Tris 0.025M 14.8 g
Glycine 0.197M 3.0 g
SDS 0.1% 1.0 g
Prepared by dissolving the reagents in 1 litre of distilled water.


22. Calculation of the nuclear to cytoplasmic concentration ratio
Calculation of the extent to which a protein is concentrated in the
nucleus depends on the relative nuclear and cytoplasmic volumes. On a
purely volumetric basis the nucleus occupies about 4% of fully grown
amphibian oocytes, but if such a value is used almost any substance that
is able to cross the nuclear envelope appears to accumulate slightly in
nuclei j^ n vivo, i.e. over 4% of the substance is found in the nucleus.
These substances include inorganic ions, sugars, amino acids, gold
particles and small proteins (see Bonner, 1978 for references). A
possible reason for this surprising observation was first proposed by
Abelson and Duryee who suggested that the low level accumulation of
exchangeable sodium ions in oocyte nuclei (where approximately 82 was in
the nucleus) was the result of different water contents in the nucleus
and the cytoplasm (Abelson and Duryee, 1949). It was subsequently
demonstrated that the relative water content between the nucleus and the 
a
cytoplasm in these cells was approximately 1.9:1 (Century e£ al,, 1970). 
This would explain the nuclear presence of about 7.6% (1.9 x 4) of the 
sodium ions.
Even allowing for these different water contents many substances were 
still found to accumulate at low levels in the nucleus. When tritiated 
sucrose, for example, was injected into amphibian oocytes approximately 
12% was found in the nucleus (Horowitz, 1972). This gives a nuclear to 
cytoplasmic concentration ratio of 3 when only the relative nuclear and 
cytoplasmic volumes are considered, and a ratio of 1.6 when the relative 
water contents are also taken into account. An earlier suggestion that
1this may reflect the inability of some of the cytoplasmic water to act 
as a solvent (Horowitz and Fenichel, 1968) was verified by an elegant 
experiment in which a defined aqueous reference phase was introduced 
into the cytoplasm (Horowitz and Paine, 1976). When sucrose was 
injected into these oocytes it accumulated in both the nucleus and the 
reference phase to a similar extent, and using this result these workers 
concluded that about 30% of the cytoplasmic water was not available to 
act as a solvent. This phenomenon of cytoplasmic exclusion is not 
restricted to oocytes and is believed to be responsible for low level 
nuclear accumulation in amoebae (Feldherr, 1962b) and the giant salivary 
gland cells of Chironomous (Paine, 1975).
Although these observations show how cytoplasmic exclusion can account 
for low level nuclear accumulation they do not specify the molecular 
mechanism(s) responsible. These mechanisms may include changes in the 
bulk solvent properties of the water, for example, through hydrophobic 
interactions or solvent-polymer hydrogen bonding, or they could involve 
restricted accessibility of the water by micro-compartmentalisation or 
polymer-solute repulsion. Similar behaviour is seen in other 
macromolecular systems such as solutions of vaccinia virus (McFarlane, 
1939), hyaluronic acid (Ogston and Phelps, 1960) and the cross-linked 
dextrans used in chromatography.
In amphibian oocytes another factor needs to be considered. The 
cytoplasm of these cells contains a large number of yolk platelets which 
contribute to the excluded volume as they are impermeable to injected 
proteins (Bonner, 1975a).
Talcing all these factors into consideration it has been estimated that 
the nucleus represents 12% of the oocyte volume accessible to most 
macromolecules (Bonner, 1978).
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23. Injection of the plasmid pTKNP into cultured cells
The injection of the plasmid pTKNP into cultured cells was performed by 
Dr. A. Colman using the method of Graessmann e£ al^ . (1980). BHK-21 
cells were grown on ethanol washed, heat-sterilised 16 mm glass 
coverslips in 5 cm plastic Petri dishes. The plates were seeded at 1-2 
x 10® cells per plate and allowed to grow to 30-50% confluency prior to 
injection with DNA at a concentration of 1 mg/ml.
24. Fluorescent antibody staining of cultured cells
Cells injected with the plasmid pTKP or infected with influenza virus 
A/NT/60/68 were incubated for 8 h prior to analysis by indirect 
fluorescent antibody staining. This analysis was performed by Miss E. 
Wallis using the method of Ash ££ al^ . (1977 ). Fluorescence was observed 
with a Zeiss microscope (Micro-Instruments Ltd., Oxford).
METHODS B
THE CONSTRUCTION OF PLASMIDS
1 3 0
The construction and basic features of the eukaryotic expression vector 
pTK2 is described in Krieg e£ al. (1984) and Figure 8.
Influenza virus contains a genome consisting of eight segments of single 
stranded RNA which is of opposite polarity to mRNA and therefore termed 
negative sense (Baltimore, 1971). The majority of these segments encode 
a single polypeptide (see 'General Introduction', Section VII) and the 
fifth largest segment, band 5, encodes the nucleoprotein (NP). A full 
Length double stranded DNA copy of band 5 of influenza virus A/NT/60/68 
was kindly provided by Professor G. G. Brownlee (Huddleston and 
Brownlee, 1982) and inserted into the Pvu II site of the plasmid pAT/Pvu 
H / 8  (Anson e_t a 1. , 1984) to produce pATNP. The NP coding region of 
pATNP was excised and inserted into the vector pTK2 to give pTKNP 
(Figure 9).
To ease description of the manipulations of pTKNP a numbering system was 
employed. The reference origin is taken as being midway through the 
Pvu II site at the junction between the pBR322 and TK promotor 
fragments. Numbering is in the direction of transcription from the TK 
promotor and gives a total of 5423 bp.
1. Construction of the plasmid pTKNP
1The plasmid pSV S-SFV (d-1 ) (Kondor-Koch e£ al_., 1983) contains part of 
the Semiiki Forest virus (SFV) genome (stipled box) under the 
expressional control of elements from the simian virus (SV) 40 genome 
(open box). The SV40 early promoter (betwen the Pvu II and Hind III 
sites) and the SFV sequence were removed by digestion with Pvu II and 
Hind III and replaced by the Pvu II/Bgl II fragment of pTKl. The 
plasmid pTKl consists of a fragment of the herpes simplex virus (HSV) 
genome (solid box) containing the thymidine kinase (TK) gene cloned into 
the Bam HI site of pAT 153 (thin line) (Wilkie e£ a U , 1980). The 
resulting vector, pTK2 , contains the 2.3 Kbp fragment of plasmid pBR322 
from the Eco RI site at position 4360 to the Pvu II site at position 
2067 (Sutcliffe, 1978) (thick line). This carries the origin for DNA 
replication and the gene conferring resistance to ampicillin; the 988 
bp Eco RI/Bcl I fragment of the SV40 genome (open box) containing the 
polyadenylation signal for the SV40 early transcripts (Tooze, 1980); a 
250 bp Pvu II/Bgl II fragment of the plasmid pTKl (shaded box), 
containing the transcription promotor region of the TK gene but lacking 
the ATG translation initiation codon. The direction of transcription is 
indicated by the arrow. A 21 bp synthetic oligonucleotide containing 
translation termination codons in all three reading frames (Pettersson 
et al. , 1983) (hatched box). In future this region is termed the stop
Figure 8 C o nstruction of the expression vector pTK0
region.
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Figure 9 Construction of the plasmid pTKNP
A full length double stranded DNA copy of the nucleoprotein gene of 
influenza virus a /NT/60/68 (stipled box) was blunt end ligated into the 
Pvu II site of pAT/Pvu II/8 to produce pATNP. The NP coding region was 
excised from pATNP using Cla I and Sal I and the fragment was end-filled 
using the Klenow fragment of Escherichia coli DNA polymerase prior to 
blunt end ligation into the end-filled Hind III site of the expression 
vector PTK2 to give pTKNP. The elements in pTKNP have the same key as 
those for p T ^  in Figure 8 with the addition of the NP gene (stipled 
box) and the flanking sequences from pAT/Pvu II/8 (thin line).
2. Construction of mutants plasmids lacking various amounts of the
carboxyl terminus of the NP gene
In the production of these mutants use was made of the Hind III 
restriction site created when the end-filled Sal I site of the NP gene 
containing insert was ligated to the end-filled Hind III site of the 
vector pTK2 (see Figure 9). This Hind III site is therefore immediately 
before the stop region of pTKNP. The idea was to remove from pTKNP a 
region from a chosen restriction site within the NP coding sequence to 
this Hind III site and thereby remove that region of NP to the carboxyl 
side of the chosen site. Since such a manipulation removes the 
authentic NP translation terminator the resulting mutants are terminated 
by codons in the stop region. Six clones were constructed using this 
procedure:
A.
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a ) Construction of the plasmid pTKNP Hind 1348
The plasmid pTKNP contains 3 Hind III sites; one in the short pAT/Pvu 
II/8 sequence at the amino end of the NP gene (at position 263); one 
within the NP coding region (1348) and a third which is recreated at the 
carboxyl end of the NP insert (2118). A Hind III partial digestion of 
pTKNP was performed and the 4653 bp fragment from Hind III (2118) to 
Hind III (1348) was purified by gel electrophoresis. This was ligated 
to give pTKNP Hind 1348. These manipulations are illustrated 
diagrammatica1ly in Figure 10 while Figure 11 shows the relevant 
manipulations at the nucleotide level.
The predicted protein from pTKNP Hind 1348 has the first 345 amino acids 
of NP plus 4 amino acids encoded by the stop region. From the 
nucleotide sequence it has a MW of 39,405.
Hindi
Hind I
Hind III
Figure 10 Construction of the plasmid pTKNP Hind 1348
See text for details of the construction. The key for the various 
elements is:
Thick line pBR322 fragment
Solid box TK promotor
Thin line Flanking sequence from pAT/Pvu II/8
Stipled box NP coding sequence
Hatched box Stop region
Open box SV40 polyadenylation signal
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Figure 11 Construction of the plasmid pTKNP Hind 1348 at the 
nucleotide level
Only those regions around the Hind III sites at positions 1348 and 2118 
are shown. The numbers below the top sequence refer to the positions of 
the nucleotides in the plasmid pTKNP while above the sequence are the 
encoded amino acids and their positions in NP. The letters and numbers 
below the bottom sequence refer to the amino acids encoded by the stop 
region and their positions in the mutant protein.
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b ) Construction of the plasmids pTKNP Pvu 705, pTKNP Pvu 1011 and 
pTKNP Pvu 1295
The plasmid pTKNP contains four Pvu II sites; the one used as the 
reference origin and three within the NP coding region. The relative 
positions of these sites are shown in Figure 12. After partial 
digestion with Pvu II three DNA fragments were purified by 
electrophoresis: the 708 bp fragment from Pvu II (-3) to Pvu II (705);
the 1014 bp fragment from Pvu II (-3) to Pvu II (1011) and the 1298 bp 
fragment from Pvu II (-3) to Pvu II (1295). To accomodate these 
fragments the plasmid pTKNP was digested with Pvu II and Hind III and 
the resulting 3305 bp fragment from Hind III (2118) to Pvu II (-3) 
purified and end filled. Ligation of the three fragments to this 
manipulated vector resulted in the plasmids pTKNP Pvu 705, pTKNP Pvu 
1011 and pTKNP Pvu 1295 respectively.
Figure 13 shows the construction of pTKNP Pvu 705 at the nucleotide 
level while figures 14 and 15 show the final constructs of pTKNP Pvu 
1011 and pTKNP Pvu 1295 respectively.
The predicted protein from pTKNP Pvu 705 has 134 amino acids, the first 
130 of NP and 4 encoded by the stop region, and a MW of 15,450. The 
predicted protein from pTKNP Pvu 1011 has 236 amino acids, the first 232 
amino acids of NP and 4 encoded by the stop rgion, and a MW of 26,983. 
The predicted protein from pTKNP Pvu 1295 has 332 amino acids, the first 
327 amino acids of NP and 5 encoded by the stop region, and a MW of
37,487.
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Figure 12 Construction of the plasmids pTKNP Pvu 705, pTKNP 
Pvu 1011 and pTKNP Pvu 1295
See text for details of the construction. The key for the various
elements is as in Figure 10.
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Construction of the plasmid pTKNP Pvu 705
nucleotide level
Only those regions around the Pvu II site (705) and the Hind III site 
(2118) are shown. The numbers below the top sequence refer to the 
positions of the nucleotides in the plasmid pTKNP while above the 
sequence are the encoded amino acids and their positions in NP. The 
letters and numbers below the bottom sequence refer to the amino acids 
encoded by the stop region and their positions in the mutant protein.
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Figure 14 The carboxyl terminus of the NP encoding region of 
the plasmid pTKNP Pvu 1011
This shows the result of ligating the Pvu II site at position 1011 to 
the end- filled Hind III site (2118). Above the sequence are the 
encoded amino acids and their positions in NP while below the sequence 
are the amino acids encoded by the stop region and their positions in 
the mutant protein.
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Figure 15 The carboxyl terminus of the NP encoding region of 
the plasmid pTKNP Pvu 1295
This shows the result of ligating the Pvu II site at position 1295 to 
the end-filled Hind III site (2118). Above the sequence are the encoded 
amino acids and their positions in NP while below the sequence are the 
amino acids encoded by the stop region and their positions in the mutant 
protein.
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c ) Construction of the plasmid pTKNP Acc 1250
Due to the presence of inconvenient restriction sites in pTKNP, the 
plasmid pATNP was used as the starting point in the construction of 
pTKNP Acc 1250. As shown in Figure 16 pATNP has two Acc I and one Cla I 
restriction sites. Digestion of pATNP with Acc I and Cla I resulted in 
the production of a 993 bp fragment which was purified, end filled and 
blunt end ligated into the end filled Hind III site of the vector pT^ 
(Figure 16).
These manipulations are shown at the nucleotide level in Figure 17. The 
resulting clone is identical to pTKNP at the amino end of the insert 
(see Figure 9). The predicted protein has the first 312 amino acids of
NP and a MW of 35,212.
1 4 3
Cla  I
Figure 16 Construction of the plasmid pTKNP Acc 1250
See text for details of the construction. The key for the various
elements is as in Figure 10.
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Figure 17 Construction of the plasmid pTKNP Acc 1250 at the 
nucleotide level
The encoded amino acids and their positions in NP are shown at the
relevant Acc I site in the plasmid pATNP. In the final construct the
translation termination codon from the stop region is also shown.
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d ) Construction of the plasmid pTKNP Hae 1474
Due to the presence of inconvenient restriction sites in pTKNP the 
plasmid pATNP was used as the starting point in the construction of 
pTKNP Hae 1474. Figure 18 shows the position of the unique Cla I site 
in pATNP and the first Hae III site in a clockwise direction from this 
Cla I site. The other twentyone Hae III sites are omitted for clarity. 
Digestion of pATNP with Hae III and Cla I resulted in the production of 
a 1217 bp fragment which was purified, end filled and blunt end ligated 
into the end filled Hind III site of the vector pT^ (Figure 18). These 
manipulations are shown at the nucleotide level in Figure 19. The 
resulting clone is identical to pTKNP at the amino end of the insert 
(see Figure 9). The predicted protein has 390 amino acids, the first 
386 of NP and 4 encoded by the stop region, and a MW of 44,029.
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Figure 18 Construction of the plasmid pTKNP Hae 1474
See text for details of the construction. The key for the various
elements is as in Figure 10.
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Figure 19 Construction of the plasmid pTKNP Hae 1474 at the 
nucleotide level
The encoded amino acids and their positions in NP are shown at the
relevant Hae III site in the plasmid pATNP. In the final construct the
translation termination codon from the stop region is also shown.
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3. Construction of mutant plasmids lacking regions from within 
the NP gene
By using carefully chosen restriction enzymes it is possible to remove a 
region from within the NP coding sequence of pTKNP such that religation 
of the remaining amino and carboxyl termini recreates the correct 
reading frame. Four clones were constructed using this procedure:
a ) Construction of the plasmid pTKNP Bam 577/793
The plasmid pTKNP contains four Bam HI sites; two within the NP coding 
region (at positions 577 and 793); one in the pAT/Pvu II/8 sequence at 
the carboxyl end of the NP gene (1839) and one in the SV40 region 
(2376). A Bam HI partial digestion of pTKNP was performed and the 5207 
bp fragment from Bam Hi (793) to Bam HI (577) was purified by gel 
electrophoresis. This was ligated to itself to give pTKNP Bam 577/793 
(Figure 20). The relevant manipulations are shown at the nucleotide 
level in Figure 21.
The predicted protein from pTKNP Bam 577/793 has a MW of 47,512 and is 
identical to NP apart from lacking amino acids 88 to 159 inclusive.
1 4 9
Bam HI partial 
digestion
Isolate 5 2 0 7 b p  
fragment
j ü g a t e
Figure 20 Construction of the plasmid pTKNP Bam 577/793
See text for details of the construction. The key for the various
elements is as in Figure 10.
1 5 0
8 7 88 89
K D P
- a a g G A T C C  T
- T T C C T A G G  A
-----A A G
-----T T C  C T A  G
159 160 161
M D p
■ A T G G A T C C C - - -
-T A C C T A
u->o
fN.
G G G -  -  -
Bam HI partial  digestion 
Isolate 5 2 0 7  bp f ragment
G A T  C C C -----
G G -----
Ligate
8 7  160 161
K D P
----- A A G  G A T  C C C -----
-----T T C  C T A  G G G ------
Figure 21 Construction of the plasmid pTKNP Bam 577/793 at the 
nucleotide level
Only those regions around the Bam HI sites at positions 577 and 793 are 
shown. The numbers below the sequence refer to the positions of the 
nucleotides in the plasmid pTKNP while above the sequence are the 
encoded amino acids and their positions in NP.
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b ) Construction of the plasmid pTKNP Pvu 705/1011
The plasmid pTKNP contains four Pvu II sites; the one used as the 
reference origin (position -3) and three within the NP coding region (at 
positions 705, 1011 and 1295). A Pvu II partial digestion of pTKNP was 
performed and the 5117 bp fragment from Pvu II (1011) to Pvu II (705) 
was purified by gel electrophoresis. This was ligated to itself to give 
pTKNP Pvu 705/1011 (Figure 22). The relevant manipulations are shown at 
the nucleotide level in Figure 23.
The predicted protein from pTKNP Pvu 705/1011 has a MW of 44,357 and is 
identical to NP apart from lacking amino acids 131 to 232 inclusive.
1 5 2
Pvu II partial  
digestion 
Isolate 5 1 1 7  bp 
fragment
Figure 22 Construction of the plasmid pTKNP Pvu 705/1011
See text for details of the construction,
elements is as in Figure 10.
The key for the various
1 Ç 7
1 3 0  131 13 2 2 3 2  2 3 3 2 3 4
T A G T A A
A C A  G C T G G T - - A C A  G C T G C A -
T G T  C G A C C A - T G T  C G A C G T -•no O O «Or*v o  o
Pvu II partial digestion
Isolate 5 1 1 7  bp fragment
'
-----A C A G C T  G C A - _  _
-----T G T C G a  c g t - —
Ligate
130 2 3 3 2 3 4
T A A
- A C A G C  T G C A - - -
- T G T C G A C G T -----
Figure 23 Construction of the plasmid pTKNP Pvu 705/1011 at the 
nucleotide level
Only those regions around the Pvu II sites at positions 705 and 1011 are 
shown. The numbers below the sequence refer to the positions of the 
nucleotides in the plasmid pTKNP while above the sequence are the 
encoded amino acids and their positions in NP.
*c ) Construction of the plasmid pTKNP Bgl 1078/1333
The plasmid pTKNP contains two Bgl II sites, both in the NP coding 
region (at positions 1078 and 1333). A Bgl II digestion of pTKNP was 
performed and the 5168 bp fragment from Bgl II (1333) to Bgl II (1078) 
was purified by gel electrophoresis. This was ligated to itself to give 
pTKNP Bgl 1078/133 (Figure 24). The relevant manipulations are shown at 
the nucleotide level in Figure 25.
The predicted protein from pTKNP Bgl 1078/1333 has a MW of 46,630 and is 
identical to NP apart from lacking amino acids 255 to 339 inclusive.
1 54
1 5 5
Figure 24 Construction of the plasmid pTKNP Bgl 1078/1333
See text for details of the construction. The key for the
elements is as in Fig u r e  10.
various
1 5 6
2 5 4  2 5 5 2 5 6 3 3 9 3 4 0 3 4 1
E D L E D L
g a a  g a t C T C ....... ....... G a a g a  t C T A
C T T  C T A G a g - - - ....... C T T C T A G A T
Bgl II
Isolate 5 16 8  bp fragment
-----G  A  A
— C T T  C T A G
G A T  C T A -----
A T ---
Ligate
2 5 4 3 4 0 341
E D L
— G a a g a t C T A -----
- - - C T T C T A G A T -----
Figure 25 Construction of the plasmid pTKNP Bgi 1078/1333 at the 
nucleotide level
Only those regions around the Bgl II sites at positions 1078 and 1333 
are shown. The numbers below the sequence refer to the positions of the 
nucleotides in the plasmid pTKNP while above the sequence are the 
encoded amino acids and their positions in NP.
1 5 7
d ) Construction of the plasmid pTKNP IMP 1295
The plasmid pTKNP has seven Aha II sites. The first of these, in the 
direction of transcription, is at position 319 which is just downstream 
of the NP initiation codon. Digestion of pTKNP with Pvu II and Aha II 
produced a 322 bp fragment containing the TK promotor and the ATG 
initiator. This was purified, end filled and ligated to the 4125 bp 
fragment (from Pvu II (1295) to Pvu II (-3)) produced by Pvu II 
digestion of pTKNP. These manipulations are illustrated in Figure 26 
and at the nucleotide level in Figure 27. The resulting construct, 
pTKNP IMP 1295, should direct the synthesis of a protein having a MW of 
19,164 and be identical to NP apart from lacking amino acids 3 to 327
inclusive.
Figure 26 Construction of Che plasmid pTKNP IMP 1295
See text for details of the construction. The key for the various 
elements is as in Figure 10. P represents Pvu II sites and A 
represents AHA II sites.
1 5 9
-A A T C 
-T T A G
—  T
1 2 3 3 2 6 3 2 7  3 2 8 3 2 9
M A S S Q L V
A T G G C G T C C ---- ....... A G  T C A G  C T G G T G - - -
T A C C G C A G G — ....... T C  A G  TC  G A C C A C  —OiN «OCN S  o
5  8
Aha II
!
Pvu II
A T C A T G G C T G  G T G ----
T A G T A C C G C G A C  C A C - - -
— A A  T C A T G  G C G  
---- T T A G  T A C  C G C
End fill
' r
C T G  G  T G ----
G  A C  C A C - - -
Ligate
1 2 3 2 8 3 2 9
M A L V
---- A A T C A T G G C G C T G G T G
---- T T A G T A C C G C G A C C A C
Figure 27 Construction of the plasmid pTKNP IMP 1295 at the 
nucleotide level
Only those regions around the Aha II sites at position 319 and the Pvu 
II site at 1295 are shown. The numbers below the sequence refer to the 
position of the nucleotides in the plasmid pTKNP while above the
sequence is the encoded amino acid and its position in NP
4. Construction of mutant plasmids lacking various amounts of the 
amino terminus of the NP gene
In the construction of these mutants use was made of the Hind III site 
at position 263 which is in the short pAT/Pvu II/8 sequence at the amino 
end of the NP gene and is therefore after the TK transcription promotor 
region but before the authentic NP translation initiation codon. The 
idea was to remove from pTKNP a region from a chosen restriction site 
within the NP coding sequence to this Hind III site and thereby remove 
that region of NP to the amino side of the chosen site. Five clones 
constructed using this procedure:were
161
a ) Construction of the plasmid pTKNP Hind 1348C
The plasmid pTKNP contains three Hind III sites; one in the short 
pAT/Pvu II/8 sequence at the amino end of the NP gene (position 263); 
one within the NP coding region (1348) and a third which is recreated at 
the carboxyl end of the NP insert (2118). A Hind III partial digestion 
of pTKNP was performed and the 4338 bp fragment from Hind III (1348) to 
Hind III (263) was purified by gel electrophoresis. This was ligated to 
itself to give pTKNP Hind 1348C. These manipulations are illustrated 
diagrammatically in Figure 28 while Figure 29 shows the relevant 
manipulations at the nucleotide level.
The first ATG after the transcriptional promotor in pTKNP Hind 1348C 
spans the codons that encoded amino acids 368 and 369 in the authentic 
NP and so translation initation at this point will give a protein 
bearing no resemblance to NP. In fact, initiation at this triplet gives 
a peptide of 13 amino acids (Figure 30). Translation initiation at the 
second ATG, which encodes amino acid number 371 in the authentic NP, 
would give a protein having the last 128 amino acids of NP and a MW of
14,262.
Figure 28
162 1
Construction of the plasmid pTKNP Hind 1348C
See text for details of the construction. The key for the various
elements is as in Figure 10.
1 6 3
3 4 4 3 4 5 3 4 6
L S F
A A G C  T T  — ........T T A A G C T T C
T T C G A A -----
•Oo
CN
....... A A  T T C G
a
n
A A G
3 6 7 3 6 8 3 69 3 7 0 3 7 1
S N E N M
• T C A A A  T g a a A A C A T G
- A G  T T T A C T T T T G T A C
Hind III partial  digestion 
Isolate 4 3 3 8  bp fragment
-----A A G C  T T C -----
—  T T C G A  A G - - -
Ligate
3 4 5 3 4 6 3 6 7
S F S
A A G C T T C ....... -----T C A
T T C G A A G ....... -----A G  T
3 6 8  369 3 7 0 37 1
N E N M
A A T G A A A A C A T G —
T T A C T T T T G T A C —
First First
ATG Iin phase'  
ATG
Figure 29 Construction of the plasmid pTKNP Hind 1348C at the 
nucleotide level
Only those regions around the Hind III sites at positions 263 and 1348 
and at the first ATG codon after 1348 are shown. The numbers below the 
sequence refer to the positions of the nucleotides in the plasmid pTKNP 
while above the sequence are the encoded amino acids and their positions 
in NP. The final construct shows the first downstream ATG and the first 
in phase ATG.
1 6 4
370  375 380
S N E N M D A M E S S T I E I R
--------T C A A A T G A A A A C A T  G G A  T G C  T A T G G A  A T C A A G T  A C T C T T G a A C T G A G A --------
M K T W M L W N Q V l  L N *
1 5 )0
Figure 30 The peptide resulting from translation initiation at the 
first ATG in pTKNP Hind 1348C
The nucleotide sequence is written in the coding sense. Above the 
sequence is the encoded amino acid and its position in NP while below 
the sequence is the peptide resulting from initiation at the first ATG 
in pTKNP Hind 1348C.
b ) Construction of the plasmids pTKNP Met 136, pTKNP Met 238 and 
pTKNP Met 331/S
The plasmid pTKNP contains four Pvu II sites; the one used as the 
reference origin (-3) and three within the NP coding region (at 
positions 705, 1011 and 1295). After partial digestion with Pvu II 
three DNA fragments were purified by electrophoresis; the 4715 bp 
fragment from Pvu II (705) to Pvu II (-3); the 4409 bp fragment from 
Pvu II (1011) to Pvu (-3) and the 4125 bp fragment from Pvu II (1295) to 
Pvu II (-3). These fragments were ligated to the 266 bp fragment 
containing the TK promotor region that was isolated after digestion of 
pTKNP with Pvu II and Hind III. This fragment was end filled prior to 
ligation. Ligation gave the plasmids pTKNP Met 136, pTKNP Met 238 and 
PTKNP Met 331/S respectively. These manipulations are illustrated in 
Figure 31.
In pTKNP Met 136 it is thought that translation initiation will occur at 
the ATG codon encoding amino acid number 136 in NP (Figure 32). This 
would give a product containing the last 363 amino acids of NP and 
having a MW of 40,407. In pTKNP Met 238 it is thought that translation 
initiation will occur at the ATG codon encoding amino acid number 238 in 
NP (Figure 33). This would give a product containing the last 261 amino 
acids of NP and having a MW of 28,856. In pTKNP Met 331/S it is thought 
that translation initiation will occur at the ATG codon encoding amino 
acid number 331 in NP (Figure 34). This would give a product containing 
the last 168 amino acids of NP and having a MW of 18,564.
1 65
1 6 6
Figure 31 Construction of the plasmids pTKNP Met 136, pTKNP 
Met 238 and pTKNP Met 331/S
See text for details of the construction. The key for the various 
elements is as in Figure 10.
1 6 7
1 30 131  1 32
T A G
-----A A G C T  T ........ - - • - AC A G C T  G G T
-----T T C G A A ......... ----T G T C G A  C C A•O oCN
Hind III Pvu II
----- A C T G G T -----
----- T T C G A G A C C A - - -
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- - - A A G C T C T G G T -----
—  T T C G A G A C C A - - -
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1 3 2 1 33 1 3 4 135 1 3 6
G L T H M
-----A A G C T C T G G T C T G A C T C A C  A T G
-----T T C G A G A C C A G A C T G A G T G  T A C  
M
l
Figure 32 Construction of the plasmid pTKNP Met 136 at the 
nucleotide level
Only those regions around the Hind III sites at position 263 and and the 
Pvu II site at 705 ire shown. Above the sequence is the encoded amino 
acid and its position in NP while below the sequence is initially the 
position of the nucleotides in pTKNP, and finally the position of 
proposed translation initiation in the mutant construct.
1 6 8
2 3 2 2 3 3  2 3 4
T A A
-----A A G C T T.......... - • -AC A G C T  G C A
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<o O <n
CN o O
Hind III Pvu II
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----- T T C G A G A C G T -----
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----- A A G C  T C T G C A - - -
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Figure 33 Construction of the plasmid pTKNP Met 238 at the 
nucleotide level
Only those regions around the Hind III sites at position 263 and the Pvu 
II site at 1011 are shown. Above the sequence is the encoded amino acid 
and its position in NP while below the sequence is initially the 
position of the nucleotides in pTKNP, and finally the position of 
proposed translation initiation in the mutant construct.
1 6 9
- A A G C  T T- 
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M
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the plasmid pTKNP Met 331/S <
nucleotide level
Only Chose regions around the Hind III sites at position 263 and the Pvu 
II site at 1295 are shown. Above the sequence is the encoded amino acid 
and its position in NP while below the sequence is initially the 
position of the nucleotides in pTKNP, and finally the position of 
proposed translation initiation in the mutant construct.
1 7 0
Due to the presence of inconvenient restriction sites in pTKNP the 
plasmid pATNP was used as the starting point in the construction of 
pTKNP Met 331/L. The plasmid pATNP has two Acc I sites: one within the 
NP gene and one downstream of the carboxyl end of the gene. This second 
site is also recognised by the enzyme Sal I although this pair of 
isoschizomers cut the target site at different places. Digestion of 
pATNP with Sal I produced a linear molecule which was purified and 
further digested with Acc I. The smaller of the two fragments produced 
by this second digestion (the 864 bp Acc I/Sal I fragment of pATNP) was 
.purified, end filled and blunt end ligated into the end filled Hind III 
site of pTKNP. The resulting clone is identical to pTKNP at the 
carboxyl end of the insert (see Figure 9). These manipulations are 
illustrated in Figure 35, and at the nucleotide level in Figure 36.
In pTKNP Met 331/L it is thought that translation initiation will occur 
at the ATG codon encoding amino acid number 331 in NP. This would give 
a product containing the last 168 amino acids of NP and having a MW of
c ) Construction of the plasmid pTKNP Met 331/L
Figure 35 Construction of the plasmid pTKNP Met 331/L
See text for details of the construction. The key for the various 
elements is as in Figure 10.
pTKNP
— A A G C T T —  — C A A
----- T T C G A A   -------G T T
•n
OCN
Hind III
"
-----A
-----T T C G A
pATNP
3 1 2  3 1 3 3 1 4 3 3 1
V Y S M
G T A  T A C A G C ....... -----A T G -
C A T  A T G T C G ........ ■ • - - T A C -
Acc I
A T A C  A G C -----
T G  T C G -----
End fill End fill
-----A A G C  T
-----T T C G A
A T A C  A G C -----
T A T G  T C G -----
M
1
Figure 36 Construction of Che plasmid pTKNP Met 331/L at the 
nucleotide level
The regions around the Hind III site at position 263 in pTKNP and the 
relevant Acc I site in pATNP are shown. Also shown is the first ATG
downstream of this Acc I site. Above the bottom sequence is the encoded
amino acid and its position in NP while below the sequence is the
»■
position of the proposed translation initiation in the mutant construct.
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The plasmid PGOV2 (kindly supplied by V. Lingappa, UCSF California, USA) 
contains a full length cDNA copy of the chimpanzee a^globin. At the 
carboxyl end of the globin coding region there is part of a cDNA copy of 
chicken ovalbumin from the Pst I site at amino acid 139 through to the 
translation terminator. Digestion of pGOV2 with Nco I (the Nco I site 
spans the initiation codon of the globin gene) and Stu I (the Stu I site 
spans the codon for amino acid number 252 of the ovalbumin gene) yielded 
a fragment of 990 bp which was purified by electrophoresis.
The plasmid pTK20V+ (kindly supplied by A. Colman; Krieg et a_l. , 1984) 
contains a full length cDNA copy of the chicken ovalbumin gene cloned 
into the Hind III site of the expression vector pTK2. Digestion of 
pTK20V+ with Nco I (the Nco I site spans the initiation codon of the 
ovalbumin gene) and Stu I (the Stu I site spans the codon for amino acid 
number 252 of the ovalbumin gene) yielded a large fragment of 4121 bp 
which was purified by electrophoresis.
The two fragments were ligated to give the plasmid pTKG which has the 
complete globin gene followed by part of the chicken ovalbumin gene from 
the Pst I site at amino acid 139 through to the translation terminator 
(amino acids 139 to 251 are encoded by sequences from the plasmid pG0V2 
and amino acids 252 to the end being encoded by sequences from the 
plasmid pTK2OV+). It should be noted that the short sequence upstream 
of the globin initator in pTKG is derived from the ovalbumin gene.
These manipulations are illustrated in Figure 37.
5. Construction of the plasmid pTKG
The plasmid pTKG should direct the synthesis of wild-type chimpanzee
a^globin since the coding region is intact and the initiator codon 
the first ATG downstream of the TK transcription promoter.
;Figure 37 Construction of the plasmid pTKG
See text for details of the construction. The only elements shown are 
the globin gene (open box), the ovalbumin gene (hatched box) and the TK 
promotor region (solid box). The cross-hatching of the ovalbumin gene 
is done at different angles to indicate from which parent plasmid the 
regions werevarious derived.
6. Construction of plasmids encoding NP-globin fusion proteins
The plasmid pTKG has unique Nco I and Pst I sites. The Nco I site spans 
the globin initiation codon while the Pst I site is at the end of the 
globin cDNA, so Nco I/Pst I digestion of pTKG will remove the globin 
gene in its entirity. The plasmid pTKG was cut with Nco I, end filled, 
cut with Pst I and the 650 bp fragment containing the globin gene 
purified by electrophoresis. This was inserted into M13 mplO which had 
been cut with Bam HI and Pst I and had had the Bam HI site end filled. 
The resulting clone, M13G, was digested with Sma I and Bgl I to release 
a 500 bp fragment containing the entire globin coding region (the Bgl I 
site is downstream of the globin termination codon). This is called 
fragment A. In the literature M13 mplO has a Bgl I site but I was 
unable to cut the DNA at this site.
There are two Bgl I sites in pTKG; one downstream of the globin 
termination codon and the other is in the ^ -lactamase gene of the vector 
region. Digestion of pTKG with Bgl I yields a 2660 bp fragment. This 
is called fragment B.
These manipulations are illustrated in Figure 38 while Figure 39 shows 
how these manipulations affect the region around the globin initiation
isotare smaller 
rrogm enr
▼
Fragment A
3gi ISm a I
Figure 38 Construction of the Fragments A and B
See text for details of the construction. For simplification the 
plasmids are not drawn to scale and the majority of elements in pTKG are 
omitted, only the TK transcriptional promotor region (solid box) is 
shown to indicate the direction of transcription. The globin cDNA is 
also shown (open box).
1 7 8
pTKG
M 3 mpio
Bam HI 
End fill
■ - C C C G G G G A T C  
- G G G C C C C  T A G
C
G
Neo I 
End fill 
1 2
M V
A T G  G T G -  
T A C  C A C - -
Li gate
^  1 2
M V
- C C C G G G G A T  C C  A T G  G T G - -  
- G G G C C C C  T A G G  T A C  C A C -  ■
Sma
1 2
M V
G G G G A T C C  A T G  G T G -  
C C C C T A G G  T A C  C A C -
Figure 39 Construction of Fragment A at the nucleotide level
This shows how the construction of Fragment A affects the region around 
the globin initiation codon. The first two amino acids of globin are 
shown.
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a ) Construction of the plasmids pTKNP X30G and pTKNP 232G
The plasmid pTKNP contains four Pvu II sites: the one used as the 
reference origin (position -3) and three within the NP coding region, at 
positions 705, 1011 and 1295. Partial digestion of pTKNP with Pvu II 
was followed by Bgl I digestion and purification of two fragments: the 
2379 bp fragment from Bgl I to Pvu II (705) and the 2685 bp fragment 
from Bgl I to Pvu II (1011). These fragments were ligated to fragments 
A and B (see Figure 38) to give the plasmids pTKNP 130G and pTKNP 232G 
respectively. These manipulations are illustrated in Figure 40. It 
should be pointed out that although fragment B can insert in either 
direction, the fact tht the Bgl I site is in the fi-lactamase gene means 
that the "incorrect" orientation is not viable when grown in the 
presence of ampicillin.
The protein predicted from pTKNP 130G has 275 amino acids; the first 
130 of NP, 3 encoded by the linking sequence originally from M13 raplO 
and the 142 amino acids of globin (see Figure 41). The protein 
predicted from pTKNP 232G has 377 amino acids; the first 232 of NP, 3 
encoded by the linking sequence and the 142 of globin (see Figure 42).
Pvu II ion 
Pvu II 705
See text for details of the construction. Only the TK transcription 
promotor (shaded box), the NP gene (stipled box) and the globin gene 
(open box) are shown. Fragments A and B are from Figure 38.
1 8 1
pTKNP
Fragment A
1 2 
M v
G G G G A T C C  A T G  G T G -----
C C C C T A G G  T A C  C A C -----
Ligate
1 3 0 ■ O’ 1 2
T G G S M V
----- A C A G G G G G A T C C A T G G T G
-----T G T C C C C C  T A G G T A C C A C
Figure 41 Construction of the plasmid pTKNP 130G at the 
nucleotide level
Only those regions around the Pvu II site at position 705 in pTKNP and 
at the amino end of Fragment A are shown. The encoded amino acids of 
NP, globin and the resulting fusion protein are shown above the
130 131 132
T A G
----- A C  A G C T G G T -
-----T G  T
inO
c g a C C A -
o
£
Pvu II
-----A C  A G
-----T G T  C
sequence. The numbers above the amino acids indicate their positions in 
the wild—type proteins.
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A
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Figure 42 Construction of the plasmid pTKNP 232G at the 
nucleotide level
Only those regions around the Pvu II site at position 1011 in pTKNP and 
at the amino end of Fragment A are shown. The encoded amino acids of 
HP» globin and the resulting fusion protein are shown above the 
sequence. The numbers above the amino acids indicate their positions in 
the wild-type proteins.
1 8 3
The plasmid pTKNP has two Acc I sites; one within the NP coding region 
(position 1250) and the other in the pBR322 region of the expression 
vector. pTKNP was partially digested with Acc I, end filled, digested 
with Bgl I and the 2673 bp fragment was purified by electrophoresis. 
This was ligated to fragments A and B (see Figure 38) to give pTKNP 
312G. These manipulations are illustrated in Figure 43.
The protein predicted from pTKNP 312G has 457 amino acids; the first 
312 of NP, 3 encoded by the linking sequence and the 142 amino acids of 
globin (Figure 44).
b ) Construction of the plasmid pTKNP 312G
* 1 *
1 8 4
See text for details of the construction. Only the TK transcription 
promotor (solid box), the NP gene (stipled box) and the globin gene 
(open box) are shown. Fragments A and B are from Figure 38.
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Construction of the plasmid pTKNP 312G at the
nucleotide level
Only those regions around the Acc I site at position 1250 in pTKNP and 
at the amino end of Fragment A are shown. The encoded amino acids of 
NP, globin and the resulting fusion protein are shown above the 
sequence. The numbers above the amino acids indicate their positions in 
the wild-type proteins.
7. Construction of the plas m i d  pTKNPG
The plasmid pTKNP has a unique Nae I site at position 1865 which is 
downstream of the NP termination codon at position 1811. The enzyme Nae 
I was used to linearise pTKNP and this was treated with exonuclease Bal- 
31 to produce a series of molecules containing various amounts of the NP 
gene. These molecules were digested with Bgl I and ligated to a 
fragment obtained from pTKG. The plasmid pTKG contains two Bgl I sites 
and a unique Nco I site which spans the globin initiation codon. 
Digestion with Nco I was followed by an end filling reaction and partial 
digestion with Bgl I. The resulting 3160 bp fragment contains the 
complete globin gene. These manipulations are illustrated in Figure 45.
The clones were screened using restriction enzymes and a number were 
selected which had lost the NP termination codon. These were tested for 
production of a fusion protein in Xenopus oocytes. One clone, 
designated pTKNPG, produced a protein that reacted with antibodies to 
both NP and globin indicating that the proper reading frame was 
maintained between the NP and globin sequences. The protein had a MW of 
65,000 which, allowing for approximately 12,500 MW of globin, suggests 
it contained the amino terminal 52,500 MW of NP. Restriction digestion 
of pTKNPG suggested that the Bal-31 treatment had removed the last 40 or 
so amino acids of NP which is consistent with the protein that was 
produced. The plasmid pTKNPG appears therefore to specify a chimeric 
protein with the first 460 amino acids of NP at its amino terminus and 
the entire globin sequence at its carboxyl terminus.
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Figure 45 Construction of the plasmid pTKNPG
See text for details of the construction. Only the TK transcription 
promotor (solid box), the NP gene (stipled box) and the globin gene
. • ,i . •
(open box) are shown.
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A plasmid that gave the same restriction enzyme digestion pattern as 
pTKNPG, designated pTKNPMG, directed the synthesis of a 53,500 MW 
protein in Xenopus oocytes. This protein was precipitated using 
antibodies against NP but was not immunoreactive with anti— globin 
antibodies indicating that the proper reading frame had not been 
maintained between the NP and globin sequences.

SECTION I
SYNTHESIS OF NP IN OOCYTES INJECTED WITH
THE PLASMID pTKNP
191
1. Introduction
Recombinant DNA technology has enabled the expression of cloned 
influenza virus genes in both prokaryotic and eukaryotic hosts (for 
review see Gething and Sambrook, 1983). The influenza proteins HA 
(Emtage et^ a_l., 1980; Davis et , 1981; Heiland and Gething, 1981), 
NS1 (Young et a_l. , 1983 ) and NP (I. Jones and G. G. Brownlee, 
unpublished data) have all been expressed in fS. coli as has a truncated 
form of NA (Jones and Brownlee, unpublished data). Expression of 
influenza genes in eukaryotes has relied upon the use of SV40 vector 
systems in which the influenza gene replaces either the early or late 
regions of the SV40 genome. In this way the influenza proteins HA 
(Gething and Sambrook, 1981; Sveda and Lai, 1981; Hartman et^  al., 
1982), M (Lamb and Lai, 1982) and NP (Lin and Lai, 1983) have been 
expressed in cultured cells.
This section describes the synthesis and identification of a protein 
directed by the plasmid pTKNP after injection into Xenopus oocytes. The 
plasmid pTKNP contains the NP gene from influenza virus A/NT/60/68 under 
the control of eukaryotic expression elements.
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2. Results
When injected into Xenopus oocytes the plasmid pTKNP directed the 
synthesis of a new protein. This protein was identified as the 
influenza NP by its migration by SDS-PAGE and its reactivity to both 
polyclonal and monoclonal (van Wyke a_l., 1980) antibodies specific to 
NP (Figure 46).
To demostrate the specificity of the monoclonal antibodies oocytes were 
injected with mRNA prepared from CEF ceils infected with FP/R virus.
Like the NP sythesised from pTKNP the NP synthesised from the mRNA was 
precipitated by polyclonal anti-NP antibody but exhibited different 
reactivities to the monoclonal antibodies (Figure 47).
Figure 46 Synthesis of NP following the injection of pTKNP into
oocytes
SDS-PAGE analysis of oocytes injected with water or pTKNP. Track V 
contains vS-methionme-labelled lysate from CEF cells infected with 
FP/R virus as marker. The pTKNP-injected oocytes were immuno- 
precipitated using both polyclonal (P) and monoclonal antibodies. The 
notation for the monoclonal antibodies is as in van Wyke e£ a_l. (1980). 
The equivalent of one oocyte was loaded per track.
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Figure 46 Synthesis of NP following the injection of pTKNP into 
oocytes
SDS-PAGE analysis of oocytes injected with water or pTKNP. Track V 
contains ^S-methionine-labelled lysate from CEF cells infected with 
FP/R virus as marker. The pTKNP-injected oocytes were immuno- 
precipitated using both polyclonal (P) and monoclonal antibodies. The 
notation for the monoclonal antibodies is as in van Wyke et al_. (1980 ). 
The equivalent of one oocyte was loaded per track.
Figure 47 Synthesis of NP following the injection of viral m R N A
into oocytes
SDS-PAGE analysis of oocytes injected with water or mRNA prepared from 
CEF cells infected with FP/R virus. Track V contains purified ^ S -  
methionine FP/R virus as marker. The mRNA-injected oocytes were 
immunoprecipitated using both polyclonal (P) and monoclonal antibodies. 
The notation for the monoclonal antibodies is as in van Wyke et al.
(1980). The equivalent of one oocyte was loaded per track.
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Figure 47 Synthesis of NP following the injection of viral mKNA
into oocytes
SDS-PAGE analysis of oocytes injected with water or mRNA prepared from 
CEF cells infected with FP/R virus. Track V contains purified ^^S- 
methionine FP/R virus as marker. The mRNA-injected oocytes were 
immunoprecipitated using both polyclonal (P) and monoclonal antibodies. 
The notation for the monoclonal antibodies is as in van Wyke et al.
(1980). The equivalent of one oocyte was loaded per track.
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The protein expressed from pTKNP after injection into oocytes had a MW 
of 56,000. It was precipitated by polyclonal anti-NP antibody and by 
the monoclonal antibodies 3/1, 5/1 and 7/3. The NP gene in pTKNP was 
derived from the influenza strain A/NT/60/68 and the reactivity of the 
oocyte-synthesised NP with the monoclonal antibodies is the same as that 
observed for the NPs of influenza viruses isolated at the same time as 
A/NT/60/68 (van Wyke e£ al_., 1980).
The 56,000 dalton protein synthesised in oocytes injected with mRNA 
prepared from CEF cells infected with FP/R virus was also precipitated 
by polyclonal anti-NP antibody but was precipitated by the monoclonal 
antibodies 3/1, 51, 150/4 and 469/6. This is the same reactivity with 
the monoclonal antibodies as the NP from influenza a /PR/8/34 (van Wyke 
et al., 1980) which was isolated at the same time as FP/R (Fowl 
Plague/Ros tock/34).
In conclusion therefore, oocytes injected with pTKNP synthesise a 
protein of 56,000 daltons which is antigenica1ly identical to the NP of
3. Discussion
influenza A/NT/60/68.

1. Introduction
This section describes experiments to determine the amount of DNA which 
has to be injected into oocytes in order to obtain maximum protein 
production. It also describes differences in NP production observed 
when oocytes were injected with DNA prepared by two different methods.
Since the level of protein produced from DNA injected into oocytes 
isolated from different frogs is variable (Asselbergs et a_l . , 1983; 
Colman, 1984a) all of the experiments described in this section were 
performed using the same batch of oocytes.
1The CsCl-gradient method of preparing DNA for injection into oocytes is 
described here,rather than with all the other methods used in the thesis 
since this is the only time it was used. The DNA was kindly prepared by 
Mr. D. Jackson (University of Warwick).
A 500 ml culture of bacteria was grown as described previously and the 
bacterial pellet was resuspended in 14.5 ml of ice cold resuspension 
buffer (50 mM Tris, pH 8.0, 25% sucrose and 1.75 mg/ml lysozyme). This
mixture was left on ice for 5 min with occasional mixing, made to 75 mM 
EDTA, pH 8.0 and incubated on ice for a further 5 min. 20 ml of ice 
cold lysis buffer (50 mM Tris, pH 8.0, 75 mM EDTA, 0.1% Triton X-100) 
was added and after thorough mixing the tube was centrifuged at 65,000g 
for 30 min at 4°C. The supernatant was collected, made to 0.2 M NaCl, 
extracted twice with phenol: chloroform, twice with chloroform and 
dialysed against 1 mM Tris, pH 8.5, 1 mM EDTA for 3 h with several 
changes of buffer. The sample was ethanol precipitated and after 
collection by centrifugation the precipitate was resuspended in 10 ml of 
l/10th SSC (15 mM NaCl, 1.5 raM trisodium citrate). Digestion of the RNA 
was attained by the addition of 60 Kunitz units of RNase A and 300 units 
of T1 RNase and incubating the sample at 37°C for 1 h with continuous 
agitation. After being made to 0.3 M NaCl and extracted twice with 
pheno1:chloroform and twice with chloroform, the DNA was collected by 
ethanol precipitation. The pellet was disolved in 5 ml of l/10th SSC 
and loaded onto 25 ml of CsCl at 1.3 mg/ml in l/10th SSC supplemented 
with ethidium bromide at 5 mg/ml. Centrifugation was at 240,000g for
2. Me thods
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16 h and the band corresponding to the closed circular DNA was collected 
by piercing the tube with a 23 gauge needle. After extracting the 
ethidium bromide with iso-amyl alcohol the sample was dialysed against 
10 mM Tris, pH 8.5, 1 mM EDTA for 3 h with several changes of buffer.
The DNA was collected by ethanol precipitation and further purified on a 
10-40% sucrose gradient as described previously.
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3 . Re s u 11 s
Oocytes were injected with various amounts of DNA and the amount of 
protein produced was determined. The volume injected into each oocyte 
was kept constant at 25 nl. This is larger than the 10 nl suggested by 
Wickens and Gurdon (1983), but had no adverse effect on the oocytes as 
judged by their viability and the structural integrity of the nucleus 
after injection.
The plasmid pTKNP was diluted to different concentrations in distilled 
water and injected into oocytes. Injection, radiolabelling, 
homogenisation and immunoprécipitation with anti-NP antibody were 
performed as described in 'Methods A'. The immunoprécipitations were 
designed to precipitate all of the NP in the samples. After analysis by 
SDS-PAGE (Figure 48) the NP bands were excised from the dried gels and 
the amount of radioactivity in each band was determined. The relative 
amount of NP produced in each sample is shown in Figure 49.
The results show that maximum NP production was obtained in oocytes 
injected with 3.75 ng of pTKNP, that is, about
300 times the total chromosomal DNA content (12 pg) of the 
(tetraploid) oocyte. When supra-optimal amounts of pTKNP were injected 
inhibition of NP production was observed. This dose-response 
relationship is not oocyte specific since oocytes prepared from another 
frog gave the same results (data not shown), and it is not unique to the 
plasmid pTKNP since similar results were seen using the plasmid pTKNP 
Acc 1250 (Figure 50).
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Figure 48 SDS-PAGE analysis of oocytes injected with various 
amounts of the plasmid pTKNP
DNA was prepared by the alkali-SDS method. The oocytes were injectée'., 
radio label led, homogenised and immunoprecipitated with the anti-NP 
antibody as described in 'Methods A 1. The equivalent of one oocyte was
loaded in each track.
p T K N P  in je c te d  p e r  o o c y t e  ( n g )
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Figure 48 SDS-PAGE analysis of oocytes injected with various 
amounts of the plasmid pTKNP
DNA was prepared by the alkali-SDS method. The oocytes were injected, 
radioiabe1 led, homogenised and immunoprecipitated with the anti-NP 
antibody as described in 'Methods A 1. The equivalent of one oocyte was
loaded in each track.
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Figure 48 SDS-PAGE analysis of oocytes injected with various 
amounts of the plasmid pTKNP
DNA was prepared by the alkali-SDS method. The oocytes were injected, 
radiolabe1led, homogenised and immunoprecipitated with the anti-NP 
antibody as described in 'Methods a '. The equivalent of one oocyte was
loaded in each track.
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Figure 49 Relationship between Che amount of NP produced in 
oocytes and the amount of pTKNP injected
pTKNP was prepared by the alkali-SDS method. Quantitation of the amount 
of NP produced is described in 'Methods A 1.
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Figure 50 Relationship between the amount of NP Acc 1250 produced 
in oocytes and the amount of pTKNP Acc 1250 injected
pTKNP Acc 1250 was prepared by the alkali-SDS method.
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When the amount of DNA injected into each oocyte was kept constant (at 
25 ng/oocyte) by the co-injection of carrier pBR322 DNA (prepared by the 
alkali-SDS method) (Figure 51) the maximum amount of NP produced was 
reduced compared to oocytes injected with pTKNP alone. It also seems 
that the inhibition of NP production observed with supra-optimal amounts 
of pTKNP was reduced in these oocytes. These results suggest that the 
production of NP is not only dependent upon the amount of pTKNP injected 
into the oocytes but also upon the total amount of DNA injected.
To investigate if NP production is influenced by the method of preparing 
the DNA for injection the above experiments were also performed with 
pTKNP and pBR322 prepared by the CsCl-gradient method described at the 
beginning of this section. These results are shown in Figure 52.
Maximum NP production was obtained following the injection of 6.25 ng of 
pTKNP and although the production of NP was again inhibited at supra- 
optimal amounts of pTKNP, the degree of inhibition was less than with 
pTKNP prepared by the alkali-SDS method (see Figure 49). When the 
amount of DNA injected per oocyte was kept constant by the co-injection 
of carrier pBR322 the production of NP did not significantly change from 
that observed with the pTKNP alone.
The maximum production of NP from pTKNP prepared by the alkali-SDS 
method was 76% of the maximum obtained from pTKNP prepared by the CsCl-
gradient method.
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Figure 51 Relationship between the amount of NP produced in 
oocytes and the amount of DNA injected (alkali-SDS 
preparation )
The filled symbols represent the assay where different amounts of pTKNP 
were injected while the open symbols represent the assay where the DNA 
concentration was kept constant at 25 ng per oocyte using pBR322 DNA as 
carrier. Both pTKNP and pBR322 were prepared by the alkali-SDS method.
206
Figure 52 Relationship between the amount of NP produced in
oocytes and the amount of DNA injected (CsCl-gradient 
preparation )
The filled symbols represent the assay where different amounts of pTKNP 
were injected while the open symbols represent the assay where the DNA 
concentration was kept constant at 25 ng per oocyte using pBR322 DNA as 
carrier. Both pTKNP and pBR322 were prepared by the CsC1-gradient 
me thod.
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4. Discussion
Fully grown Xenopus oocytes contain approximately 12 pg of chromosomal 
DNA but their high content of RNA polymerase II (Roeder, 1974) is 
responsible for their ability to rapidly transcribe very large amounts 
of injected DNA. Indeed there are several reports that maximum 
transcription from genes normally transcribed by RNA polymerase II is 
obtained following the injection of between 6 ng (Mertz and Gurdon,
1977) and 10 ng (Gurdon and Melton, 1981; Colman, 1984a) of DNA per 
oocyte. This is in contrast to the situation with ribosomal DNA 
(transcribed by RNA polymerase I) where maximum transcription is 
obtained at 25-50 pg of DNA per oocyte and no transcripts are detectable 
in oocytes injected with 10 ng of DNA (Moss, 1982). The reasons for 
these differences are not clearly understood but the necessity of 
injecting such low amounts of rDNA have been recently disputed (R. 
Roeder, personal communication to A. Colman). Although not proven, the 
fact that transcription from all my constructs is under the control of 
the promotor from the thymidine kinase gene, indicates RNA polymerase II 
is the enzyme resposible (McKnight and Gavis, 1980) (see 'Results', 
Section II). It might therefore have been predicted that maximum 
transcription would occur following the injection of between 6 and 10 ng 
of pTKNP per oocyte. Indeed the results show that maximum NP production 
occured in oocytes injected with either 3.75 ng or 6.25 ng of plasmid 
depending upon the method of DNA preparation. However, since the level 
of transcription was not studied it is not possible to conclude whether 
or not maximum transcription is coincident with the maximum production 
of protein.
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When pTKNP, prepared by the CsCl-gradient method, was injected into 
oocytes at supra-optimal amounts there was a slight inhibition of NP 
production (Figure 52). This inhibition was not altered by the co­
injection of carrier pBR322 DNA suggesting that it was due to a gene 
dosage effect, possibly resulting from competition for a common factor 
such as RNA polymerase II. The same effect has also been observed 
following the injection of supra-optimal amounts of adenovirus DNA 
(either pronase-treated whole adenovirus DNA or plasmid containing the 
E2A gene) into Xe no pus oocytes (Asselbergs e^ al^ . , 1983 ). Again the 
inhibition was not affected by the co-injection of carrier pBR322 DNA.
In this case the plasmid DNA was prepared by the rapid boiling procedure 
of Holmes and Quigley (1981), and the supercoiled form was further 
purified by banding in CsCl.
As well as being dependant upon the amount of pTKNP injected into the 
oocytes the production of NP also appears to depend upon the method used 
to prepare the DNA. When pTKNP was prepared by the alkali-SDS method 
the maximum production of NP was reduced compared to that from pTKNP 
prepared by the CsCl-gradient method and was further reduced by the co­
injection of carrier pBR322 DNA also prepared by the alkali-SDS method. 
This indicates that NP production in oocytes injected with DNA prepared 
by the alkali-SDS method is not only dependant upon the amount of pTKNP 
injected but also upon the total amount of DNA injected.
Why the dependence of NP production on the total amount of DNA injected 
should be more noticeable with DNA prepared by the alkali-SDS method is 
not known. One possible explanation is that the DNA prepared by the
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CsCl-gradient method is more free of contaminating products which 
inhibit NP production. Whether these inhibitors act at the level of 
transcription or at the level of translation is not known. It is also 
not known if these inhibitors are of bacterial origin or are introduced 
during the isolation of the DNA.
NP was produced in all pTKNP-injected oocytes, but since the lowest 
amount of DNA injected was 1.25 ng it is not possible to conclude 
whether or not a lower threshold value exists as was found with 
adenovirus DNA (Asselbergs e£ al^ . , 1983). Injection of less than 0.5 ng 
of adenovirus DNA per oocyte gave no detectable protein production. It 
is not known however, whether this threshold effect is a consequence of 
measuring gene expression at the protein level or whether it is specific 
for the adenovirus DNA since no threshold effect was observed in studies 
on the transcription of SV40 DNA with RNA polymerase II (Mertz and 
Gurdon, 1977).
Under optimal conditions the NP contained 7.8% of the total 
radioactivity incorporated into pTKNP-injected oocytes. This compares 
very favourably with the 1-2% obtained for the E2A 75K protein in 
oocytes injected with adenovirus DNA (Asselbergs et al., 1983), the 
0.25-1% obtained for VP1 after injection of SV40 DNA (Rungger and 
Turler, 1978) and the 0.01% obtained for ovalbumin after injection of a 
cloned chicken ovalbumin gene (Wickens e_t al., 1980).
For the routine production of DNA for injection it was felt that the 
speed of the alkali-SDS method outweighed the advantages of the more
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1 . Introduction
Whereas all of the other sections in this thesis describe results 
obtained using the expression vector pT^ with the protein coding region 
downstream of the thymidine kinase promotor, this section describes the 
production of NP in a variety of vector/promotor combinations.
22. Plasmid Construction
a ) pTKNP
This is described in detail in 'Methods B 1 and is again illustrated in 
Figure 53.
b ) pTKNP Minus 
The construction of pTKNP 
that clones were selected 
into PTK2 in the opposite
Minus was identical to that of pTKNP except 
in which the NP coding region was inserted 
polarity to the TK promotor (Figure 53).
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Figure 53 Construction of the plasmids pTKNP and pTKNP Minus
See text for details of the construction. The key for the various 
elements is as in Figure 10 (see 'Methods B 1), and is repeated below for 
convenience. Sequences from pAT/Pvu II/8 (thin line); pBR322 region 
(thick line); TK promotor region (solid box); NP gene (stipled box); 
Stop region (hatched box) and SV40 region (open box). The arrows 
indicate the 5'-*-3' direction of the NP coding strand.
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c ) pNP
The vector pTI^ was restricted with Pvu II and Hind III and the larger 
fragment was isolated by gel electrophoresis. After end filling the 
Hind III site, this fragment was ligated to the same fragment containing 
the NP coding region that was used in the construction of pTKNP. Clones 
were selected in which the NP coding sequence was in the same polarity 
as the TK promotor (Figure 54).
d ) pNP Minus
The construction of pNP Minus was identical to that of pNP except that 
clones were selected in which the NP coding sequence was in the opposite 
polarity to the TK promotor (Figure 54).
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Figure 54 Construction of the plasmids pNP and pNP Minus
See text for details of the construction and Figure 53 for the key to
the various elements. The arrows indicate the 5 * — 3' direction of the
NP coding strand.
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e ) pTKNP Bam 1339/2376
The plasmid pTKNP contains four Bam HI sites: two in the NP coding 
region at positions 577 and 793, one in the pAT/Pvu II/8 sequence at the 
carboxyl terminus of the NP coding sequence (1839) and one in the 
sequence derived from SV40 (2376). After partial digestion of pTKNP 
with Bam Hi the 4886 bp fragment from position 2376 to position 1839 was 
isolated by gel electrophoresis and ligated to itself to give pTKNP Bam 
1839/2376 (Figure 55).
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Figure 55 Construction of the plasmid pTKNP Bam 1839/2376
See text for details of the construction. The key for the various
elements is as Figure 53. The arrow indicates the 5'-*-3' direction of
the NP coding strand.
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f ) pTKNP HB 2118/2376 Minus
The vector PTK2 was restricted with Bam Hi and Hind III and the larger 
fragment was isolated by gel electrophoresis. After end filling the 
restriction sites, this fragment was ligated to the same fragment 
containing the NP coding region that was used in the construction of 
pTKNP. Clones were selected in which the NP coding region was in the 
opposite polarity to the TK promotor (Figure 56).
2 2 0
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Figure 56 Construction of the plasmid pTKNP HB 2118/2376 Minus
See text for details of the construction. The key for the various
elements is as Figure 53. The arrow indicates the 5'-»3' direction of
the NP coding strand.
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3. Results
Each of the plasmids described above were injected into oocytes at 
3.75 ng of DNA per oocyte. All of the oocytes were obtained from the 
same frog. The oocytes were radiolabe1led, homogenised and immuno- 
precipitated with anti-NP antibodies as described in 'Methods A'. The 
immunoprecipitated samples were analysed by SDS-PAGE (Figure 57) and the 
relative amount of NP protein produced in each sample was calculated by 
determining the amount of radioactivity in each NP band. These results 
are shown in Table 11.
NP was produced from all of the plasmids except pTKNP Bam 1839/2376 and 
pTKNP HB 2118/2376 Minus.
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Figure 57 SDS—PAGE analysis of the NP produced by oocytes injected 
with plasmids containing different constructions of the 
vector pTKg
See text for details of the injection and analysis of the oocytes. 
After immunoprécipitation the equivalent of one oocyte was loaded in
each track.
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Figure 57 SDS—PAGE analysis of the NP produced by oocytes injected 
with plasmids containing different constructions of the 
vector pTKt
See text for details of the injection and analysis of the oocytes. 
After immunoprécipitation the equivalent of one oocyte was loaded in
each track.
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Table 11 Relative production of NP in oocytes injected with plasmids 
containing different constructions of the vector pTK0
Plasmid Percentage relative 
production of NP
pTKNP 100
pTKNP Minus 10.6
pNP 11.8
pNP Minus 5.8
pTKNP Bam 1839/2376 0
pTKNP HB 2118/2376 Minus 0
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4. Discussion
Interpretation of the results is necessarily inconclusive since no 
attempt was made to analyse the transcripts synthesised from the various 
constructs. Other workers however have used Xenopus oocytes to study 
the transcription of both the thymidine kinase gene (McKnight and Gavis, 
1980; McKnight ejt a_l. , 1981) and plasmids very similar to those 
described above (Krieg e_t al^ ., 1984), and using these results it is 
possible to suggest reasons for my findings at the protein level.
Earlier in the thesis I suggested that the transcripts from pTKNP were 
produced by RNA polymerase II after initiation at the TK promotor. This 
promotor is accurately and efficiently transcribed in Xenopus oocytes 
when present either with the complete TK gene (McKnight and Gavis, 1980; 
McKnight £t al^ . , 1981) or as part of a plasmid containing the eukaryotic 
expression vector pT^ (Krieg e_t a_l. , 1984) (see Figure 58). The only 
difference between the plasmid used in the study by Krieg and co­
workers, pTK0V+, and pTKNP was the replacement of the chicken ovalbumin 
coding sequence with that of the influenza NP.
The use of in vitro mutagenesis has defined three spatially distinct 
regions within the TK promotor that control transcription (McKnight e£ 
al., 1981; McKnight, 1982; McKnight and Kingsbury, 1982). These are 
called the proximal signal, the first distal signal and the second 
distal signal (see Figure 58). The DNA sequence of the proximal signal 
harbours the TATA homology for which there is ample evidence for a 
fundamental role in transcription initiation (for reviews see Corden
end-filled Cla I site
Figure 58
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Figure 58 Sequence around the major transcription initiation site of 
pTKNP and pTKNP Bam 1839/2376
The numbers above the nucleotides indicate their positions in the 
plasmid pTKNP. The site of transcription initiation is indicated as are 
the proximal signal, the first distal signal and the second distal 
signal (McKnight, 1982). The translation initiation codon upstream of 
the NP initiator is shown. Translation from this initiator is 
responsible for the production of the extended ovalbumin by pTKOV+ and 
is presumed to produce a 51 amino acid peptide in oocytes injected with 
pTKNP. The translation terminator for this peptide is also indicated.
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al., 1980; Breathnach and Chambon, 1981). In contrast, the two distal 
transcriptional signals do not contain strongly conserved sequences and 
are believed to represent elements that control the efficiency of 
transcription (McKnight and Kingsbury, 1982).
When the plasmid pTK0V+ was injected into oocytes it not only directed 
the synthesis of ovalbumin but also of a second, larger protein which 
was found to be an ovalbumin polypeptide extended by 51 amino acids at 
the amino terminus (Krieg et^  a_l., 1984). This second protein was the 
result of translational initiation at an upstream in phase AUG in 
transcripts arising from promotor(s) upstream of the authentic TK 
promotor sequence (see below). The position of this ATG in the TK 
region is shown in Figure 58. Although there are no translation 
termination codons in the sequence between this ATG and the normal 
ovalbumin initiator in the plasmid pTK0V+ there is one in the 
corresponding intervening sequence in pTKNP. Translational initiation 
at this upstream initiator in pTKNP would produce a peptide containing 
51 amino acids which would be undetected in the analysis.
During the analysis of pTKOV+ several transcripts were detected which 
were of higher MW than the transcript initiated at the authentic TK 
promotor sequence (Krieg £t^  a_l., 1984). These large transcripts have 
not been mapped at the nucleotide level, but at least one is presumably 
responsible for the production of the extended ovalbumin polypeptide 
discussed above. It is possible that some of these large transcripts 
are initiated in the pBR322 region of the plasmid (L. Tabe, personal 
communication). Transcription from these sites could explain the low
but significant production of NP in oocytes injected with the plasmid 
pNP in which the TK promotor region is absent. The much greater number 
of transcripts initiated at the authentic TK promotor compared to those 
initiated upstream of this region (Krieg et al., 1984) is likely to 
explain the greater production of NP from pTKNP compared to that from 
pNP.
The lack of NP production from the plasmid pTKNP Bam 1839/2376 is 
presumably not due to a lack of transcriptional initiation since the 
sequences upstream of the NP coding sequence are the same in this 
plasmid as in the plasmid pTKNP. It seems therefore that the removal of 
a region downstream of the NP coding sequence results in the loss of NP 
production. The apparent reason for this becomes evident when the 
termination of transcription in pTKNP is considered. Although 
transcription termination has not been analysed either here or in Krieg 
et al. (1984) it is presumably controlled by the SV40 sequence in the 
vector pT^. Termination and polyadenylation would therefore be 
identical to that of the early transcripts of SV40 (see Reddy et al.,
1979) with polyadenylation occuring at nucleotides 2327/2328 in pTKNP 
which corresponds to nucleotides 2586/2587 in the SV40 genome (Figure 
59). Just upstream of this position is the sequence AATAAA which is 
common to many polyadenylated eukaryotic mRNAs and may direct the 
enzymes which cleave the primary transcript and/or which add the poly(A) 
tract to the new 3' end (see Tooze, 1980). These sequences are absent 
in pTKNP Bam 1839/2376 (see Figure 59) and their absence may result in 
the production of transcripts which are either unstable or cannot be 
translated. The lack of translation could be due to incorrect
22 7
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Figure 59 Sequence around the transcription termination site of pTKNP 
and pNP
The numbers below the nucleotides indicate their positions in the 
plasmid pTKNP while those above the nucleotides indicate their positions 
in the SV40 genome using the SV numbering system described in Tooze 
(1980). The site of polyadenylation is indicated (Reddy ££ al. , 1979), 
as is the sequence proposed to be important in determining the site of 
termination and/or the site of polyadenylation. The Bam Hi restriction 
site (position 2376) is indicated for ease of comparison with the other 
figures.
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processing of Che transcripts and their subsequent lack of transport 
into the cytoplasm.
Although pTKNP Bam 1839/2376 contains the complete NP gene including the 
non-translated flanking sequences which control the initiation and 
termination of transcription, these signals are presumably inactive in 
oocytes. During infection the influenza genome remains as RNA and the 
signals for the initiation and termination of transcription are 
interpreted by a viral-encoded RNA-dependant RNA polymerase (Schubert et 
al. i 1980; Krug et^  a_l., 1981; Robertson e£ a_l^ ., 1981). When converted 
to DNA, as in pTKNP, these signals are different to those that control 
initiation and termination by the cell’s DNA-dependant RNA polymerases.
The plasmid pTKNP Minus contains the same elements as pTKNP but the TK 
promotor and the NP coding sequence are of opposing polarities. 
Therefore, it was rather surprising that this plasmid directed the 
synthesis of NP. A similar result, however, was found using the plasmid 
pTKOV- (Krieg e^ al^ . , 1984). This plasmid bears the same relationship 
to pTKOV+ as pTKNP Minus does to pTKNP, that is, the protein coding 
region is of the opposite polarity to the TK promotor. To account for 
the production of the proteins from pTKOV- and pTKNP Minus transcripts 
of the opposite polarity to the TK transcripts must be synthesised.
Indeed the analysis of transcripts from pTKOV- revealed the presence of 
a "promotor" region in the SV40 sequence (Krieg et al., 1984). The 
initiation site of these transcripts is shown in Figure 60 which also 
shows the presence of various promotor-like sequences upstream of this 
site. Since the SV40 sequence remains intact in both pTKNP Minus and
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Figure 60 Sequence around the SV40 promotor region active in pTKNP 
Minus and pNP Minus
The numbers above the nucleotides indicate their positions in the SV40 
genome using the SV numbering system described in Tooze (1980). The 
site of transcription initiation is indicated and the sequences 
underlined are those which bear a striking resemblance to sequences 
important in initiating transcription. The translation initiation codon 
upstream of the NP initiator is shown. Translation from this initiator 
is rsponsible for the production of the extented ovalbumin by pTKOV- 
(Krieg et a 1 . , 1984), and is presumed to produce a 21 amino acid peptide 
in oocytes injected with pTKNP Minus and pNP Minus.
Transcripts produced from this promotor are presumed to be terminated by 
the signals responsible for the termination of the SV40 late 
transcripts. The sequence proposed to be important in determining the 
site of transcription termination and/or the site of polyadenylation is 
indicated as is the site of polyadenylation.
In the plasmid pTKNP HB 2118/2376 Minus the region between the Bam HI 
site and the end-filled Cla 1 site is absent.
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pNP Minus it is presumed that the production of NP by these plasmids is 
a consequence of transcription from this promotor.
It is not known if the use of this SV40 "promotor" reflects a special 
characteristic of amphibian oocyte nuclei or amphibian cell nuclei in 
general, but it does not appear to function in cultured mammalian cells 
(Krieg et a_l., 1984).
When the plasmid pTKOV- was injected into oocytes it not only directed 
the synthesis of ovalbumin but also of a second, more abundant, larger 
protein which was found to be an ovalbumin polypeptide extended by 21 
amino acids at the amino terminus (Krieg et_ al., 1984). This second 
protein was the result of translational initiation at an upstream in 
phase AUG in the same transcript that directs the synthesis of 
ovalbumin. When translation is initiated at two AUG codons in a single 
transcript two factors govern which initiator is used preferentially.
The first of these factors is the position effect in which the 5'- 
proximal AUG is usually used to initiate translation. This holds true 
for 95Z of eukaryotic mRNAs (Kozak, 1984a). The second factor was 
revealed by a survey of eukaryotic mRNA sequences (Kozak, 1983) which 
found that functional initiation codons occur in a restricted sequence 
context with 5 1—ANNAUGG—3 1 (wild—type ovalbumin) being favoured over 5'— 
GNNAUGG-3' (extended ovalbumin). The fact that the extended ovalbumin 
was produced in greater amounts than the wild type ovalbumin suggests 
that translation is preferentially initiated at the 5'-proximal AUG even 
though it is in a less favoured sequence context. This dominance of 
position effect over sequence context has also been reported in
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experiments involving the mutagenesis of the 5' non-coding sequence of 
preproinsulin (Kozak, 1984b). The effects of position and sequence 
context on translation initiation at a given AUG is discussed more fully 
in a later section of the thesis.
No extended NP polypeptide was produced from either pTKNP Minus or pNP 
Minus. Translation initiation presumably still occurs at the 5'- 
proximal AUG, but as shown in Figure 60 there is a translation 
termination codon in the non—coding sequence upstream of the NP 
initiator. The resulting peptide of 21 amino acids would not be 
detected during the analysis.
NP production from pTKNP is approximately 10-fold greater than that from 
pTKNP Minus. This is probably a reflection of both the greater level of 
transcription from the TK promotor (Krieg e£ a_l., 1984) and also the 
fact that in the transcripts produced from the SV40 "promotor" 
translation inititaion probably occurs preferentially at the AUG codon 
upstream of the NP initiatior.
As discussed above, the transcripts produced from the SV40 "promotor" 
are unlikely to be terminated and polyadenylated by signals in the 
region containing the NP coding sequence. It is more likely that the 
transcripts are terminated and polyadenylated by signals in the region 
containing the SV40 sequence. As well as containing the signals to 
terminate and polyadenylate the SV40 early transcripts this sequence 
also contains the same signals for the SV40 late transcripts (Reddy £t 
al., 1979) (see Figure 60). As can be seen from Figure 60 this would
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mean Chat Che transcripts are virtually complete copies of the plasmid.
The plasmid pTKNP HB 2118/2376 Minus did not direct the synthesis of NP. 
Presumably this is due to the removal of the SV40 "promotor" (Figure 
60).
Conclusion
The results presented in this section are consistent with the existence 
of at least three proraotors in the expression vector pTK2 > the 
authentic TK promotor which promotes transcription in a anti-clockwise 
direction (promotor 1 in Figure 61); a promotor in the SV40 sequence 
which promotes transcription in a clockwise direction (promotor 2), and 
a promotor which lies upstream of the TK promotor region and promotes 
transcription in an anticlockwise direction (promotor 3). There also 
seems to be at least one promotor in the TK region upstream of the 
authentic TK promotor (promotor 4). The clockwise and anti-clockwise 
directions refer to pTK2 as drawn in Figure 61.
There appears to be two regions which control transcriptional 
termination and polyadenylation. These are both in the SV40 sequence 
but operate in different polarities. These regions are responsible for 
controlling the termination and polyadenylation of early and late 
transcripts of SV40.
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Figure 61 Sites of transcription initiation and termination in Che 
vector pTKo
To help interpretation an unspecified insert (stipled box) is shown in 
the vector. The key for the other elements is the same as that used 
throughout the thesis, that is: TK promotor region (solid box); stop 
region (hatched box); SV40 region (open box) and the pBR322 region 
(thick line). The transcripts are indicted by the thin lines. The 
numbers are used to indicate the sites of transcription initiation:
1 ” Transcripts produced from the authentic TK promotor.
2 * Transcripts produced from the SV40 promotor.
3 and 4 " Transcripts produced from promotors upstream of the
authentic TK promotor. These transcripts have not been 
studied in detail but there is evidence that at least some 
are initiated upstream of the TK promotor region.
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SECTION IV
THE ACCUMULATION OF NP IN THE NUCLEI OF 
XENOPUS OOCYTES
2 3 6
1. Introduction
NP was first detected in the nuclei of influenza-infected cells by 
immunofluorescence staining (Watson and Coons, 1954; Liu, 1955; 
Breitenfeld and Schaffer, 1957). The analysis of radiolabelled proteins 
following the fractionation of infected cells revealed that after 
cytoplasmic synthesis the majority of the NP rapidly migrates to the 
nucleus where it associates with the nucleoplasm (Dimmock, 1969; Taylor 
et al., 1969, 1970; Lazarowitz e£ al_. , 1971; Krug and Etkind, 1973;
Hay and Skehel, 1975; Briedis e_t a K  , 1981).
This section describes the accumulation of NP in the nuclei of Xenopus 
oocytes following its introduction as the protein itself or encoded in 
mRNA or DNA.
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2. Results
a ) In jection of NP protein
When CEF cells are infected with FP/R virus and radiolabelled with S- 
methionine for 10 min at 3.5 h p.i. the most heavily radiolabelled 
protein is NP (Figure 62). Whole lysate prepared from these labelled 
cells was injected into the cytoplasm of Xenopus oocytes.
At various times after injection the oocytes were enucleated and the 
isolated nuclear and cytoplasmic fractions were analysed by SDS-PAGE 
(Figure 63). Calculation of the extent to which NP is concentrated in 
the nucleus depends upon the relative nuclear and cytoplasmic volumes.
As discussed in 'Methods A', although the nucleus occupies 4% of the 
oocyte volume it has been estimated that it represents 12% of the volume 
accessible to most macromolecules (Bonner, 1978). This means, for 
example, that if both compartments contain the same amount of a protein 
then the concentration in the nucleus is 7.33 fold higher than in the 
cytoplasm. Figure 64 shows the increase with time of the nuclear to 
cytoplasmic concentration ratio following the injection of radiolabelled 
NP into the cytoplasm. The NP became concentrated in the nucleus 
achieving a maximum ratio of 4.24 after 48 h. Since the total 
radioactivity incorporated into the NP did not significantly change 
during the experiment I conclude that little or no degradation of NP 
occurred in either the cytoplasm or the nucleus.
When the experiment was performed at 4°C, instead of 20°C, the NP still 
entered the nucleus but to a much lesser extent (Figure 64).
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Figure 62 Radiolabe1led lysate of CEF cells infected with FP/R virus
CEF cells were infected with FP/R virus and radiolabelled with ^ S -  
methionine for 10 min at 3.5 h p.i. The lysate was analysed without 
dilution and with consecutive two-fold dilutions. Non-infected cell 
lysate (NI ) is included as a control.
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Figure 62 Radio Labe 1 led lysate of CEF cells infected with FP/R virus
CEF cells were infected with FP/R virus and radiolabe1led with ^ S -  
methionine for 10 min at 3.5 h p.i. The lysate was analysed without 
dilution and with consecutive two-fold dilutions. Non-infected cell 
lysate (NI ) is included as a control.
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Figure 63 SDS-PAGE analysis of oocytes injected with r a d i o l a b e 1led NP
Radiolabelled lysate from CEF cells infected with FP/R virus was 
injected into the cytoplasm of Xenopus oocytes. The oocytes were 
enucleated at various times after injection and the separated nuclear 
(N) and cytoplasmic (C) fractions analysed by SDS-PAGE. A minimum of 
ten nuclei and ten cytoplasms were pooled for each time point and the 
equivalent of one nucleus and one cytoplasm loaded per track.
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Figure 63 SDS-PAGE analysis of oocytes injected with radio Labe 1led NP
Radio labelled lysate from CEF cells infected with FP/R virus was 
injected into the cytoplasm of Xenopus oocytes. The oocytes were 
enucleated at various times after injection and the separated nuclear 
(N) and cytoplasmic (C) fractions analysed by SDS-PAGE. A minimum of 
ten nuclei and ten cytoplasms were pooled for each time point and the 
equivalent of one nucleus and one cytoplasm loaded per track.
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Figure 64 The migration of radiolabe1led NP inco the nuclei of oocytes
The solid symbols represent the results at 20°C while the open symbols 
represent those at 4°C.
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Messenger RNA was prepared from CEF cells infected with FP/R virus and 
injected into Xenopus oocytes. These oocytes, and control oocytes 
injected with the same volume of water, were incubated for 20 h to allow 
the mRNA to become assimilated into polysomes and then labelled for a 
further 24 h in the presence of ^S-methionine. The oocytes were 
enucleated and the separated fractions analysed by SDS-PAGE (Figure 65). 
Three new proteins were synthesised in detectable amounts. From their 
migration by SDS-PAGE and their precipitation by specific antibodies 
these were identified as the influenza virus proteins; NP (56 Kd), 
matrix protein (M) (26 Kd ) and the non-structural protein NS1 (25 Kd).
Whereas NS1 is normally concentrated in the nucleoli of infected cells 
(Dimmock, 1969; Krug and Etkind, 1973; Krug and Soiero, 1975) it 
remained largely in the oocyte cytoplasm. Both NP and M associated with 
the oocyte nucleus although only the NP became concentrated there (Table 
12). When the nuclear fraction was centrifuged at 12,000g M was 
pelleted (Figure 65 and Table 12) indicating that it is associated with 
some nuclear structure. NP was not pelleted under the same conditions.
b ) Injection of mRNA
£
mRNA Water
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Figure 65 The nuclear association of influenza virus proteins following
the injection of viral mRNA into oocytes
Total (T), cytoplasmic (C), nuclear (N ) fractions and the supernatant 
from the centrifugation of the nuclear fraction (SN ) of oocytes injected 
with water or mRNA were analysed by SDS-PAGE. Approximately equal 
amounts of radioactivity in each track was achieved by loading the 
equivalent of one total oocyte (T), 1.5 cytoplasms (C) and 10 nuclei (N 
and SN). Track V contains purified S-methionine FP/R virus as marker.
Table 12 The nuclear association of N P , M and NS1 following the
injection of viral mRNA into oocytes
Protein Nuclear to cytoplasmic 
concentration ratio
'Spun' nuclear to 
concentration
cytoplasmic
ratio3
NP 3.69 3.55
M 0.95 0.16
NS1 0.29 0.28
a Nuclear fraction after centrifugation at 12,000g for 5 min.
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The plasmid pTKNP was injected into Xenopus oocytes. These oocytes, and 
control oocytes injected with the same volume of water, were incubated 
for 20 h to allow assembly of chromatin and the accumulation of mRNA 
before being labelled with JJS-methionine for 6 h. The oocytes were 
enucleated and the isolated nuclear and cytoplasmic fractions 
immunoprecipitated using polyclonal anti-NP antibody before being 
analysed by SDS-PAGE (Figure 66). The NP was 8.27 fold more 
concentrated in the nucleus than in the cytoplasm (this is the average 
of six experiments ).
To investigate whether or not this eight fold concentration was the 
maximum attainable by the NP, oocytes injected with pTKNP and 
radiolabel led as above were chased for 24 h in the absence of -^S- 
methionine. After enucleation of these chased oocytes the nuclear to 
cytoplasmic concentration ratio was again calculated (Table 13). Since 
there was no appreciable change in the ratio it appears that the eight 
fold concentration in the nucleus represents the NP distribution at 
equilibrium. The stability of the NP in the oocytes is demonstrated by 
the fact that the radioactivity incorporated into NP is approximately 
the same in chased and unchased oocytes (Table 13).
c ) Injection of DNA
Figure 66 The nuclear accumulation of NP following the injection of
pTKNP into oocytes
The isolated nuclear (N) and cytoplasmic (C) fractions of water or 
pTKNP-injected oocytes were immunoprecipitated using polyclonal 
antibodies against NP and analysed by SDS-PAGE. One nucleus and one
cytoplasm were loaded in each track.
Table 13 Nuclear to cytoplasmic concentration ratios of chased
and unchased oocytes injected with pTKNP
Radioactivity in Nuclear to cytoplasmic
the NP band concentration
Nucleus Cytoplasm ratio
Unchased oocytes 12,462 11,501 7.95
Chased oocytes 13,185 11,506 8.41
The radioactivity values shown represent the counts per minute obtained 
from the equivalent of one nucleus and one cytoplasm. For convenience 
the background radioactivity in each track has already been substracted.
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I demonstrate above that, at equilibrium, the NP synthesised in oocytes 
from injected pTKNP is over eight fold more concentrated in the nucleus 
than in the cytoplasm. This ratio is small relative to that observed 
with other karyophilic proteins in Xenopus oocytes (Gurdon, 1970; 
Bonner, 1975a; Dingwall ££ a_l., 1982). One possible explanation for 
this low level of accumulation is that at equilibrium the NP in the 
cytoplasm is prevented from entering the nucleus by binding to a non­
nuclear substrate. To investigate this I injected pTKNP into oocytes 
and prepared radiolabel led NP from both the nucleus (nuc-NP) and the 
cytoplasm (cyt-NP) of these oocytes. The nuc-NP and cyt-NP were 
injected separately into the nuclear and cytoplasmic regions of freshly 
isolated oocytes which were then incubated for 48 h before being 
enucleated. The isolated nuclear and cytoplasmic fractions were 
immunoprecipitated with anti-NP antibody and analysed by SDS-PAGE 
(Figure 67). All of the oocytes in which cyt-NP was injected into the 
nucleus died within 6 h. In all other cases the radiolabelled NP was 
found in both cellular compartments but was between six and seven fold 
more concentrated in the nucleus than in the cytoplasm.
d ) Injection of cloned NP protein
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Figure 67 Injection of cloned NP protein into oocytes
Cytoplasmic (C) and nuclear (N ) fractions of oocytes injected with 
cloned NP protein. 1: cyt-NP injected into cytoplasm; 2: nuc-NP 
injected into cytoplasm; 3: nuc-NP injected into nucleus. Oocytes 
were analysed individually and representative examples are shown. The 
nuclear to cytoplasmic concentration ratio (N/C) for each sample was 
calculated as normal.
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Figure 67 Injection of cloned NP protein into oocytes
Cytoplasmic (C) and nuclear (N) fractions of oocytes injected with 
cloned NP protein. 1: cyt-NP injected into cytoplasm; 2: nuc-NP 
injected into cytoplasm; 3: nuc-NP injected into nucleus. Oocytes 
were analysed individually and representative examples are shown. The 
nuclear to cytoplasmic concentration ratio (N/C) for each sample was 
calculated as normal.
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e ) Injection of pTKNP into tissue culture cells
The plasmid pTKNP was injected into the nuclei of cultured BHK-21 cells. 
After 8 h the injected cells were fixed and immunofluorescently stained 
using polyclonal antibody against NP (Figure 68A). As a control, 
monolayers of BHK-21 cells were infected with influenza virus A/NT/60/68 
and fixed and stained 24 h after infection (Figure 68B). The NP 
produced in the cells injected with pTKNP was predominantly nuclear and 
the pattern of nuclear fluorescence was the same as that seen in the 
cells infected with A/NT/60/68. No immunofluorescence was detected in 
the uninjected cells in Figure 68a .
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Figure 68 Indirect: immunofluorescence of NP in BHK-21 cells
A and C: Injected with pTKNP 
B and D: Infected with A/NT/60/68 virus.
The cell monolayers were fixed with acetone and incubated with a 
polyclonal anti-NP rabbit antibody and subsequently FITC—conjugated goat 
anti-rabbit serum. The majority of cells in the pTRNP-injected sample 
are uninjected and serve as internal controls. Figures A and B show the 
immunofluorescence photographs, while C and D are the corresponding 
phase contrast images. All photographs are at the same magnification 
and the bar in Figure A represents 50 pm.
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Figure 68 Indirect immunofluorescence of NP in BHK-21 cells
A and C: Injected with pTKNP 
B and D: Infected with A/NT/60/68 virus.
The cell monolayers were fixed with acetone and incubated with a 
polyclonal anti-NP rabbit antibody and subsequently FITC-conjugated goat 
anti-rabbit serum. The majority of cells in the pTKNP-injected sample 
are uninjected and serve as internal controls. Figures A and B show the 
immunofluorescence photographs, while C and D are the corresponding 
phase contrast images. All photographs are at the same magnification 
and the bar in Figure A represents 50 pm.
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3. Discussion
a ) The nuclear association of the influenza virus proteins M and NS1 
The matrix protein (M) did not concentrate in the oocyte nucleus but 
became evenly distributed between this compartment and the cytoplasm. M 
was removed from the nuclear lysate by centrifugation at 12,000g for 5 
min suggesting it is likely to be associated with some relatively large 
nuclear structure. Since M is associated with cellular membranes during 
infection (Klenk et a_l., 1974; Meier-Ewert and Compans, 1974; Hay and 
Skehel, 1975) and the lipid envelope in the virus particle (Apostolov 
and Flewett, 1969; Compans and Dimmock, 1969; Gregoriades and 
Frangione, 1981), and isolated M has a high affinity for lipid in vitro 
(Gregoriades, 1980) this structure could be the nuclear envelope. It is 
therefore possible that M does not enter the oocyte nucleus but 
associates with the outer face of the nuclear envelope and that its 
apparently even distribution between the nucleus and the cytoplasm is 
fortuitous. In cells infected with influenza virus the extent of 
nuclear accumulation of M appears to be dependent on both the virus 
strain and the host cell type being studied (Lazarowitz et al., 1971; 
Gregoriades, 1973, 1977; Krug and Etkind, 1973; Hay and Skehel, 1975; 
Flawith and Dimmock, 1979; Mahy e_t a_l. , 1980; Briedis et^  a_l. , 1981). 
Since the mRNA injected into the oocytes was prepared from a virus-cell 
combination in which M accumulates in the nucleus during infection (Hay 
and Skehel, 1975; P. J. Rees and N. J. Dimmock, unpublished data) it 
appears that any property conferred on the M to cause its accumulation 
in nuclei is either not evident at the level of the mRNA or is different 
between CEF cells and Xenopus oocytes.
2 5 2
The non-struetura1 protein NS1 did not appreciably associate with the 
oocyte nucleus. This is unlike the situation in cells infected with 
influenza virus where NS1 migrates to the nucleus (Taylor e£ al., 1969, 
1970; Lazarowitz et a K , 1971; Hay and Skehel, 1975). and 
concentrates in the nucleoli (Dimmock, 1969; Krug and Etkind, 1973;
Krug and Soiero, 1975). Since, in the oocytes, the NS1 did not evenly 
distribute between the nucleus and the cytoplasm it is possible that it 
is actively prevented from entering the nucleus by being associated with 
some cytoplasmic structure.
In other regards the oocyte handles influenza proteins normally since in 
earlier experiments performed in our laboratory the two virus 
glycoproteins, HA and NA, were enriched in the membrane vesicles of 
oocytes injected with influenza mRNA (T. Petri, N. J. Dimmock and A. 
Colman, unpublished data). This agrees with data from cells infected 
with influenza virus where, like the majority of integral membrane 
proteins, they are synthesised on the rough endoplasmic reticulum and 
transported to the plasma membrane via smooth internal membranes 
(Compans, 1973a; Stanley ££ a_l. , 1973; Hay, 1974; Klenk £t al.,
1974).
b ) The nuclear association of the influenza virus NP 
Regardless of whether the NP was introduced into the oocytes as the 
protein itself or encoded in RNA or DNA is entered into and accumulated 
in the nucleus. This accumulation occurs post-translationally with no 
apparent modification of the protein.
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Although the molecular dimensions of NP are unknown its entry into the 
oocyte nucleus is more rapid than that predicted for a protein of 56,000 
dal tons (see Bonner, 1978 ). NP injected into the cytoplasm became 
evenly distributed between the nucleus and the cytoplasm within about 1 
h while injected ovalbumin (44,000 MW) takes 72 h to become evenly 
distributed, and BSA (67,000 MW) is still not evenly distributed after 
72 h (Bonner, 1975a). This rapid entry of NP into oocyte nuclei is 
consistent with the existence of a mediated transport process as has 
been suggested for RNl, a 148,000 MW protein of Rana pipiens oocytes 
(Feldherr et^  a_l., 1983).
This is probably an over-simplification of the situation since it is 
unlikely that proteins exist in cells in a soluble, monomeric state 
(Fulton, 1982). A detailed mathematical model of protein solutions 
containing high concentrations of proteins indicates that such solutions 
are non-ideal (Minton, 1981): the proteins tend to be forced into 
compact configurations rather than extended ones, and the solutions 
favour self- and hetero-associations that would be less frequent in 
dilute solutions. Xenopus oocytes appear to be an extreme example of a 
non-ideal solution since the cytoplasm, excluding the yolk proteins, is 
30-40% protein by weight and it has been estimated that less than 20% of 
the cytoplasmic protein, excluding yolk proteins, is able to diffuse 
freely throughout the oocyte (Paine, 1982). The NP has the added 
complication of being associated with viral RNA to form
ribonucleoprotein (RNP ) complexes in both the virus particle (Duesberg, 
1969; Pons e£ a_l. , 1969; Compans , et al^ . , 1972; Rees and Dimmock, 
1981a) and infected cells (Pons, 1971, 1975; Caliguiri and Gerstein,
1978; Rees and Dimmock, 1981b, 1982). These RNPs are found in both the
cytoplasm and the nucleus of infected cells (Krug, 1971) and appear able 
to cross the nuclear envelope in either direction (Hudson et al., 1978; 
Flawith and Dimraock, 1979).
The rapid entry of NP into the nucleus was also seen in oocytes injected 
with pTKNP. However, it is not clear if the average path length taken 
by an injected nuclear protein is similar to that taken by the same
t
protein when it is expressed in oocytes via injected DNA; in the lq(ter 
case it is possible that the encoding mRNA, and therefore translation, 
are concentrated around the nucleus (D. Drummond and A. Colman, 
unpublished data).
Although cyt-NP was toxic when injected into the nuclei of fresh oocytes 
its accumulation in the nucleus after injection into the cytoplasm shows 
that at equilibrium the NP in the oocyte cytoplasm is capable of 
entering the nucleus. Similarly the NP in the oocyte nucleus is capable 
of migrating back into the cytoplasm.
Due to the large energy reserves within the oocyte it is not feasible to 
use inhibitors to test for any energy requirement in the nuclear 
accumulation of NP. However, if the migration is an energy dependent 
process it should be virtually abolished by chilling to 4°C but be 
relatively unaffected if due to diffusion (Wu and Warner, 1971). In 
fact, when radiolabe1 led NP was injected into oocytes incubated at 4°C 
the rate of nuclear migration was decreased to less than 10% of that at 
20°C. A similar result was obtained using nucleoplasmin (Dingwall et 
al. , 1982) but, as discussed by these workers, interpretation is 
difficult since the low temperature is likely to affect many parameters.
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Since no other influenza components are present in the oocytes injected 
with pTKNP the ability of the NP to accumulate in the nucleus is likely 
to be a property of the NP itself, while the similarity between the 
distribution of the cloned and authentic NP in BHK-21 cells suggests 
that the cloned protein is behaving normally. The influenza virus NP 
therefore appeared to be a good candidate for further analysis of 
nuclear accumulation and the following section describes the use of DNA 
recombinant methodology to produce mutant NP proteins in an attempt to 
identify those regions of the protein responsible for its nuclear 
accumulation.
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1 . Introduction
The previous section described the nuclear accumulation of NP in Xenopus 
oocytes following its introduction into the oocytes as the protein 
itself or encoded in RNA or DNA. This accumulation appears to be a 
property of the protein itself, and since it occurs without any 
detectable modification of the protein it is likely to be controlled by 
a signal within the mature protein. This is the karyophilic signal (De 
Robertis e£ a_l., 1978). To establish the location of this signal I have 
used recombinant DNA methodology to delete various regions of the NP 
gene in pTKNP and then determined the location of the mutant NP proteins 
after injection of the deleted plasmids into Xenopus oocytes. This 
approach has previously been used successfully to locate other topogenic 
sequences (see 'General Introduction').
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2. Results
a ) Proteins lacking the carboxyl terminus of NP
Plasmids were constructed in which varying amounts of the region 
encoding the carboxyl terminus of NP was removed from pTKNP (see 
'Methods B' and Table 14). After injection into oocytes each plasmid 
directed the synthesis of a protein of the predicted MW by SDS-PAGE 
(Figure 69). Several oocytes were enucleated and the isolated nuclear 
and cytoplasmic fractions immunoprecipitated with anti-NP antibody prior 
to analysis by SDS-PAGE (Figure 70). The concentration of the mutant NP 
proteins in each cellular compartment was determined and the resulting 
nuclear to cytoplasmic concentration ratios are summarised in Figure 71.
All of the proteins entered the nucleus, but only those containing the 
first 345 amino acids of the wild-type NP accumulated there; smaller 
proteins became evenly distributed between this compartment and the 
cytoplasm. One could argue that the reduced nuclear accumulation of the 
protein encoded by pTKNP Hind 1348 and the lack of accumulation of the 
smaller proteins is due either to a preferential degradation of these 
proteins in the nucleus or a decrease in their rates of nuclear entry. 
Both possibilities were investigated by performing a 48 h unlabelled 
chase on these oocytes after radiolabe1 ling (Figure 72). The nuclear to 
cytoplasmic concentration ratios for these chased oocytes are shown in 
Table 15. Since there was no appreciable change in any of the ratios or 
In the total radioactivity incorporated into the mutant NPs it seems 
that the impairment of nuclear accumulation was due to the removal of 
all or part of a signal sequence necessary for such accumulation. These 
data also indicate that the mutant NP proteins had reached equilibrium
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Table 14 Sequence and MW of mutant NP proteins encoded by 
plasmids lacking various amounts of the carboxyl 
terminus of the NP gene
Plasmid Sequence at carboxyl terminus Molecular weight
129 130
pTKNP Pvu 705 A T E L A D end 15,450
GCA ACA GAG CTT GCT GAT TGA
231 232
pTKNP P vu 1011 Q T E L A D end 26,983
CAA ACA GAG CTT GCT GAT TGA
311 312
pTKNP Acc 1250 Q V end 35,212
CAA GTA TAG
326 327
pTKNP Pvu 1295 S Q S L L I D end 37,487
AGT CAG AGC TTG CTG ATT GAT TGA
344 345
pTKNP Hind 1345 L S L L I D end 39,405
TAA AGC TTG CTG ATT GAT TGA
385 386
pTKNP Hae 1474 Y W E L A D end 44,029
TAC TGG GAG CTT GCT GAT TGA
4 96 497 498
pTKNP Y 0 N end 55,890
TAC GAC AAT TAA
Amino acids are indicated by the single-letter code shown above the DNA
sequence. The number indicates the position of the amino acid in the 
wild-type NP, the amino acids without numbers being encoded by the stop
region.
Figure 69
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Synthesis of mutant NP proteins in oocytes injected with 
plasmids Lacking various regions of the carboxyl terminus 
of the NP gene
i
After injection and radio labelling the oocytes were homogenised and 
analysed by SDS-PAGE. The equivalent of one oocyte was loaded per 
track. Track M contains ^S-methionine-labelled lysate from CEF cells 
infected with FP/R virus as marker.
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Figure 69 Synthesis of mutant NP proteins in oocytes injected with 
plasmids lacking various regions of the carboxyl terminus 
of the NP gene
After injection and radiolabe11ing the oocytes were homogenised and 
analysed by SDS-PAGE. The equivalent of one oocyte was loaded per 
track. Track M contains ^S-methionine-labelled lysate from CEF cells
infected with FP/R virus as marker.
Figure 70 The nuclear association of mutant NP proteins lacking the 
carboxyl terminus of wild-type NP
Oocytes injected with the various plasmids were enucleated and the 
isolated nuclear and cytoplasmic fractions immunoprecipitated with anti 
NP antibody prior to SDS-PAGE. The equivalent of one nucleus (N) and 
one cytoplasm (C) was loaded per track.
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Figure 70 The nuclear association of mutant NP proteins lacking the 
carboxyl terminus of wild-type NP
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Oocytes injected with the various plasmids were enucleated and the 
isolated nuclear and cytoplasmic fractions immunoprecipitated with anti- 
NP antibody prior to SDS-PAGE. The equivalent of one nucleus (N) and 
one cytoplasm (C) was loaded per track.
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Figure 71 Nuclear to cytoplasmic concentration ratios of mutant NP 
proteins lacking the carboxyl terminus of wild-type NP
The thin line represents the region missing from the wild-type NP. The 
numbers refer to the positions of the terminal amino acids in NP. For 
convenience the amino acids encoded by the stop region are omitted.
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Figure 72 SDS-PAGE analysis of chased and unchased oocytes injected 
with plasmids lacking various amounts of the carboxyl 
terminus of the NP gene
After injection and radiolabe11ing half of the oocytes in each sample 
were enucleated while the remainder were incubated in unlabelled medium 
for 48 h prior to enucleation. The isolated nuclear (N) and cytoplasmic 
(C) fractions were immunoprecipitated with anti-NP antibody and analysed 
by SDS-PAGE. The equivalent of one nucleus and one cytoplasm was loaded 
per track. In each case sample A was obtained from the unchased oocytes 
while sample B was obtained from the chased oocytes.
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Figure 72 SDS-PAGE analysis of chased and unchased oocytes injected 
with plasmids lacking various amounts of the carboxyl 
terminus of the NP gene
After injection and radiolabe1 Ling half of the oocytes in each sample 
were enucleated while the remainder were incubated in unlabelled medium 
for 48 h prior to enucleation. The isolated nuclear (N) and cytoplasmic 
(C) fractions were iramunoprecipitated with anti-NP antibody and analysed 
by SDS-PAGE. The equivalent of one nucleus and one cytoplasm was loaded 
per track. In each case sample A was obtained from the unchased oocytes 
while sample B was obtained from the chased oocytes.
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The nuclear to cytoplasmic concentration ratios for unchased 
and chased oocytes injected with plasmids lacking various 
amounts of the carboxyl terminus of the NP gene
Plasmid Nuclear to cytoplasmic concentration ratio
Unchased Chased
pTKNP 8.27 8.41
pTKNP Hae 1474 8.82 9.12
pTKNP Hind 1348 3.77 4.10
pTKNP Pvu 1295 1.02 1.09
pTKNP Acc 1250 1.29 1.02
pTKNP Pvu 1011 0.92 1.11
pTKNP Pvu 705 0.98 1.08
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b ) Proteins lacking internal regions of NP
Plasmids were constructed in which regions were removed from within the 
NP coding sequence of pTKNP (see 'Methods B'). The predicted sequences 
of the mutant NPs are summarised in Table 16. After injection into 
oocytes each plasmid directed the synthesis of a protein of the 
predicted MW by SDS-PAGE (Figure 73). Several oocytes were enucleated 
and the isolated nuclear and cytoplasmic fractions immunoprecipitated 
with anti-NP antibody prior to analysis by SDS-PAGE (Figure 74). The 
nuclear to cytoplasmic concentration ratios of these proteins are 
summarised in Figure 75. All the mutant proteins accumulated in the 
nucleus, but the mutant lacking amino acids 255 to ¿39 did so to a much 
lesser extent than the others.
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Table 16 Sequence and MW of mutant NP proteins encoded by plasmids 
lacking sequences from within the NP gene
Plasmid Sequence aC 
ligation point
Molecular weight
86 87 160 161
pTKNP Bam 577/793 G K D P 47,512
GGG AAG GAT CCC
129 130 233 234
pTKNP Pvu 705/1011 A T A A 44,357
GCA ACA GCT GCA
253 254 340 341
pTKNP Bgl 1078/1333 I E D L 46,630
ATC GAA GAT CTA
1 2 328 329
pTKNP Imp 1295 M A L V 19,164
ATG GCG CTG GTG
Amino acids are indicated by the single-letter code shown above the DNA 
sequence. The number indicates the positions of the amino acid in the 
wild-type NP.
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Figure 73 Synthesis of mutant NP proteins in oocytes injected with 
plasmids lacking sequences from within the NP gene
After injection and radiolabelling the oocytes were homogenised and 
analysed by SDS-PAGE. The equivalent of one oocyte was loaded per 
track. Track M contains 35S-methionine-labelled lysate from CEF cells 
infected with FP/R virus as marker.
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Figure 73 Synthesis of mutant NP proteins in oocytes injected with 
plasmids lacking sequences from within the NP gene
After injection and radiolabe11ing the oocytes were homogenised and 
analysed by SDS—PAGE. The equivalent of one oocyte was loaded per 
track. Track M contains 35S-methionine-labelled lysate from CEF cells 
infected with FP/R virus as marker.
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Figure 74 The nuclear association of mutant NP proteins lacking 
internal regions of wild-type NP
Oocytes injected with the various plasmids were enucleated and the 
isolated nuclear and cytoplasmic fractions immunoprecipitated with anti- 
NP antibody prior to SDS-PAGE. The equivalent of one nucleus (N) and 
one cytoplasm (C) was loaded per track.
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Figure 74 The nuclear association of mutant NP proteins lacking 
internal regions of wild-type NP
Oocytes injected with the various plasmids were enucleated and the 
isolated nuclear and cytoplasmic fractions immunoprecipitated with 
NP antibody prior to SDS-PAGE. The equivalent of one nucleus (N) 
one cytoplasm (C) was loaded per track.
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Figure 75 Nuclear to cytoplasmic concentration ratios of mutant NP
proteins lacking internal regions of wild-type NP
The thin line represents the region missing from the wild-type NP. The 
numbers refer to the positions of the terminal amino acids in NP.
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c ) Proteins lacking the amino terminus of NP
Plasmids were constructed in which varying amounts of the region 
encoding the amino terminus of NP was removed from pTKNP (see 'Methods 
B‘ and Table 17). After injection of these plasmids into oocytes no NP- 
related proteins were detected even upon immunoprécipitation with anti- 
NP antibody.
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Table 17 Sequence and MW of mutant NP proteins encoded by plasmids
lacking various amounts of the amino terminus of the NP gene
Plasmid Sequence at Molecular weight
amino terminus
1 2
pTKNP M A 55,890
AAAATC ATG GCG
371 372
pTKNP Hind 1348C M D 14,262
GAAAAC ATG GAT
136 137
pTKNP Met 136 M M 40,407
ATCCAC ATG ATG
238 239
pTKNP Met 238 M M 28,856
AGGGCA ATG ATG
331 332
pTKNP Met 331/S M A 18,564
GTGTGG ATG GCA
331 332
pTKNP Met 331/L M A 18,564
GTGTGG ATG GCA
Amino acids are indicated by the single-letter code shown above the DNA 
sequence. The number indicates the position of the amino acid in the 
wild-type NP. The first methionine should act as the initiator in the
mutant NP proteins.
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3. Discussion
a ) Proteins lacking the amino terminus of NP
Two reasons can be envisaged for the lack of detectable protein products 
following the injection of plasmids lacking the amino terminus of the NP 
gene; either the products are unstable and are rapidly degraded by the 
oocytes or no proteins are produced or are produced at very low levels. 
Since the protein NP IMP 1295 was detected whereas no NP related protein 
was detected in oocytes injected with either pTKNP Met 331/S or pTKNP 
Met 331/L (which should direct the synthesis of a protein very similar 
to NP IMP 1295) it seems that the latter possibility is more likely.
The lack of transcriptional analysis means it is not possible to 
conclude whether or not the lack of detectable protein production is the 
result of inefficient transcription or inefficient translation.
However, since each mutant plasmid has a transcriptional promotor region 
identical to pTKNP it is more likely that the problem is one of 
inefficient translation. Indeed a similar deletion of a plasmid 
encoding a secretory protein does produce a transcript which is 
transported to the cytoplasm but is not translated (L. Tabe, unpublished 
data). Possible explanations as to why such transcripts may not be 
efficiently translated are revealed by the work of Marilyn Kozak. The 
analysis of sequences from over 200 eukaryotic mRNAs of both viral and 
cellular origin has enabled Kozak to identify several conserved (or 
semi-conserved) features of these transcripts (Kozak, 1981a, 1983, 
1984a).
2i ) Translation is initiated at the first AUG triplet
In vivo initiation of translation of cytoplasmic eukaryotic mRNAs occurs
Vexclusively at AUG codons although in heterologous vitro systems in 
which the ribosomes are derived from Jï. coli GUG has also been osÿrved 
to initiate translation (Raj Bhandary and Ghosh, 1969). This is in 
contrast to both prokaryotes where GUG (Wezenbeek and Schoenmakers, 
1979), UUG (Thach e^ al^ ., 1966; Mackie, 1981), AUU (Sacerdot et^  al., 
1982), AUA (Johnston and Roth, 1981) and ACG (Thach e_t al^ . , 1966) can 
also initiate translation and mammalian mitochondrial mRNAs where 
initiation of translation usually occurs at the triplets AUU and AUA 
(Bibb et al^ ., 1981; Montoya et^  a_l. , 1981).
In about 95% of eukaryotic mRNAs the initiation of translation occurs at 
the AUG triplet that is nearest to the 5' end of the transcript (Kozak, 
1981a, 1983, 1984a). This first AUG rule holds true for mRNAs with very 
long 5' leaders (Gallwitz e^ a K , 1981; Ingolia and Craig, 1981;
Derynck e_t a_l. , 1982; Noda et a K  , 1982). In those cases where one or 
more AUG triplets occur upstream from the recognised or functional 
initiation codon (see, for example, Hendy et^  a_l. , 1981; Clerx-van 
Haaster e£ a_l. , 1982; Yoo e£ a K , 1982) the upstream AUGs are called
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'non-functional' since there is^yet no evidence that ribosomes recognise 
these sites. Theory however (see below) predicts that ribosomes should 
initiate at the upstream AUG triplets as well as at the AUG triplet that 
heads the long open reading frame.
Circumstantial evidence (reviewed by Kozak, 1978, 1980,1981b, 1982B)
supports the hypothesis that 40S ribosomal subunits bind initially at,
or near, the 5' end of the mRNA and then migrate to the initiation
codon. In the earliest version of this 'scanning model' when the 40S 
subunit encountered the first AUG triplet a 60S subunit would attach and 
translation would begin. This would mean that initiation of translation 
would always occur at the 5'-proximal AUG. As mentioned above, however, 
there are examples of mRNAs where the functional AUG codon is not the 
first in the transcript. Inspection of the nucleotide sequences 
flanking the apparently non-functinal upstream AUG triplets led to a 
modified vesion of the scanning model (Kozak, 1981b). The current 
hypothesis is that the 40S ribosomal subunits bind at the 5' end of the 
mRNA and migrate inwards as before but the efficiency with which an AUG 
triplet is recognised depends on the sequence around the AUG (this is 
discussed in more detail below). According to the modified scanning 
model, if the first AUG triplet occurs in the optimal sequence context 
40S subunits will initiate uniquely at that site; however, if the first 
AUG triplet occurs in a less favourable context some 40S subunits will 
stop and initiate there, whereas some will bypass that site and initiate 
farther downstream. It is therefore possible for a single eukaryotic 
mRNA to direct the synthesis of two proteins. Although a few such mRNAs 
have been identified (Table 18) they are rare and normally the 5'- 
proximal AUG triplet occurs in a favourable sequence context.
Since the 5'-proximal AUG is the first to be inspected most of the 
mutant NP plasmids were constructed so that the first AUG was in the 
correct reading frame, i.e. encoded an internal methionine in the wild—
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Table 18 Messenger RNAs which direct the synthesis of more than one 
protein
Simian virus 40 late 19S mRNAa 
Adenovirus Elb mRNA*5 
Bunyavirus s-RNA*3
Herpes simplex virus thymidine kinase 
pTKOV- mRNAd
Piatak e£ a_l., 1979 
Bos e£ a_l., 1981 
Bishop ££ a_l. , 1982 
raRNA0 Preston and McGeoch, 1981 
Tabe al^ . , 1984
a) The second protein is a shortened version of the first (VP2 and VP3)
b) The initiation codons are in different reading frames and two 
unrelated proteins are produced.
c) This is different to the situation which gave ovalbumin and an 
amino-termina1ly extended ovalbumin after injection of pTKOV into 
oocytes (see 'Results', Section III and Tabe e£ £l^ . , 1984).
d) see 'Results', Section III.
Ill
ii ) Distance from the 5' end of the transcript to the AUG initiation 
codon
The length of the untranslated sequence at the 5' end of eukaryotic 
mRNAs varies from 3 (Kelley et a_l. , 1982) to 742 (Kitamura et^  a_l., 1981) 
nucleotides. Exceptionally short and long leaders are rare and are 
usually confined to viral messengers (Lebowitz and Weissman, 1979; 
Kitamura e£ a_l. , 1981; Swanstrom et_ a_l. , 1982) or to the transcripts of 
unusually interesting cellular genes. Heat shock proteins, for example, 
have very long leader sequences (Holmgren et al., 1981; Ingolia and 
Craig, 1981) and this has invited a great deal of speculation about the 
possible role of the 5' non-coding region in the regulated expression of 
these genes. Most cellular mRNAs however have leader sequences of 
between 40 and 80 nucleotides (Kozak, 1982b).
From studies of the transcription of the HSV thymidine kinase promotor 
in Xenopus oocytes, when present with the complete thymidine kinase gene 
(McKnight and Gavis, 1980; McKnight £t^  a K , 1981) or as part of a 
plasmid (Krieg ££ al^ ., 1984) (see 'Results', Section III), it is 
possible to locate the site of initiation of transcription to 
nucleotides 195/196 in pTKNP (see Figure 58). Table 19 shows the number 
of nucleotides between the transcriptional initiation site and the first 
in phase ATG triplet in the plasmids lacking various regions of the 
amino terminus of the NP gene. There are no exceptionally short or long 
leader sequences and it is therefore unlikely that inefficient 
translation is due to the length of the 5' non-coding region.
Table 19 Length of the 5' non-coding sequence in the transcripts 
predicted from plasmids lacking various amounts of the 
amino terminus of the NP gene
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Plasmid Number of nucleotides from cap 
site to first in phase AUG
pTKNP 121
pTKNP Hind 1348C 138
pTKNP Met 136 78
pTKNP Met 238 78
pTKNP Met 331/S 73
pTKNP Met 331/L 119
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iii ) Initiator AUG codons occur in conserved sequence contexts 
Initiator AUG codons do not occur in random sequence environments. The 
most conspicuous conserved feature is the presence of a purine, most 
often an adenosine, in position -3, i.e. three nucleotides upstream from 
the initiator codon. As illustrated in Table 20, 7$% of the analysed 
mRNAs have A in that position, 18% have G and only 3% have a pyrimidine 
(Kozak, 1984a). This preference is not found around AUG triplets that 
code for methionine at internal positions in polypeptide chains (Table 
20). The direct demonstration of the importance of a purine at position 
-3 has been obtained using rn vitro binding experiments with various 
AUG-containing oligonucleotides (Kozak, 1981b) and, more recently, site 
directed mutagenesis of the AUG initiation codon in a cloned pre­
proinsulin gene (Kozak, 1984b). With the pre-proinsulin gene the 
replacement of a pyrimidine at position -3 with a guanosine caused a 
five-fold increase in the efficiency of translation while replacement 
with an adenosine caused a 15—fold increase. This effect has also been 
demonstrated indirectly by the insertion of AUG codons upstream of the 
functional initiation codon in a vector expressing the gene encoding the 
surface antigen of Hepatitis B virus (Liu et al_., 1984). Taken together 
these results suggest that, with all other factors being equal, the 
efficiency of an AUG triplet to act as initiator for translation 
decreases in the order ANNAUG, GNNAUG, YNNAUG where Y is a pyrimidine 
and N is either a pyrimidine or a purine.
The relevant AUG triplets in the transcripts proposed from the various 
plasmids have the sequence contexts shown in Table 21. In three of the 
five mutants there is a pyrimidine at position -3 while in pTKNP Met 238 
there is a guanosine. It is therefore possible that initiation of
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Table 20 Sequence context around AUG triplets in eukaryotic mRNAs | 
(modified from Kozak, 1983) |
Percentage of mRNAs containing sequence as:
Sequence* Functional initiator codon* Internal AUG codon-*
ANNAUG 79 30
GNNAUG 18 35
YNNAUG 3  35
1) N indicates any nucleotide while Y indicates a pyrimidine.
2) From 180 mRNAs identified in Kozak, 1981b, 1982a.
3) From 24 mRNAs identified in Kozak, 1982a.
X
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Table 21 Sequence context around the first in phase AUG triplet in 
the transcripts predicted from plasmids lacking various 
amounts of the amino terminus of the NP gene
Plasmid Sequence around the first in 
phase AUG
pTKNP ANNAUG
pTKNP Hind 1348C ANNAUG*
pTKNP Met 136 CNNAUG
pTKNP Met 238 GNNAUG
pTKNP Met 331/S UNNAUG
pTKNP Met 331/L UNNAUG
This is preceeded by an upstream, out of phase, AUG triplet with the 
sequence context 5'-CNNAUG-31.
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translation does occur at these codons but does so at an efficiency that 
is too low to allow the detection of any product. The present 
hypothesis of the scanning model for the initiation of translation (see 
above) predicts that if the 5'-proximal AUG occurs in an unfavoured 
environment then initiation will also occur at the second AUG. In each 
case this second AUG occurs within two nucleotides of the first and it 
is possible that initiation at the second triplet is inhibited by the 
binding of ribosomes to the first. The third AUG triplet in each case 
has an adenosine in pso^ition -3 but is in the wrong reading frame.
The plasmid pTKNP Hind 1348C is different to the others in that the 
first in phase AUG triplet is preceeded by another AUG which is in the 
incorect reading frame. As described in 'Methods B' initiation of 
translation at this 5'-proximal AUG would produce a peptide containing 
13 amino acids (Figure 30). This upstream AUG has a pyrimidine at 
position -3 and so would be expected to initiate translation 
inefficiently. The lack of a detectable protein product initiated at 
the second AUG even though it has an adenosine at position -3 suggests 
that initiation at this triplet is also inefficient. The effect of an 
upstream non-functional AUG triplet on the efficiency of translation 
from a functional AUG is discussed in more detail by Liu et al^ . (1984).
Although no other position around the AUG initiation codon is as highly 
conserved as position -3, the distribution of nucleotides is markedly 
non-random in every position from -1 through to -6, and perhaps beyond 
(Kozak, 1981b, 1984a). This includes the presence of guanosine at 
position +4 and, less frequently, cytosine in positions -1, -2, -4 and 
-5. Since these positions are less conserved than position -3 and have
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not been directly demonstrated to contribute to the recognition of 
eukaryotic initiation sites I will not include them in this discussion.
It should be noted that sequences other than those discussed above seem 
to be involved in the recognition process. This was demonstrated by the 
insertion of AUG triplets uptream of the functional AUG vector 
expressing the surface antigen of Hepatitis B virus (Liu e£ a K , 1984). 
The insertion of a synthetic AUG with an adenosine at position -3 and a 
guanosine at position +4 decreased the level of translation from the 
functional AUG but the inhibition of translation was increased by the 
insertion of an 'authentic' AUG.
In the above discussion I have proposed a possible explanation for the 
lack of a detectable protein product from plasmids lacking the amino- 
terminal region of the NP gene. Although this explanation is feasible 
there is no direct evidence to support it.
b ) Nuclear association of the mutant NP proteins
Although all of the mutant NP proteins entered the oocyte nuclei and at 
least became evenly distributed between this compartment and the 
cytoplasm only some mutants accumulated there. Since the loss of 
nuclear accumulation was associated with the loss of amino acids 327 to 
345 of the wild-type NP it appears that the information necessary for 
the nuclear accumulation of this protein is contained wholly or partly 
within this region. By definition therefore this region contains the 
karyophilic signal itself or is responsible for maintaining the 
integrity of a signal region elsewhere in the protein. The amino-
A
2 8 4
terminal limit is set by the protein encoded by pTKNP IMP 1295 which 
basically contains amino acids 328 to 498, and accumulated in the 
nucleus to a similar extent to wild-type NP. The carboxyl-terminal 
limit is less well defined and based principally on the nuclear 
accumulation of the protein containing the first 345 amino acids of NP. 
However, the fact that this mutant accumulated to a lesser extent than 
the wild-type NP suggests it may not contain all of the karyophilic 
signal. These observations on the accumulation of different mutant NP 
proteins whose only common feature is the segment of amino acids 327 to 
345 argue against the indirect signalling role of this region described
above.
SECTION VI
THE NUCLEAR ASSOCIATION OF NP-GLOBIN
FUSION PROTEINS
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The above use of deletion mutants suggests that the information necesary 
for the nuclear accumulation of NP resides wholly or partly within the 
region from amino acids 327 to 340 since mutant proteins lacking this 
region have a reduced ability to accumulate in the nucleus. This 
strategy, however, suffers from the criticism that the removal of large 
regions of the NP may cause gross changes in its conformation which 
could impair nuclear accumulation. The presence of a karyophilic signal 
in a region of the NP can be tested positively by constructing fusion 
proteins containing various regions of the NP and a protein which 
ordinarily does not accumulate in nuclei. Accumulation in the nucleus 
of the fusion product would then indicate that the NP region present in 
the fusion protein contained the information necessary for this process. 
The same strategy has been used to study signal sequences in prokaryotes 
(Silhavy et al^ . , 1977; Bedoulle e£ al^ ., 1980; Emr e_t al^ . , 1980), in in 
vitro systems (Lingappa e_t a_l. , 1984) and in eukaryotes (Tabe e^ al. ,
1984).
An important consideration in such experiments is the choice of protein 
to be used in the fusion. Globins are ideal candidates since they 
exhibit no affinity for membranes either j^ n vitro (Meek et al., 1982) or 
in vivo in Xenopus oocytes (Zehavi-Wi1lner and Lane, 1977), and have
recentLy been used successfully in fusions involving secretory proteins 
(Lingappa e£ a_l. , 1984; Tabe e_t a_l . , 1984).
1. Introduction
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The plasmid pTKG contains the full length cDNA of chimpanzee a^-globin 
under the control of the eukaryotic expression elements in the vector 
pTK£ (see 'Methods B' ). Upon injection into oocytes this plasmid 
directed the synthesis of a protein of approximately 12,500 daltons 
which was precipitated by anti-globin antibody and was not detected in 
the nucleus (Figure 76).
Four plasmids were constructed in which the globin cDNA was fused to 
various amino-terminal regions of the NP cDNA (see'Methods B). The 
sequence and MUs of proteins predicted from these plasmids are 
summarised in Table 22, and after injection into oocytes such proteins 
were produced. Injected oocytes were immunoprecipitated with anti- 
globin antibody while the isolated nuclear and cytoplasmic fractions 
were immunoprecipitated with anti-NP antibody prior to analysis by SDS- 
PAGE (Figure 76). Each protein was precipitated by both antibodies.
The concentration of the proteins in each cellular compartment was 
determined and used to calculate the nuclear to cytoplasmic 
concentration ratios which are summarised in Figure 77. Although all 
the fusion proteins entered the oocyte nucleus only the protein produced 
from pTKNPG accumulated there.
2. Results
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Table 22 Properties of the NP-globin fusion proteins
Plasmid Sequence at fusion point Molecular weight
129 130 1 2
A T G G S M V
pTKNP130G GCA ACA GGG GGA TCC ATG GTG 27,,700
NP Globin
231 232 1 2
Q T G G S M V
p TKNP232G CCA ACA GGG GGA TCC ATG GTG 39,,200
NP Globin
311 312 1 2
Q V W G S M V
pTKNP312G CAA GTA TGG GGA TCC ATG GTG 48,,000
NP Globin
pTKNPG Not known 65,,000
The NP and globin sequences at the fusion joints are underlined and 
labelled. The DNA that is not underlined is from M13 mplO. Amino acids 
are indicated by the single-letter code while the number above an amino 
acid indicates its position in the respective wild-type protein.
Although not known precisely it has been estimated that pTKNPG has the 
first 460 amino acids of NP. The molecular weights were calculated 
using the known amino acid compositions of the NP and linker regions and 
a value of 12,500 daltons for the globin region which was estimated from 
the migration of the protein produced in pTKG-injected oocytes.
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Figure 76 Injection into oocytes of plasmids encoding the 
NP-globin fusion proteins
Total (T), cytoplasmic (C) and nuclear (N) fractions were obtained after 
injecting oocytes with plasmids encoding a^-globin and NP-globin fusion 
proteins. The fractions of the oocytes injected with pTKG were 
immunoprecipitated with anti—globin antibodies (section A). For oocytes 
injected with plasmids encoding the NP-globin fusion proteins the 
cytoplasmic and nuclear fractions were immunoprecipitated with anti—NP 
antibody while the total oocyte fraction was immunoprecipitated with 
anti-globin antibody (section B). The equivalent of one oocyte or one 
oocyte fraction was loaded per track.
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pTKNP 130 G 
pTKNP 232 G 
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Figure 77 Nuclear to cytoplasmic concentration ratios of the 
NP-globin fusion proteins
The solid box represents the NP region of the fusion protein and the 
open box the globin region. The numbers refer to the positions of the 
terminal amino acids in the wild-type NP. For convenience the amino 
acids encoded by the linker region are omitted.
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The nuclear associations of the four NP-globin fusion proteins mimicked 
those of the NP fragments they contained (see Figure 78). The fusion 
protein containing amino acids 327 to 345 of NP attained a nuclear to 
cytoplasmic ratio of approximately 8 while the fusions lacking this 
region became evenly distributed between the cytoplasm and the nucleus. 
This localisation of the NP karyophilic signal to amino acids 327 to 345 
utilises previous results with the NP deletion mutants since from the 
use of fusion proteins alone it can only be concluded that this signal 
resides in the region from amino acids 312 to 460. A more stringent 
testing of this proposed location would be to construct fusion proteins 
containing fragments of NP which more closely delineate the 327 to 345 
amino acid region, and ultimately to construct a fusion protein 
containing all of the globin sequence and only amino acids 327 to 345 of 
NP. A lack of time prevented this further analysis.
Globin could not be detected in oocyte nuclei, but when fused to the 
first 130 amino acids of NP the resulting fusion protein was capable of 
entering the nucleus and became evenly distributed between this 
compartment and the cytoplasm. This could mean that the first 130 amino 
acids of NP contains all the information necessary for rrtinrt into 
the nucleus (see 'General Discussion').
3. Discussion
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Figure 78 Nuclear to cytoplasmic concentration ratios of the 
NP-globin fusion proteins and the relevant mutant 
NP proteins
The solid box represents the NP region and the open box the globin 
region. The numbers refer to the positions of the terminal amino acids 
in the wild-type proteins. For convenience the amino acids encoded by 
the stop region and the linker regions are omitted. The plasmid 
encoding the first 460 amino acids of NP (pTKNPMG) was a biproduct of 
the construction of pTKNPG (see 'Methods B'). Both plasmids give the 
same pattern of restriction enzyme digestion but in pTKNPMG the NP and 
globin encoding regions are in different reading frames. After 
injection into oocytes pTKNPMG directed the synthesis of a protein of 
52,000 daltons which was precipitated by anti-NP antibody, but was not 
precipitated by anti-globin antibody (see Figure 79).
293
Figure 79 Nuclear accumulation of the protein encoded by the 
plasmid pTKNPMG
Oocytes injected with pTKNPMG were enucleated and the isolated nuclear 
(N) and cytoplasmic (C) fractions immunoprecipitated with anti-NP 
antibody prior to SDS-PAGE. Total oocytes (T) were immunoprecipiated 
with anti-globin antibody. The equivalent of one oocyte or one oocyte 
fraction was loaded per track. This result is included here rather than 
in the section describing results obtained using other amino-terminal 
fragments of NP since the sequence at the carboxyl terminus of the 
protein is not known with any certainty.
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Figure 79 Nuclear accumulation of the protein encoded by the 
plasmid pTKNPMG
Oocytes injected with pTKNPMG were enucleated and the isolated nuclear 
(N) and cytoplasmic (C) fractions immunoprecipitated with anti-NP 
antibody prior to SDS—PAGE. Total oocytes (T ) were immunoprecipiated 
with anti-globin antibody. The equivalent of one oocyte or one oocyte 
fraction was loaded per track. This result is included here rather than 
in the section describing results obtained using other amino-terminal 
fragments of NP since the sequence at the carboxyl terminus of the
protein is not known with any certainty.
GENERAL DISCUSSION
This final discussion expands on some of the points raised during this 
thesis and discusses the relationship of this work to that of others.
1 . Current models for the nuclear accumulation of proteins
Two alternative models are commonly considered to explain the nuclear 
accumulation of certain proteins (Dingwall e£ al_., 1982; De Robertis, 
1983; Hall e_t a_l. , 1984). The first envisages the free diffusion of 
all proteins into the nucleus with the subsequent retention of nuclear 
proteins by their binding to non-diffusible nuclear elements, while the 
second suggests that the accumulation of nuclear proteins is due to 
their selective transport across the nuclear envelope. Since nuclear 
accumulation is selective and occurs post-translationally with no 
apparent modification of the proteins (Gurdon, 1970; Bonner, 1975a, 
1975b; De Robertis ££ al^ . , 1978; De Robertis and Black, 1981; 
Dabauvalle and Franke, 1982; Dingwall e_t al^ ., 1982) it has been 
proposed that nuclear proteins contain within their mature molecular 
structure a signal sequence (or other property such as conformation) 
which controls the ir accumula t ion (De Robertis e£ a_l. , 1978 ). In the 
first model this karyophilic signal would be responsible for the nuclear 
retention of the protein while in the second model its interaction with 
the nuclear envelope would allow selective transport of the protein into 
the nucleus. Experimental evidence however suggests that neither model 
is wholly correct. If all proteins entered nuclei by free diffusion 
then, assuming a functional nuclear pore radius of 45 A for the Xenopus 
oocyte nucleus (Paine et al., 1975) one would predict that, for these
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nuclei, proteins with a MW >70,000 would be excluded while proteins 
smaller than this would enter at rates which are dependent upon the size 
of the protein. Whereas non-nuclear proteins obey these rules after 
injection into Xenopus oocytes (Gurdon, 1970; Bonner, 1975a, 1975b), 
nuclear proteins do not. For instance, many are considerably larger 
than 70,000 daltons (De Robertis e£ a_l. , 1978; Mills et_ al_. , 1980; 
Feldherr e^ al^ . , 1983 ) and smaller proteins enter at rates which are 
faster than predicted (Gurdon, 1970; Bonner, 1975a, 1975b). Evidence 
against proteins accumulating by selective transport across the nuclear 
envelope is based on experiments which show that the puncture (Feldherr 
and Pomerantz, 1978; Feldherr and Ogburn, 1980) or removal (cited in De 
Robertis, 1983) of the nuclear envelope has little effect on the ability 
of the nucleus to accumulate the majority of nuclear proteins. On the 
basis of such previously published data and the results with influenza 
virus NP I propose a third model for the nuclear accumulation of 
proteins which combines certain aspects of both the previous models. I 
suggest that both selective (or more accurately mediated) transport and 
selective binding play a role in nuclear accumulation and that it is 
possible that these two activities are controlled by different regions 
of the protein.
2. Localisation of the NP karyophilic signal
Although all of the mutant NP proteins entered the oocyte nucleus and at 
least became equally distributed between this compartment and the 
cytoplasm only some mutants accumulated there. The loss of nuclear
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. . aChe wild-type NP suggesting that the inforiqfcion necessary for the
nuclear accumulation of this protein is contained wholly or partly
within this region. By definition therefore, this region contains the
karyophilic signal (De Robertis e_t al., 1978).
The results obtained with the NP-globin fusion proteins are consistent 
with this proposed location of the karyophilic signal since the fusion 
protein containing this region accumulated in the nucleus while those 
lacking this region did not accumulate but became evenly distributed 
between this compartment and the cytoplasm.
The identification of the NP karyophilic signal does not reveal how it 
controls the nuclear accumulation of this protein. It could act at the 
nuclear envelope by controlling a transport process which leads to 
accumulation or it could help to retain the protein in the nucleus after 
transport. By analogy to the majority of nuclear proteins, which 
accumulate in nuclei in the absence of the nuclear envelope, it could be 
suggested that the accumulation of NP is likely to result from its 
binding to a non-diffusible nuclear substrate.
•vaccumulation was associçed with the loss of amino acids 327 to 345 of
3. Sequence homologies between nuclear proteins
The amino acid sequence of wild-type NP from residues 325 to 350 is 
shown in Figure 80. Although there is no tract of basic residues 
similar to that which may be important in the nuclear accumulation of
V
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Figure 80 Amino acid sequence of wild-type NP from residues 
325 Co 350
325 330 335
Lys Ser Gin Leu Val Trp Met Ala Cys Asn Ser Ala Ala
+ H H H
340 345 350
Phe Glu Asp Leu Arg Val Leu Ser Phe lie Arg Gly Thr
H -  - H + H H H H +
Amino acids are indicted by the three-letter code and are shown as being 
basic ( + ), acidic (-) or hydrophobic (H). The number above the amino 
acid indicates its position in NP.
299
the SV40 large-T antigen (Kalderon e^ a^., 1984) there is a sequence 
similar to one within the proposed karyophilic signal-containing region 
of the yeast * 2 protein (Hall e£ a K  , 1984). The c<2 sequence has two 
basic amino acids flanking three hydrophobic residues while the NP 
sequence has two basic amino acids flanking five residues, four of which 
are hydrophobic. Whether these sequences have any importance in nuclear 
accumulation will only become evident after analysis of mutants altered 
in these residues. The ot2 sequence is also found in certain other 
yeast nuclear proteins (see Hall e£ ¿ K  , 1984) but its proposed 
involvement in the nuclear accumulation of at least one of these 
proteins, the yeast histone H2B, is difficult to reconcile with deletion 
analysis which shows that this region is unimportant to its in vivo 
function (Wallis et al., 1983 ).
When the protein sequences of the NP proteins of the influenza virus 
used in this study (A/NT/60/68; Huddleston and Brownlee, 1982), 
A/PR/8/34 (Winter and Fields, 1981) and B/Singapore/222/79 (Londo 
al., 1983) are aligned to satisfy the criteria of maximum amino acid 
homology, a highly conserved sequence within the proposed karyophilic 
signal-containing region is revealed (Figure 81). Although identical 
for the two type A NPs it may not be significant since they are highly 
conserved throughout their entire length. However, it represents the 
second most highly conserved stretch of 10 residues between type A and 
type B NPs differing only at residue 338 (phe-*-tyr), but retaining 
hydrophobicity. This is remarkable because type A and type B NPs not 
only differ in MW (56,000 and 61,600 respectively) but are antigenica1ly 
totally distinct; it could therefore reflect the need to retain a
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Figure 81 Comparison of the proposed karyophilic signal region 
of the NP of A/NT/60/68 with similar sequences from 
other influenza viruses
336 338 340 342 344
A/NT/60/68 Ala A la Phe Glu Asp Leu Arg Val Leu Ser
A/PR/8/34 Ala Ala Phe Glu Asp Leu Arg Val Leu Ser
B/Singapore/222/79 Ala Ala Tyr Glu Asp Leu Arg Val Leu Ser
392 394 396 398 400
Amino acids are indicated by the three-letter code. The number above 
the amino acid indicates its position in the type A virus NP while the 
number below the amino acid indicates its position in 
B/Singapore/222/79. Type A and type B sequences are aligned on the 
criteria of maximum homology (Londo e_t al., 1983).
r
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sequence necessary for a fundamental feature of the protein such as its 
accumulation in nuclei.
4. Transport of NP into oocyte nuclei
The injection of radiolabelled NP into the oocyte cytoplasm (see 
'Results', Section IV) suggests that the rate at which NP enters oocyte 
nuclei is faster than that predicted by free diffusion through a pore
Owith a permeant radius of 45 A (Bonner, 1978) and would be consistent
with transport by a mediated process as described for the Rana pipiens
nuclear protein RNI (Feldherr ££ a_l., 1983 ). Such mediated transport
a b i l i t y
could also explain the rapid entry nuclear proteins larger than
70,000 daltons to enter nuclei (Gurdon, 1970; Bonner, 1975a, 1975b; 
Dingwall et a_K, 1982). Since this mediated transport is limited to 
nuclear proteins it is likely to be controlled by some feature of the 
proteins themselves and one may expect this feature to be identified for 
NP by deletion analysis. However, the observation that all mutant NP 
proteins, even those which failed to accumulate there, entered the 
nucleus rapidly, cannot be used to suggest that the mutants retain a 
postulated 'rapid entry' feature for two reasons: firstly because their 
decreased size would be expected to increase the rate of entry anyway; 
and secondly because in large cells like Xenopus oocytes it is not clear 
if the average path length taken by an injected nuclear protein is 
similar to that taken by the same protein when it is expressed in 
oocytes via injected DNA. In this latter case it is possible that the 
encoding mRNA, and therefore translation, are concentrated around the
nucleus (D. Drummond and A. Colman, unpublished daca).
The data obtained with the NP—globin fusion proteins may reveal the 
presence of a third 'nuclear' signal. Although one may predict that a 
protein with a MW of 12,500 should rapidly cross the nuclear envelope, 
globin, expressed from the plasmid pTKG, remained in the oocyte 
cytoplasm. This is not unique since many proteins of a similar size 
have recently been reported to be present in only the cytoplasm of 
Xenopus oocytes and HeLa cells (Dabauvalle and Franke, 1984). Although 
these other proteins exist in the cytoplasm in a soluble form 
(Dabauvalle and Franke, 1984), it is not known if the same is true for 
globin and it is possible that the globin is prevented from entering the 
oocyte nucleus by being assembled into, or associated with, large 
particles. When globin was fused to the first 130 amino acids of NP the 
resulting fusion protein entered the nucleus and became evenly 
distributed between this compartment and the cytoplasm. This could 
indicate that the first 130 amino acids of NP contain information that 
controls the entry of proteins into nuclei. Another possibility, 
however, is that the addition of these amino acids destroys those 
features of the globin which control its karyophobic behaviour and the 
resulting fusion protein merely diffuses through the nuclear pores. It 
is not possible to distinguish between these possibilities.
The situation regarding the use of globin fusion proteins to study 
nuclear entry is therefore different to their use in the study of 
nuclear accumulation (see above) and protein segregation into 
intracellular membranes (Tabe et a 1. , 1984). In the latter two cases a
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specific signal is necessary for the observed effect whereas, since the 
majority of small particles and proteins are capable of entering nuclei 
(see 'General Introduction'), it could be argued that no similar signal 
is required for transport into the nucleus. If such a signal exists, 
however, it would appear to be located in the first 130 amino acids of 
NP.
5. Identification of karyophilic signals
In the light of the hypothesis that the mediated entry of proteins into 
nuclei and nuclear accumulation are different phenomena encoded in 
different regions of the proteins, it is instructive to review recent 
attempts to identify karyophilic signals in other proteins, viz. Xenopus 
nucleoplasmin, oc2 protein of yeast, SV40 large-T antigen and Xenopus 
histone HI.
Selective proteolysis cleaved nucleoplasmin into two fragments (Dingwall 
et al., 1982) of which only the smaller retained the ability to rapidly 
migrate into and accumulate in nuclei, the large fragment remaining in 
whichever cellular compartment it was micro injected. Since the MW of 
the latter is greater than 70,000 its inability to be transported across 
the nuclear envelope could indicate that it has lost the information 
necessary for mediated transport whi.le the nuclgjr accumulation of the 
small fragment suggests that it not only contains this information but 
also the information for nuclear accumulation.
A recent study using yeast cells in which varying amounts of the yeast 
protein »-2 were fused to a constant portion of the Escherichia coli 
,3-galactosidase (Hall et al^., 1984) is complicated by discrepancies 
resulting from different methods of analysis and the observation that 
&  -galactosidase itself is capable of entering culture cell nuclei (A.
E. Smith, personal communication). Nuclear accumulation of the hybrid 
proteins required the first 67 amino acids of <x2, and results with 
hybrids containing less than this were consistent with their retention 
in the nuclear envelope. Unfortunately, the use of indirect detection 
methods such as enzyme assays and immunofluorescence does not rule out 
the possibility that the results are due to preferential degradation of 
the proteins in one of the cellular compartments. Such differential 
stability of proteins is a well documented phenomenon both in oocytes 
(Lane e£ al^ ., 1979; Colman e£ al.. , 1981) and tissue culture cells 
(Capecchi e_t a_l., 1974; McGarry e_t al^ . , 1983 ) and its effect on the 
apparent distribution of proteins between the cytoplasm and the nucleus 
has been discussed in detail by Yamaizumi e_t al^ . (1978) and Dingwall and 
Allan (1984).
A similar criticism can be raised against the studies involving the SV40 
large-T antigen (Kalderon e_t a_l. , 1984) where the cellular location was 
determined by immunofluorescence. The mutation of a particularly basic 
tract of residues in this protein resulted in either a reduced nuclear 
accumulation or the loss of ability to enter nuclei which may indicate 
that the mutated region is involved in the entry of the protein into 
nuclei rather than in its accumulation. The fact that mutant proteins 
which showed reduced accumulation also varied in the extent to which
they accumulated in nuclei of different clona1ly-derived sibling cells 
could support this interpretation. Absence of kinetic data prevents the 
distinction between the two possibilities.
Proteolytic fragmentation of histone HI has located a karyophilic signal 
in the carboxyl-terminal domain of this protein (Dingwall and Allan, 
1984). Fragments from other domains also entered the oocyte nucleus but 
as these were more unstable in the cytoplasm they give only a false 
impression of nuclear accumulation. The small size of all the fragments 
makes it difficult to determine whether or not their rates of nuclear 
entry are in any way mediated by interaction at the nuclear envelope. 
Hence like the NP data described above, it is not possible to identify 
which region of the protein is responsible for its rapid entry into 
nuclei (Bonner, 1975b).
6. The use of Xenopus oocytes as a surrogate system for nuclear 
transport
One major concern when using a heterologous system of the type exploited 
for these studies is that any data obtained may only reflect the system 
used and have no general relevance. Thus the importance of amino acids 
327 to 345 of the influenza virus NP in the nuclear accumulation of this 
protein may be an oocyte-specific phenomenon. Since the micro injection 
of nucleic acids and proteins into cultured cells is now routine in many 
laboratories this possibility can be investigated.
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Although it is often argued, perhaps wrongly, that tissue culture cells 
more closely resemble a 'true' eukaryotic system, I believe that there 
are many reasons why Xenopus oocytes will continue to be of use as a 
surrogate system. Firstly, for reasons mentioned above, it is always an 
advantage to employ more than one surrogate system. Secondly, the ease 
and speed with which results can be produced using the oocyte should 
favour its use as a supplementary system or as a testing ground for new 
investigations. The oocyte is capable of correctly modifying and 
segregating many proteins after translation following the injection of 
mRNA or DNA encoding the protein (see 'General Introduction') and the 
efficiency of protein synthesis is often sufficiently high to preclude 
the use of indirect detection methods which can cause problems in 
interpretation. Finally, and probably most importantly from the point 
of view of studies on nuclear accumulation, the large size of the oocyte 
nucleus (approximately 0.3mm in diameter) allows its rapid manual 
isolation.
7 . Conelusion
I suggest that the nuclear accumulation of proteins may require two 
signals: the first allowing the protein to enter nuclei at a rate
faster than that predicted from its size, and the second allowing its 
nuclear accumulation. It is this second signal which we have identified
in the influenza virus NP.
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